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Abstract	  	   Cdc48/p97	  is	  an	  essential,	  highly	  abundant	  hexameric	  member	  of	  the	  AAA	  (ATPase	  associated	  with	  various	  cellular	  activities)	  family.	  It	  has	  been	  linked	  to	  a	  variety	  of	  processes	  throughout	  the	  cell	  but	  it	  is	  best	  known	  for	  its	  role	  in	  the	  ubiquitin	  proteasome	  pathway.	  In	  this	  system	  it	  is	  believed	  that	  Cdc48	  behaves	  as	  a	  segregase,	  transducing	  the	  chemical	  energy	  of	  ATP	  hydrolysis	  into	  mechanical	  force	  to	  separate	  ubiquitin-­‐conjugated	  proteins	  from	  their	  tightly-­‐bound	  partners.	  	  	  	   Current	  models	  posit	  that	  Cdc48	  is	  linked	  to	  its	  substrates	  through	  a	  variety	  of	  adaptor	  proteins,	  including	  a	  family	  of	  seven	  proteins	  (13	  in	  humans)	  that	  contain	  a	  Cdc48-­‐binding	  UBX	  domain.	  As	  such,	  due	  to	  the	  complexity	  of	  the	  network	  of	  adaptor	  proteins	  for	  which	  it	  serves	  as	  the	  hub,	  Cdc48/p97	  has	  the	  potential	  to	  exert	  a	  profound	  influence	  on	  the	  ubiquitin	  proteasome	  pathway.	  However,	  the	  number	  of	  known	  substrates	  of	  Cdc48/p97	  remains	  relatively	  small,	  and	  smaller	  still	  is	  the	  number	  of	  substrates	  that	  have	  been	  linked	  to	  a	  specific	  UBX	  domain	  protein.	  As	  such,	  the	  goal	  of	  this	  dissertation	  research	  has	  been	  to	  discover	  new	  substrates	  and	  better	  understand	  the	  functions	  of	  the	  Cdc48	  network.	  With	  this	  objective	  in	  mind,	  we	  established	  a	  proteomic	  screen	  to	  assemble	  a	  catalog	  of	  candidate	  substrate/targets	  of	  the	  Ubx	  adaptor	  system.	  	  	  	   Here	  we	  describe	  the	  implementation	  and	  optimization	  of	  a	  cutting-­‐edge	  quantitative	  mass	  spectrometry	  method	  to	  measure	  relative	  changes	  in	  the	  
Saccharomyces	  cerevisiae	  proteome.	  Utilizing	  this	  technology,	  and	  in	  order	  to	  better	  understand	  the	  breadth	  of	  function	  of	  Cdc48	  and	  its	  adaptors,	  we	  then	  performed	  a	  global	  screen	  to	  identify	  accumulating	  ubiquitin	  conjugates	  in	  cdc48-­3	  and	  ubxΔ	  
	   vi	  mutants.	  In	  this	  screen	  different	  ubx	  mutants	  exhibited	  reproducible	  patterns	  of	  conjugate	  accumulation	  that	  differed	  greatly	  from	  each	  other,	  pointing	  to	  various	  unexpected	  functional	  specializations	  of	  the	  individual	  Ubx	  proteins.	  	   As	  validation	  of	  our	  mass	  spectrometry	  findings,	  we	  then	  examined	  in	  detail	  the	  endoplasmic-­‐reticulum	  bound	  transcription	  factor	  Spt23,	  which	  we	  identified	  as	  a	  putative	  Ubx2	  substrate.	  In	  these	  studies	  ubx2Δ	  cells	  were	  deficient	  in	  processing	  of	  Spt23	  to	  its	  active	  p90	  form,	  and	  in	  localizing	  p90	  to	  the	  nucleus.	  Additionally,	  consistent	  with	  reduced	  processing	  of	  Spt23,	  ubx2Δ	  cells	  demonstrated	  a	  defect	  in	  expression	  of	  their	  target	  gene	  OLE1,	  a	  fatty	  acid	  desaturase.	  Overall,	  this	  work	  demonstrates	  the	  power	  of	  proteomics	  as	  a	  tool	  to	  identify	  new	  targets	  of	  various	  pathways	  and	  reveals	  Ubx2	  as	  a	  key	  regulator	  lipid	  membrane	  biosynthesis.	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The	  Ubiquitin	  Proteasome	  System	  	   The	  ubiquitin	  proteasome	  system	  (UPS)	  is	  a	  critical	  pathway	  found	  in	  eukaryotes	  that	  regulates	  various	  processes	  throughout	  the	  cell.	  By	  targeting	  different	  proteins	  for	  degradation	  to	  the	  proteasome,	  a	  large	  ATP-­‐dependent	  protease	  complex,	  the	  UPS	  maintains	  cellular	  homeostasis	  and	  controls	  many	  cellular	  responses.	  The	  system	  gives	  directionality	  to	  pathways	  via	  the	  quick	  degradation	  of	  regulatory	  elements	  and	  degrades	  damaged	  and	  misfolded	  proteins	  in	  the	  cell.	  The	  UPS	  participates	  in	  a	  large	  array	  of	  events	  such	  as	  transcriptional	  regulation,	  signal	  transduction,	  and	  the	  cell	  cycle[1].	  Impaired	  UPS	  activity	  has	  been	  found	  to	  play	  a	  role	  in	  neurodegenerative	  diseases,	  such	  as	  Parkinson’s[2,	  3]	  and	  Alzheimer’s[4],	  and	  multiple	  cancers.	  Additionally,	  proteasomal	  activity	  has	  been	  implicated	  in	  immune	  response	  and	  development[1].	  Furthermore,	  due	  to	  this	  system’s	  intricate	  role	  in	  the	  cell,	  it	  has	  been	  the	  focus	  of	  many	  therapeutic	  investigations[1].	  	   In	  terms	  of	  process,	  ubiquitin,	  a	  small	  conserved	  76	  amino	  acid	  protein,	  is	  covalently	  attached	  to	  substrates	  via	  an	  enzymatic	  cascade	  involving	  three	  enzymes	  known	  as	  E1s,	  E2s,	  and	  E3s.	  In	  the	  first	  step	  of	  the	  reaction,	  the	  ubiquitin-­‐activating	  enzyme	  E1	  activates	  free	  ubiquitin	  by	  forming	  a	  thioster	  bond.	  The	  activated	  ubiquitin,	  in	  another	  similar	  reaction,	  is	  then	  transferred	  to	  a	  cysteine	  residue	  of	  the	  E2	  ubiquitin-­‐conjugating	  enzyme.	  In	  a	  final	  step,	  ubiquitin	  is	  attached	  to	  a	  specific	  substrate	  via	  an	  isopeptide	  bond	  at	  the	  C-­‐terminal	  glycine	  of	  ubiquitin	  and	  a	  lysine	  residue	  on	  the	  substrate	  protein.	  This	  final	  reaction	  is	  mediated	  by	  the	  E3	  ubiquitin	  ligase	  enzyme.	  The	  E1	  enzyme	  is	  encoded	  by	  a	  single	  gene,	  Uba1,	  in	  all	  
	  	  
3	  eukaryotes[5].	  However	  there	  are	  a	  large	  variety	  of	  E2	  and	  E3	  enzymes.	  These	  different	  E2s	  and	  E3s	  act	  on	  specific	  substrates	  allowing	  for	  the	  targeting	  of	  proteins	  to	  the	  proteasome	  in	  a	  very	  regulated	  and	  specific	  manner[6-­‐8]	  (Figure	  1.1).	  	  
	  	  
Figure	  1.1	  Modification	  of	  a	  protein	  by	  ubiquitin	  occurs	  via	  a	  three-­‐enzyme	  cascade.	  Ubiquitin	  is	  activated	  by	  covalent	  attachment	  to	  an	  E1	  enzyme,	  the	  ubiquitin-­‐activating	  enzyme,	  which	  couples	  ATP	  hydrolysis	  to	  the	  formation	  of	  a	  thioester	  bond	  between	  itself	  and	  the	  ubiquitin	  molecule.	  Following	  activation,	  ubiquitin	  is	  transferred	  to	  an	  E2,	  an	  ubiquitin-­‐conjugating	  enzyme.	  Lastly	  the	  E3	  enzyme,	  an	  ubiquitin	  ligase,	  facilitates	  the	  transfer	  of	  ubiquitin	  from	  the	  E2	  to	  the	  target	  protein.	  The	  target	  protein	  can	  either	  be	  left	  monoubiquitinated,	  or	  the	  cycle	  can	  be	  repeated	  with	  the	  protein	  modified	  with	  ubiquitin	  at	  different	  lysine	  residues	  known	  as	  multi-­‐ubiquitination.	  Additionally	  the	  protein	  
	  	  
4	  can	  be	  poly-­‐ubiquitinated,	  with	  an	  ubiquitin	  chain	  building	  at	  the	  same	  lysine	  residue.	  Mono-­‐ubiquitination	  and	  multi-­‐ubiquitination	  are	  generally	  involved	  in	  protein	  regulation	  in	  a	  proteolysis-­‐independent	  manner.	  Most	  often	  poly-­‐ubiquitinated	  proteins	  are	  subsequently	  degraded	  by	  the	  26S	  proteasome.	  	  This	  cascade	  continues	  until	  a	  substrate	  has	  built	  a	  polyubiquitin	  chain.	  Polyubiquitin	  chains	  on	  substrates	  are	  formed	  via	  the	  sequential	  addition	  of	  ubiquitin	  molecules	  forming	  isopeptide	  linkages	  to	  one	  another[9].	  	  The	  ubiquitin	  molecule	  has	  multiple	  different	  lysines	  allowing	  for	  the	  formation	  of	  different	  combinations	  of	  ubiquitin	  chain	  linkages.	  Different	  chain	  linkages	  play	  a	  variety	  of	  roles	  in	  the	  cell.	  For	  instance,	  Lys-­‐48	  polyubiquitin	  linkages	  target	  substrates	  to	  the	  proteasome	  for	  degradation[7].	  A	  minimal	  tetra-­‐ubiquitin	  chain	  with	  Lys-­‐48	  linkages	  is	  believed	  to	  be	  required	  for	  proteasomal	  recognition.	  Other	  ubiquitin	  chain	  linkages	  such	  as	  Lys-­‐63	  and	  Lys-­‐29	  have	  been	  found	  to	  be	  involved	  in	  non-­‐proteasomal	  roles	  such	  as	  DNA-­‐damage	  repair,	  endocytosis,	  and	  intracellular	  trafficking[10].	  	  	  	  The	  function	  of	  other	  ubiquitin	  linkages	  such	  as	  Lys-­‐11,	  Lys-­‐27,	  and	  Lys-­‐33	  is	  not	  well	  understood.	  Additionally,	  proteins	  can	  be	  left	  mono-­‐ubiquitinated	  or	  multi-­‐ubiquitinated	  with	  ubiquitin	  modifications	  attached	  to	  different	  lysines	  on	  the	  protein.	  These	  types	  of	  modifications	  are	  also	  involved	  non-­‐proteolytic	  events.	  	  	  	  	  
The	  26S	  Proteasome	  	   The	  26S	  proteasome	  regulates	  most	  intracellular	  degradation.	  Proteins	  are	  delivered	  to	  the	  proteasome	  and	  proteolyzed	  into	  small	  peptides	  that	  can	  be	  
	  	  
5	  recycled	  to	  make	  new	  proteins.	  The	  proteasome	  is	  a	  large	  2.5	  mDa	  ATP-­‐dependent	  proteolytic	  complex,	  consisting	  of	  33	  unique	  protein	  subunits.	  The	  complex	  is	  composed	  of	  two	  main	  modules,	  a	  central	  catalytic	  core	  known	  as	  the	  20S	  and	  the	  19S	  regulatory	  cap	  subunit.	  The	  inside	  of	  the	  20S	  catalytic	  core	  is	  hollow,	  providing	  an	  enclosed	  cavity	  where	  proteins	  are	  degraded	  and	  the	  openings	  at	  the	  ends	  of	  the	  core	  allow	  for	  target	  proteins	  to	  enter.	  Each	  end	  of	  the	  catalytic	  core	  associates	  with	  a	  19S	  cap	  that	  has	  multiple	  ubiquitin	  binding	  sites	  to	  interact	  with	  substrates.	  The	  19S	  recognizes	  and	  unfolds	  polyubiquitinated	  substrates,	  allowing	  them	  to	  pass	  into	  the	  narrow	  pore	  of	  the	  catalytic	  core.	  	  	  	   In	  terms	  of	  makeup,	  the	  19S	  consists	  of	  two	  subcomplexes,	  a	  base	  that	  interacts	  with	  the	  20S,	  and	  a	  lid	  that	  recognizes	  ubiquitinated	  substrates.	  The	  19S	  lid	  is	  composed	  of	  11	  non-­‐ATPase	  subunits	  while	  the	  19S	  base	  is	  composed	  of	  two	  non-­‐ATPase	  subunits	  that	  act	  as	  scaffolding	  units	  and	  a	  heterohexameric	  ring	  of	  ATPase	  subunits	  that	  require	  energy	  for	  the	  unfolding	  of	  substrates[11-­‐13].	  The	  catalytic	  20S	  is	  made	  of	  a	  cylindrical	  core.	  It	  contains	  two	  inner	  hetero-­‐heptameric	  and	  two	  outer	  heteroheptameric	  rings[14].	  Subunits	  of	  these	  rings	  have	  various	  proteolytic	  activities	  (chymotrypsin,	  trypsin,	  and	  caspase-­‐like)	  with	  different	  cleavage	  preferences,	  in	  order	  to	  degrade	  substrates	  into	  small	  peptides[8](Figure	  1.2).	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Figure	  1.2	  The	  26S	  eukaryotic	  proteasome.	  A	  schematic	  representation	  of	  the	  proteasome	  which	  consists	  of	  the	  catalytic	  20S	  core	  and	  the	  19S	  regulatory	  particle.	  The	  19S	  can	  be	  further	  divided	  into	  the	  base	  (shown	  in	  green)	  and	  lid	  (shown	  in	  blue)	  subcomplexes.	  Rpn10	  is	  shown	  in	  yellow	  since	  it	  is	  known	  to	  be	  located	  at	  the	  base-­‐lid	  interface.	  	  
	  	  
7	  	   In	  order	  to	  undergo	  selective	  degradation,	  receptor	  proteins	  recognize	  ubiquitinated	  substrates	  and	  shuttle	  them	  to	  the	  proteasome.	  Rpn10	  was	  the	  first	  discovered	  proteasomal	  receptor,	  and	  was	  found	  to	  be	  necessary	  for	  the	  efficient	  delivery	  of	  ubiquitinated	  substrates	  at	  the	  proteasome.	  Rpn10	  is	  an	  intrinsic	  ubiquitin	  receptor	  of	  the	  proteasome	  and	  is	  believed	  to	  form	  a	  hinge	  between	  the	  19S	  and	  20S	  domains.	  It	  contains	  a	  UIM	  domain	  (ubiquitin-­‐interacting	  domain)	  that	  recognizes	  polyubiquitinated	  chains[15-­‐18].	  Interestingly,	  a	  Rpn10	  deletion	  strain	  did	  not	  display	  a	  phenotype	  indicative	  of	  a	  large-­‐scale	  deficiency	  in	  cellular	  protein	  degradation	  suggesting	  that	  there	  are	  multiple	  proteins	  involved	  in	  recognition	  and	  delivery	  of	  substrate	  to	  the	  proteasome	  [19].	  	  Not	  surprisingly,	  several	  other	  receptors,	  including	  Rad23,	  Dsk2,	  and	  Ddi1,	  known	  as	  UBA-­‐UBL	  proteins,	  were	  later	  discovered[13,	  20-­‐22].	  These	  proteins	  loosely	  associate	  with	  the	  proteasome,	  rapidly	  binding	  and	  unbinding	  the	  complex,	  delivering	  ubiquitinated	  substrates.	  The	  proteins	  recognize	  and	  interact	  with	  ubiquitin	  chains	  on	  substrates	  via	  their	  UBA	  domain	  (ubiquitin-­‐associated	  domain)	  and	  dock	  to	  the	  proteasome	  via	  their	  UBL	  domain	  (ubiquitin-­‐like	  domain)[23,	  24].	  However,	  a	  triple	  Rpn10,	  Rad23,	  and	  Dsk2	  mutant	  is	  not	  lethal,	  suggesting	  that	  there	  are	  yet	  more	  proteasome	  receptors	  playing	  a	  role	  in	  proteasomal	  delivery[22].	  	  	  Additionally,	  it	  has	  been	  suggested	  that	  Cdc48,	  a	  large	  ATP-­‐dependent	  molecular	  chaperone,	  and	  its	  adaptors	  play	  a	  role	  in	  delivery	  of	  substrates.	  Cdc48	  is	  believed	  to	  work	  in	  conjunction	  with	  the	  receptors	  Rad23/Dsk2	  in	  aiding	  target	  proteins	  to	  the	  proteasome.	  A	  working	  model	  is	  that	  an	  ubiquitinated	  substrate	  is	  recruited	  to	  Cdc48	  by	  its	  adaptors	  Ufd1	  and	  Npl4.	  After	  recruitment	  the	  substrate	  is	  
	  	  
8	  ubiquitinated	  further	  by	  the	  chain	  elongation	  factor,	  Ufd2,	  an	  adaptor	  of	  Cdc48.	  Ufd2	  then	  recruits	  Rad23/Dsk2	  to	  the	  substrate-­‐bound	  Cdc48	  complex	  and	  the	  substrate	  is	  targeted	  for	  degradation	  by	  the	  proteasome[15,	  25].	  However,	  the	  exact	  role	  for	  Cdc48	  at	  the	  proteasome	  is	  a	  subject	  of	  much	  debate.	  It	  is	  unclear	  whether	  Cdc48’s	  function	  is	  to	  shuttle	  substrate	  to	  the	  proteasome	  like	  Rad23/Dsk2/Ddi1,	  or	  if	  it	  is	  required	  at	  the	  proteasome	  for	  remodeling	  rather	  than	  delivery.	  	  
The	  Cdc48/p97	  ATPase	  The	  previously	  mentioned	  Cdc48	  (p97/VCP	  in	  mammals)	  is	  an	  essential,	  highly	  abundant,	  ATP-­‐driven	  machine	  in	  the	  cell.	  Discovered	  over	  twenty-­‐five	  years	  ago	  in	  a	  screen	  for	  conditional	  mutants	  causing	  cell-­‐cycle	  arrest	  in	  yeast,	  the	  complex	  has	  been	  shown	  to	  play	  a	  central	  role	  in	  ubiquitin-­‐dependent	  degradation.	  It	  is	  a	  member	  of	  the	  AAA	  ATPases	  (ATPases	  associated	  with	  various	  cellular	  activities)	  and	  has	  a	  large	  array	  of	  functions	  throughout	  the	  cell	  (Figure	  1.3).	  The	  protein	  is	  best	  known	  for	  its	  critical	  role	  in	  ERAD	  (endoplasmic	  reticulum	  associated	  protein	  degradation	  by	  the	  ubiquitin	  proteasome	  system),	  but	  is	  involved	  in	  a	  myriad	  of	  processes	  including	  cell-­‐cycle	  progression,	  homotypic	  membrane	  fusion,	  chromatin	  remodeling,	  autophagy,	  and	  transcriptional	  and	  metabolic	  regulation[26-­‐29].	  It	  is	  believed	  that	  Cdc48	  acts	  as	  a	  “segregase”	  in	  these	  processes,	  using	  the	  energy	  from	  ATP	  hydrolysis	  to	  extract	  substrate	  ubiquitinated	  proteins	  from	  protein	  complexes	  or	  membranes.	  Cdc48	  has	  been	  the	  subject	  of	  much	  attention	  over	  the	  last	  few	  years	  due	  to	  its	  causal	  link	  to	  amyotrophic	  lateral	  sclerosis	  (ALS)	  and	  inclusion	  body	  myopathy,	  Paget’s	  disease	  of	  the	  bone,	  and	  frontotemporal	  dementia	  
	  	  
9	  (IBMPFD),	  as	  well	  as	  its	  implied	  role	  in	  a	  variety	  of	  diseases	  including	  cancer[30-­‐34].	  As	  a	  result,	  p97	  has	  been	  the	  subject	  of	  multiple	  drug	  development	  efforts[35,	  36].	  
	  	  
Figure	  1.3	  Multiple	  functions	  of	  Cdc48/p97.	  N-­‐terminal	  cofactors	  involved	  in	  each	  function	  are	  indicated.	  	  In	  terms	  of	  structure,	  Cdc48	  forms	  a	  homohexameric	  complex,	  with	  the	  six	  subunits	  arranged	  in	  a	  barrel	  shape	  with	  a	  central	  tunnel.	  Each	  subunit	  consists	  of	  two	  ATPase	  domains,	  D1	  and	  D2,	  connected	  by	  a	  short	  linker	  (the	  two	  domains	  form	  stacked	  rings),	  a	  N-­‐terminal	  domain,	  and	  a	  C-­‐terminal	  tail.	  Cdc48	  has	  in	  total	  12	  different	  ATPase	  sites,	  with	  the	  D1	  domain	  showing	  weak	  ATPase	  activity	  under	  physiological	  conditions,	  leaving	  a	  majority	  of	  the	  activity	  at	  the	  D2	  domain[26,	  37].	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  During	  ATP	  hydrolysis,	  Cdc48	  undergoes	  conformational	  changes	  which	  result	  in	  the	  opening	  and	  closing	  of	  the	  D1	  and	  D2	  rings[38].	  	  It	  is	  believed	  that	  these	  conformational	  changes	  provide	  the	  force	  for	  Cdc48	  to	  disassemble	  protein	  complexes	  and	  extract	  substrates	  from	  intracellular	  structures.	  However,	  the	  detailed	  mechanism	  of	  substrate	  handling	  by	  Cdc48	  is	  still	  not	  well	  understood.	  Additionally,	  even	  though	  Cdc48	  has	  been	  largely	  deemed	  a	  “segregase,”	  others	  believe	  the	  complex	  primarily	  functions	  as	  “unfoldase”,	  unfolding	  substrates	  and	  aiding	  in	  their	  degradation	  by	  the	  proteasome[39].	  	  The	  detailed	  mechanism	  for	  both	  of	  these	  suggested	  functions	  is	  the	  subject	  of	  much	  debate	  within	  the	  field.	  	  	  
	  
Cdc48	  Cofactors	  and	  Binding	  Partners	  Cdc48	  is	  associated	  with	  a	  multitude	  of	  cofactors	  and	  binding	  partners.	  It	  is	  believed	  that	  these	  cofactors	  help	  facilitate	  and	  provide	  specificity	  to	  the	  numerous	  processes	  Cdc48	  is	  involved	  in,	  mediating	  a	  stable	  interaction	  between	  the	  Cdc48	  complex	  and	  ubiquitinated	  proteins.	  With	  the	  exception	  of	  a	  few	  proteins,	  most	  cofactors	  interact	  with	  Cdc48	  via	  the	  N-­‐terminal	  domain.	  Perhaps	  the	  best	  characterized	  adaptors	  of	  Cdc48	  are	  Ufd1	  and	  Npl4,	  which	  form	  a	  heterodimer	  and	  are	  involved	  in	  ubiquitin	  dependent	  degradation.	  These	  proteins	  are	  both	  essential	  in	  yeast.	  Ufd1	  and	  Npl4	  have	  been	  shown	  to	  bind	  Cdc48	  alone	  or	  in	  conjunction	  with	  other	  cofactors.	  [40-­‐43].	  	  	  	  	  Another	  class	  of	  cofactors	  is	  the	  UBX	  ‘Ubiquitin	  regulatory	  X’	  domain	  containing	  family	  of	  proteins.	  Although	  the	  largest	  family	  of	  Cdc48	  cofactors,	  it	  is	  still	  very	  poorly	  characterized	  with	  the	  cellular	  function	  of	  many	  of	  the	  Ubx	  proteins	  
	  	  
11	  largely	  unknown.	  To	  date,	  there	  have	  been	  thirteen	  UBX	  proteins	  identified	  in	  mammals,	  seven	  of	  which	  are	  found	  in	  yeast.	  The	  carboxy-­‐terminal	  UBX	  domain	  (which	  is	  also	  found	  in	  Npl4)	  is	  similar	  in	  structure	  to	  ubiquitin	  and	  serves	  as	  a	  binding	  module	  to	  Cdc48.	  Among	  the	  UBX	  proteins,	  there	  is	  a	  subfamily	  of	  proteins	  containing	  a	  UBA	  domain.	  These	  amino-­‐terminal	  domains	  are	  involved	  in	  binding	  ubiquitinated	  substrates	  directly[41,	  42](Figure	  1.4).	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
	  	  	  
Figure	  1.4	  UBX	  proteins	  found	  in	  Saccharomyces	  cerevisiae.	  UBX	  (yellow)	  and	  UBA	  (red)	  domains	  of	  proteins	  are	  indicated.	  Proteins	  demonstrating	  substantial	  homology	  outside	  of	  these	  domains	  are	  shown	  in	  similar	  colors.	  	  	   	  	   As	  mentioned,	  very	  little	  is	  known	  about	  UBX	  proteins,	  the	  processes	  they	  are	  involved	  in,	  and	  their	  potential	  substrates.	  Yeast	  Shp1,	  also	  known	  as	  Ubx1,	  is	  an	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  UBA/UBX	  domain-­‐containing	  adaptor	  with	  a	  mammalian	  ortholog,	  p47.	  Shp1	  seemingly	  plays	  an	  important	  role	  in	  cells,	  as	  a	  deletion	  strain	  is	  hardly	  viable.	  Shp1	  and	  p47	  have	  been	  linked	  to	  homotypic	  membrane	  fusion	  and	  autophagy[26,	  28,	  29].	  The	  Buchberger	  lab	  recently	  demonstrated	  Cdc48/Shp1	  complex	  involvement	  in	  the	  promotion	  of	  cell	  cycle	  progression	  by	  the	  positive	  regulation	  the	  protein	  phosphatase	  Glc7	  in	  yeast.	  It	  is	  theorized	  that	  the	  complex	  moderates	  Glc7	  by	  regulating	  its	  interaction	  with	  the	  activator	  protein	  Glc8[44].	  	  Lastly,	  Shp1	  has	  been	  shown	  to	  interact	  with	  Cdc48	  exclusively	  of	  Ufd1	  and	  Npl4[39,	  45].	  	   Contrastingly,	  the	  UBX	  protein	  Ubx2	  has	  been	  demonstrated	  to	  work	  in	  complex	  with	  Ufd1	  and	  Npl4.	  Ubx2	  (also	  known	  as	  Sel1)	  and	  its	  mammalian	  ortholog	  UBXD8	  are	  ER	  membrane	  UBA-­‐UBX	  proteins.	  In	  both	  systems,	  the	  proteins	  have	  been	  linked	  to	  the	  regulation	  of	  lipid	  droplet	  homeostasis	  and	  are	  involved	  in	  ERAD[46-­‐49].	  	  	   Also	  localized	  at	  the	  ER	  and	  throughout	  the	  cytoplasm	  is	  the	  adaptor	  Ubx4.	  Ubx4,	  containing	  only	  a	  UBX	  domain,	  has	  been	  linked	  to	  ERAD,	  the	  degradation	  of	  the	  metabolic	  enzyme	  FBPase,	  and	  the	  degradation	  of	  the	  largest	  subunit	  of	  RNA	  Polymerase	  II,	  Rpb1	  after	  UV	  treatment	  along	  with	  Ubx5[50-­‐52].	  Ubx5,	  another	  UBA/UBX	  protein,	  is	  localized	  to	  the	  nucleus	  on	  chromatin	  and	  throughout	  the	  cytoplasm.	  It	  has	  a	  mammalian	  ortholog,	  UBXD7	  that	  has	  been	  found	  to	  link	  the	  interaction	  of	  p97	  and	  its	  substrate	  HIF1α,	  as	  well	  as	  play	  a	  role	  in	  linking	  in	  p97	  to	  neddylated	  cullin	  ring	  ligases	  via	  its	  unique	  UIM	  domain[53,	  54].	  The	  other	  UBX	  containing	  cofactors	  are	  Ubx3,	  Ubx6,	  and	  Ubx7.	  Very	  little	  is	  known	  about	  these	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  proteins.	  Ubx6	  and	  Ubx7	  share	  large	  sequence	  homology	  and	  a	  triple	  mutant	  ubx4Δ	  
ubx6Δ	  ubx7Δ	  has	  a	  known	  meiotic	  defect[55].	  	  Npl4,	  Ufd1,	  and	  the	  UBX	  proteins	  are	  all	  known	  as	  substrate-­‐recruiting	  factors,	  which	  are	  believed	  to	  facilitate	  the	  decision	  between	  major	  cellular	  pathways	  and	  to	  improve	  binding	  of	  Cdc48	  to	  substrate.	  There	  is	  another	  class	  of	  cofactors,	  known	  as	  substrate-­‐processing	  cofactors.	  These	  cofactors	  have	  additional	  enzymatic	  activity	  and	  are	  involved	  in	  substrate	  regulation	  such	  as	  deubiquitination	  or	  chain	  elongation.	  Some	  of	  these	  proteins	  include	  Otu1,	  Ufd3,	  and	  Ufd2[25,	  42].	  The	  large	  variety	  of	  proteins	  associated	  with	  Cdc48	  allows	  the	  protein	  to	  assemble	  a	  large	  array	  of	  cofactor	  complexes	  with	  distinct	  functions	  and	  interaction	  networks.	  Although	  many	  cofactors	  of	  Cdc48	  have	  been	  discovered,	  their	  number	  is	  still	  growing.	  	  
Cdc48	  and	  Proteasome-­Dependent	  Degradation	  As	  mentioned	  above,	  the	  best	  understood	  role	  of	  Cdc48	  is	  its	  role	  in	  ERAD	  and	  proteasome-­‐dependent	  processes.	  In	  ERAD,	  Cdc48,	  in	  complex	  with	  Npl4	  and	  Ufd1,	  are	  recruited	  to	  the	  ER	  membrane	  via	  Ubx2,	  an	  integral	  membrane	  protein.	  During	  this	  process,	  the	  complex	  binds	  ubiquitinated	  ERAD	  substrates,	  which	  are	  misfolded	  or	  incompletely	  assembled.	  The	  target	  proteins	  are	  retrotranslated	  and	  segregated	  from	  the	  ER	  membrane	  or	  their	  binding	  partners	  and	  are	  then	  delivered	  to	  the	  proteasome	  for	  degradation.	  Ubx4	  has	  also	  been	  shown	  to	  play	  a	  role	  in	  ERAD,	  however	  its	  role	  in	  the	  process	  is	  not	  well	  understood[47].	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  Recently	  Cdc48	  was	  linked	  to	  protein	  quality	  control/mitochondrial	  stress	  response	  at	  the	  mitochondrial	  outer	  membrane.	  Upon	  exposure	  of	  cells	  to	  rapamycin	  or	  hydrogen	  peroxide,	  Cdc48	  is	  recruited	  to	  the	  mitochondrial	  membrane	  via	  a	  new	  adaptor,	  Vms1,	  where	  it	  binds	  ubiquitinated	  proteins	  and	  transports	  them	  to	  the	  cytosol	  for	  degradation.	  Npl4	  was	  found	  to	  be	  involved	  in	  this	  process,	  forming	  a	  heterodimer	  with	  Vms1[56,	  57].	  The	  Cdc48-­‐Npl4-­‐Vms1	  complex	  activates	  degradation	  of	  Fzo1,	  a	  yeast	  mitofusin	  protein,	  which	  is	  degraded	  by	  the	  proteasome	  via	  the	  SCF-­‐Mdm30	  complex.	  Human	  orthologs	  of	  Fzo1,	  MFN1	  and	  MFN2,	  are	  also	  degraded	  by	  the	  UPS	  and	  the	  human	  E3	  ligase	  Parkin	  in	  a	  p97	  dependent	  manner[58].	  Detailed	  mechanism	  of	  Cdc48/p97	  at	  the	  mitochondria	  is	  not	  yet	  understood,	  but	  it	  is	  feasible	  that	  the	  Cdc48-­‐dependent	  mitochondrial	  retrotranslocation	  system	  works	  similarly	  to	  the	  one	  in	  ERAD.	  It	  is	  has	  also	  been	  speculated	  that	  Cdc48-­‐mediated	  degradation	  may	  have	  a	  regulatory	  role	  in	  mitochondrial	  membrane	  fusion	  (mitophagy),	  preventing	  the	  fusion	  of	  defective	  and	  healthy	  mitochondria,	  and	  facilitating	  the	  degradation	  of	  damaged	  mitochondria	  via	  autophagy[59].	  	  	  Additionally,	  Cdc48	  is	  involved	  in	  cytoplasmic	  and	  nuclear	  protein	  degradation.	  Cytoplasmic	  degradation	  via	  Cdc48	  was	  first	  demonstrated	  with	  synthetic	  substrates	  of	  the	  UFD	  pathway.	  Following	  this	  discovery,	  native	  cytoplasmic	  proteins,	  fructose-­‐1,6-­‐bisphosphatase	  (FBPase)	  and	  phosphoenolpyruvate	  carboxykinase	  (PEPCK)	  were	  found	  to	  undergo	  Cdc48-­‐dependent	  degradation	  during	  the	  gluconeogenic	  switch,	  the	  catabolite	  inactivation	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  upon	  glucose	  signaling.	  The	  UBX	  protein	  Ubx4	  was	  later	  linked	  to	  the	  degradation	  of	  FBPase	  in	  this	  pathway[26,	  51,	  60].	  	  	  In	  the	  nucleus,	  Cdc48	  was	  found	  to	  play	  a	  role	  in	  the	  UV-­‐induced	  proteasomal	  degradation	  of	  chromatin-­‐bound	  Rpb1	  (RNA	  polymerase	  II)	  at	  DNA	  lesions.	  Once	  RNA	  polymerase	  has	  stalled	  and	  undergoes	  ubiquitination	  by	  the	  ligase	  Cul3,	  the	  UBX	  cofactor	  Ubx5	  recruits	  Cdc48	  to	  remove	  Rpb1	  from	  the	  chromatin	  bound	  complex[52].	  	  A	  similar	  chromatin-­‐associated	  function	  was	  found	  for	  p97	  prior	  to	  this	  finding	  with	  the	  extraction	  of	  Aurora	  B	  kinase	  from	  mitotic	  chromosomes.	  These	  studies	  linked	  Cdc48/p97	  to	  cell	  cycle	  regulation,	  as	  the	  function	  of	  Aurora	  B	  kinase	  is	  to	  regulate	  the	  attachment	  of	  mitotic	  spindle	  to	  the	  centromere.	  It	  was	  shown	  that	  during	  mitosis,	  p97-­‐Ufd1-­‐Npl4,	  by	  removing	  the	  kinase,	  inhibits	  its	  activity	  and	  allows	  for	  chromatin	  decondensation	  and	  nuclear	  envelope	  formation[61,	  62].	  In	  yeast,	  Cdc48	  has	  been	  linked	  to	  the	  degradation	  of	  Far1,	  a	  G1-­‐cyclin-­‐dependent	  kinase	  inhibitor,	  thereby	  promoting	  the	  cell-­‐cycle[63].	  	  	  
Cdc48	  and	  Proteasome-­Independent	  Processes	  Although	  Cdc48	  was	  first	  believed	  to	  be	  involved	  exclusively	  in	  proteasome-­‐dependent	  processes,	  the	  complex	  was	  recently	  linked	  to	  the	  other	  major	  degradative	  system	  in	  the	  cell,	  the	  lysosome.	  Cdc48	  and	  Ubx1/Shp1	  are	  involved	  in	  macroautophagy,	  specifically	  in	  autophagosome	  biogenesis.	  The	  first	  implication	  of	  a	  role	  for	  Cdc48/p97	  in	  autophagy	  was	  from	  studies	  on	  the	  pathogenesis	  of	  Paget’s	  disease	  of	  the	  bone	  and	  frontotemporal	  dementia	  (IBMPFD),	  a	  disease	  with	  missense	  mutations	  in	  p97.	  A	  phenotype	  seen	  in	  these	  patient’s	  tissues	  is	  vacuoles	  
	  	  
16	  rimmed	  with	  LC3	  (Atg8	  in	  yeast),	  implying	  aberrant	  autophagosome	  formation.	  LC3/Atg8	  are	  proteins	  involved	  in	  the	  maturation	  of	  vacuoles	  and	  are	  known	  targets	  of	  the	  Cdc48-­‐Shp1/p97-­‐p47	  complex.	  This	  phenotype	  was	  shown	  again	  in	  transgenic	  mice	  overexpressing	  disease	  mutants	  of	  p97[64-­‐67].	  However,	  even	  though	  Cdc48	  has	  been	  linked	  to	  this	  process,	  the	  exact	  molecular	  function	  is	  unknown.	  	  In	  terms	  of	  other	  proteasome-­‐independent	  processes,	  Cdc48	  has	  been	  linked	  to	  endolysosomal	  trafficking,	  membrane	  fusion,	  and	  reformation	  of	  the	  Golgi	  complex	  following	  mitotic	  disassembly[42,	  68,	  69].	  	  	  Lastly,	  Cdc48/p97	  has	  been	  linked	  to	  transcriptional	  regulation.	  It	  was	  reported	  that	  p97	  interacts	  with	  ΙkΒα,	  the	  inhibitory	  factor	  of	  the	  NF-­‐kB	  pathway.	  A	  possible	  regulatory	  role	  for	  p97	  in	  this	  pathway	  may	  be	  control	  of	  ΙkΒα	  stability[29].	  Cdc48	  has	  been	  linked	  to	  a	  similar	  processing	  pathway	  in	  yeast,	  the	  OLE	  pathway,	  which	  regulates	  the	  expression	  of	  genes	  involved	  in	  fatty	  acid	  metabolism.	  In	  this	  pathway	  the	  proteasome	  is	  involved	  in	  processing	  but	  the	  substrate	  only	  undergoes	  partial	  degradation[70].	  	  	  	  
The	  OLE	  Pathway	  	   The	  fluidity	  of	  yeast	  membranes	  is	  largely	  controlled	  by	  Ole1,	  a	  Δ9-­‐fatty	  acid	  desaturase	  enzyme	  that	  converts	  saturated	  fatty	  acids	  into	  unsaturated	  fatty	  acids	  by	  introducing	  double	  bonds	  into	  their	  carbon	  chains.	  Known	  as	  the	  OLE	  pathway,	  this	  process	  is	  essential	  for	  cell	  viability	  and	  is	  regulated	  by	  the	  UPS	  and	  Cdc48-­‐
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  Npl4-­‐Ufd1	  complex[71].	  In	  this	  process,	  ER	  membrane-­‐bound	  transcription	  factors	  are	  processed	  and	  transported	  to	  the	  nucleus	  to	  promote	  OLE1	  transcription.	  	  	  	   The	  first	  step	  of	  the	  OLE	  pathway	  involves	  the	  ubiquitin-­‐proteasome	  dependent	  processing	  of	  Spt23	  and	  Mga2.	  Spt23	  and	  Mga2	  are	  homologous	  transcription	  factors	  that	  are	  essential	  for	  activation	  of	  OLE1	  expression.	  Deletion	  of	  either	  gene	  has	  little	  effect,	  however,	  the	  double	  deletion	  causes	  fatty	  acid	  auxotrophy	  and	  is	  lethal	  but	  can	  be	  rescued	  by	  providing	  an	  external	  source	  of	  unsaturated	  fatty	  acids.	  Spt23	  and	  Mga2	  exist	  in	  two	  forms:	  an	  inactive	  ER	  membrane-­‐bound	  120kDa	  precursor	  protein	  and	  a	  processed	  soluble	  90kDa	  protein	  that	  is	  localized	  to	  the	  nucleus	  and	  cytoplasm.	  The	  inactive	  precursor	  forms	  of	  Spt23	  and	  Mga2	  are	  bound	  to	  the	  ER	  as	  homodimers	  via	  a	  single	  20	  amino	  acid	  hydrophobic	  domain	  at	  their	  C-­‐termini.	  Upon	  fatty	  acid	  depletion,	  Spt23	  and	  Mga2	  are	  ubiquitinated	  by	  the	  HECT	  E3	  ligase	  Rsp5	  leading	  to	  the	  processing	  of	  the	  p120	  by	  the	  proteasome.	  During	  processing	  it	  is	  believed	  that	  the	  protein	  forms	  a	  hairpin	  loop	  with	  the	  proteasome	  beginning	  processing	  internally,	  degrading	  through	  the	  C-­‐terminus,	  and	  leaving	  the	  N-­‐terminal	  active	  form	  intact[72-­‐77].	  	  	  	  	   After	  the	  active	  p90	  molecule	  is	  produced,	  the	  protein	  remains	  tethered	  to	  its	  partner	  p120	  molecule	  at	  the	  ER	  membrane.	  In	  a	  second	  step,	  the	  transcriptionally	  active	  p90	  fragment	  is	  released	  from	  the	  membrane	  by	  the	  Cdc48-­‐Npl4-­‐Ufd1	  complex.	  The	  p90	  protein	  is	  then	  translocated	  to	  the	  nucleus	  to	  activate	  OLE1	  transcription	  to	  create	  more	  unsaturated	  fatty	  acids	  in	  the	  cell.	  Once	  the	  active	  protein	  is	  translocated	  it	  is	  thought	  to	  be	  very	  unstable[75,	  78](Figure	  1.5).	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  Figure	  1.5	  The	  OLE	  Pathway.	  Spt23	  (blue)	  and	  Mga2	  (green)	  are	  activated	  upon	  a	  depletion	  of	  unsaturated	  fatty	  acids	  in	  the	  cell.	  	  Spt23	  is	  monoubiquitinated	  by	  the	  Rsp5	  ubiquitin	  ligase	  which	  is	  required	  for	  processing	  by	  the	  proteasome	  (gray	  and	  blue	  barrel).	  Post-­‐processing,	  the	  Cdc48-­‐Ufd1-­‐Npl4	  complex	  (red)	  liberates	  the	  active	  p90	  form	  of	  Spt23	  from	  its	  p120	  binding	  partner	  and	  p90	  is	  translocated	  to	  the	  nucleus	  for	  transcription.	  	  In	  the	  case	  of	  Mga2,	  Rsp5	  is	  dispensable	  for	  initiation	  of	  processing	  and	  the	  E3	  ligase	  at	  this	  step	  is	  unknown.	  	  Post–processing	  by	  the	  proteasome	  the	  active	  p90	  form	  is	  released	  from	  its	  p120	  binding	  partner	  by	  the	  Cdc48-­‐Ufd1-­‐Npl4	  complex.	  	  However,	  for	  this	  step	  polyubiquitination	  of	  the	  p120	  	  binding	  partner	  by	  Rsp5	  is	  required	  for	  release.	  	  Mga2	  is	  then	  translocated	  to	  the	  nucleus	  for	  transcription.	  Production	  of	  Ole1	  leads	  to	  increased	  unsaturated	  fatty	  acid	  levels,	  which	  thereby	  inhibit	  processing	  of	  Spt23.	  	  	  In	  addition,	  Cdc48	  and	  its	  binding	  partners	  have	  been	  linked	  to	  Spt23	  p90	  stability.	  Ufd2,	  an	  E4	  ligase	  that	  binds	  to	  Cdc48,	  extends	  the	  ubiquitin	  chain	  on	  the	  
	  	  
19	  transcription	  factor	  enabling	  the	  targeting	  of	  the	  protein	  to	  the	  proteasome.	  In	  ufd2	  deletion	  strains,	  Spt23	  p90	  is	  stabilized,	  causing	  excessive	  expression	  of	  Ole1	  and	  sensitivity	  of	  the	  strain	  to	  unsaturated	  fatty	  acids.	  In	  addition,	  once	  translated,	  the	  Ole1	  protein	  is	  a	  highly	  unstable	  protein	  that	  is	  degraded	  by	  ERAD.	  Ole1	  stability	  is	  regulated	  by	  unsaturated	  fatty	  acid	  levels	  in	  the	  cell,	  thereby	  creating	  a	  tightly	  regulated	  negative	  feedback	  loop[25,	  79].	  	  Although	  much	  of	  the	  OLE	  pathway	  has	  been	  characterized,	  there	  is	  still	  much	  to	  be	  understood.	  The	  actual	  mechanism	  of	  fatty	  acid	  regulation	  of	  Spt23/Mga2	  activation	  is	  still	  unclear.	  As	  mentioned	  above,	  the	  pathway	  is	  based	  on	  feedback	  regulation[79].	  Production	  of	  Ole1p	  leads	  to	  the	  production	  of	  unsaturated	  fatty	  acids	  which	  in	  turn	  has	  been	  shown	  to	  inhibit	  Spt23	  processing.	  It	  has	  been	  demonstrated	  that	  dimerization	  of	  Spt23	  is	  necessary	  for	  ubiquitination.	  This	  has	  led	  to	  the	  belief	  that	  processing	  is	  regulated	  at	  either	  the	  level	  of	  dimerization	  or	  upon	  ubiquitination	  by	  Rsp5[71].	  	  The	  UFA	  sensor,	  whether	  it	  is	  Rsp5	  or	  upstream	  of	  Rsp5,	  is	  still	  largely	  unknown.	  	  	  Additionally,	  although	  homologous,	  Spt23	  and	  Mga2	  have	  demonstrated	  some	  differences	  in	  processing.	  	  At	  the	  level	  of	  ubiquitination,	  Mga2	  uses	  an	  Rsp5-­‐independent	  mode	  of	  processing	  and	  the	  E3	  ligase	  is	  unknown.	  Post-­‐processing,	  Rsp5	  dependent	  ubiquitination	  appears	  to	  be	  required	  for	  mobilization	  of	  the	  processed	  Mga2[76,	  80].	  	  In	  the	  case	  of	  Spt23,	  processing	  requires	  Rsp5	  dependent	  ubiquitination.	  	  Furthermore,	  the	  level	  of	  ubiquitination	  post-­‐processing	  of	  the	  two	  transcription	  factors	  is	  different.	  The	  active	  Spt23	  p90	  form	  is	  monoubiquitinated[75]	  but	  in	  the	  Mga2	  pathway,	  the	  inactive	  p120	  binding	  partner	  
	  	  
20	  of	  p90	  is	  polyubiquitinated	  prior	  to	  mobilization[76].	  Lastly,	  addition	  of	  unsaturated	  fatty	  acids	  represses	  the	  processing	  of	  Spt23.	  In	  contrast,	  Mga2	  processing	  is	  unaffected	  by	  the	  addition	  of	  unsaturated	  fatty	  acids.	  However,	  OLE1	  transcription	  is	  still	  repressed	  indicating	  that	  fatty	  acid	  mediated	  OLE1	  repression	  seems	  to	  act	  post-­‐processing	  for	  Mga2	  and	  prior	  to	  processing	  of	  Spt23[81].	  All	  this	  evidence	  indicates	  that	  the	  processing	  pathways	  are	  much	  more	  complex	  and	  Spt23	  and	  Mga2	  may	  play	  slightly	  different	  roles[82].	  Finally,	  the	  role	  of	  the	  Cdc48-­‐Ufd1-­‐Npl4	  complex	  in	  the	  OLE	  pathway	  is	  still	  unclear.	  As	  mentioned	  above,	  a	  role	  for	  Cdc48-­‐Ufd1-­‐Npl4	  in	  the	  release	  of	  p90	  from	  the	  ER	  membrane	  after	  proteasomal	  processing	  is	  known.	  The	  dismantling	  of	  the	  active	  p90	  from	  its	  p120	  binding	  partner	  was	  demonstrated	  in	  vitro	  with	  the	  addition	  of	  Cdc48	  to	  cell	  extracts.	  However,	  another	  group	  suggested	  that	  Cdc48,	  Ufd1,	  and	  Npl4	  may	  also	  be	  involved	  in	  proteasome-­‐dependent	  processing[83].	  	  In	  temperature	  sensitive	  mutant	  strains	  of	  the	  mentioned	  proteins	  Spt23	  and	  Mga2	  were	  shown	  to	  be	  less	  efficiently	  processed	  as	  compared	  to	  wild-­‐type	  strains.	  	  However,	  the	  role	  of	  the	  complex	  in	  this	  part	  of	  the	  pathway	  is	  not	  yet	  understood.	  Some	  possible	  functions	  include	  extraction	  of	  the	  C-­‐terminus	  of	  one	  of	  the	  transcription	  factor	  monomers	  to	  aid	  degradation	  by	  the	  proteasome.	  	  However,	  if	  the	  transcription	  factors	  undergo	  internal	  processing	  a	  non-­‐“extraction”	  role	  for	  the	  complex	  is	  possible.	  	  Perhaps	  the	  complex	  recruits	  proteasome	  to	  the	  substrate	  and	  aids	  in	  processing.	  	  With	  all	  these	  questions	  and	  unknowns,	  it	  is	  evident	  that	  much	  more	  work	  needs	  to	  be	  done	  to	  better	  understand	  the	  intricacies	  of	  the	  OLE	  pathway[75,	  83,	  84].	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Shotgun	  Mass	  Spectrometry	  	  As	  can	  be	  deduced	  from	  the	  summary	  above,	  the	  UPS/Cdc48	  system	  plays	  an	  integral	  role	  in	  the	  cell.	  We	  have	  only	  begun	  to	  understand	  its	  breadth	  of	  influence	  and	  have	  yet	  to	  discover	  many	  new	  substrates.	  	  However,	  the	  complexity	  and	  the	  intricacies	  of	  this	  system	  make	  it	  extremely	  challenging	  to	  study	  in	  a	  global	  manner.	  As	  such,	  much	  of	  the	  work	  has	  been	  on	  the	  details	  of	  specific	  pathways	  and	  discovery	  of	  new	  targets	  has	  proven	  difficult.	  	  In	  the	  last	  decade	  there	  have	  been	  major	  advances	  in	  shotgun	  mass	  spectrometry	  techniques	  and	  data	  analysis	  software	  that	  have	  enabled	  quantitative	  analysis	  of	  changes	  in	  protein	  level	  on	  a	  proteome-­‐wide	  scale.	  	  These	  new	  technologies	  have	  enabled	  one	  to	  look	  at	  complex	  samples	  and	  analyze	  and	  quantify	  a	  large	  number	  of	  proteins	  under	  varying	  conditions,	  revolutionizing	  the	  field	  of	  proteomics[85-­‐87].	  At	  the	  heart	  of	  whole	  proteome	  sequencing	  is	  utilizing	  the	  proper	  pre-­‐fractionation	  technique	  to	  expand	  dynamic	  range.	  	  Often,	  high	  abundance	  peptides	  prevent	  the	  sequencing	  of	  low	  abundance	  ones,	  which	  limits	  sequencing	  depth.	  	  Historically,	  the	  GeLC	  [88-­‐91]and	  MudPIT[92-­‐94]	  approaches	  have	  been	  the	  most	  common	  pre-­‐fractionation	  techniques.	  	  These	  approaches	  separate	  proteins	  by	  molecular	  weight	  (GeLC)	  and	  peptides	  by	  cationic	  exchange	  and	  reverse	  phase	  fractionation	  (MudPIT)	  and	  decrease	  analyte	  complexity.	  	  However,	  no	  group	  has	  been	  able	  to	  sequence	  at	  the	  Saccharomyces	  cerevisiae	  proteome	  depth	  using	  these	  approaches.	  	  In	  response	  to	  this	  continued	  issue	  of	  scale,	  the	  Mann	  Laboratory	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  developed	  a	  few	  new	  methodologies	  and	  performed	  the	  most	  comprehensive	  identification	  and	  quantification	  of	  the	  budding	  yeast	  proteome	  to	  date[95].	  	  In	  these	  experiments,	  an	  Agilent	  OFF-­‐GEL,	  an	  apparatus	  that	  performs	  isoelectric	  focusing	  of	  proteins	  and	  peptides	  in	  solution	  separating	  them	  into	  different	  wells	  on	  a	  pH	  gradient,	  was	  used	  for	  fractionation[96-­‐98].	  	  Additionally,	  the	  Mann	  Group	  developed	  a	  strong	  anionic	  exchange	  (SAX)	  stage	  tip	  method	  as	  another	  fractionation	  means	  for	  deep	  sequencing[99].	  	  They	  also	  developed	  a	  comprehensive	  software	  package,	  MaxQuant,	  for	  very	  accurate	  identification	  and	  quantitation	  of	  protein	  ratios[100].	  	  Adaptation	  and	  implementation	  the	  above	  system	  to	  carry	  out	  accurate	  and	  reproducible	  quantitative	  mass	  spectrometry	  on	  a	  proteome-­‐wide	  scale	  would	  be	  a	  powerful	  tool	  to	  discover	  new	  substrates	  and	  function	  of	  the	  UPS/Cdc48	  system.	  	  	  
 
Research	  Objectives	  	   With	  the	  current	  tools	  available	  discovering	  new	  roles	  and	  substrates	  of	  Cdc48	  and	  its	  adaptors	  has	  proven	  difficult.	  	  In	  this	  dissertation	  I	  describe	  the	  implementation	  and	  optimization	  of	  a	  quantitative	  mass	  spectrometry	  method	  to	  monitor	  changes	  in	  Saccharomyces	  cerevisiae	  protein	  levels	  on	  a	  proteome-­‐wide	  scale	  (Chapter	  2).	  	  After	  establishing	  this	  technology	  at	  Caltech,	  I	  developed	  a	  screen	  to	  survey	  changes	  in	  the	  ubiquitin	  proteome	  in	  cdc48	  and	  ubx	  mutants	  in	  the	  hope	  to	  find	  new	  targets	  of	  the	  Cdc48	  network	  (Chapter	  3).	  Different	  mutants	  displayed	  reproducible	  patterns	  of	  ubiquitin	  conjugate	  accumulation	  that	  differed	  greatly	  from	  each	  other	  supporting	  the	  idea	  of	  functional	  and	  pathway	  specializations	  of	  
	  	  
23	  individual	  Ubx	  proteins.	  	  The	  results	  of	  this	  screen	  suggested	  a	  wide	  variety	  of	  new	  functions	  and	  potential	  new	  substrates	  of	  various	  Ubx	  proteins	  of	  which	  previously	  very	  little	  was	  known.	  	  	  	   To	  further	  validate	  my	  mass	  spectrometry	  findings,	  I	  examined	  in	  detail	  the	  ER-­‐membrane	  bound	  transcription	  factor	  Spt23	  of	  the	  OLE	  pathway,	  which	  was	  identified	  as	  a	  putative	  Ubx2	  substrate.	  I	  verified	  Spt23	  as	  an	  Ubx2	  substrate,	  demonstrating	  a	  role	  for	  Ubx2	  in	  Spt23	  processing	  and	  stability,	  and	  as	  a	  regulator	  of	  lipid	  biosynthesis	  (Chapter	  3).	  In	  addition,	  this	  work	  illustrates	  the	  value	  of	  proteomics	  to	  identify	  new	  targets	  for	  ubiquitin	  receptor	  pathways	  and	  the	  dataset	  is	  a	  rich	  resource	  for	  future	  investigations	  into	  the	  role	  of	  the	  Cdc48	  network.	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Introduction	  	   Proteomics	  is	  a	  rapidly	  evolving	  science	  created	  to	  analyze	  large	  amounts	  of	  proteins,	  even	  an	  entire	  proteome,	  in	  a	  single	  experiment.	  Mass	  spectrometry	  has	  become	  the	  most	  popular	  tool	  in	  the	  field	  and	  is	  used	  to	  identify	  and	  characterize	  proteins	  in	  complex	  mixtures.	  In	  contrast	  to	  gene	  expression	  studies	  in	  genomics,	  proteomics	  directly	  analyzes	  the	  level	  of	  gene	  products	  present	  and	  can	  analyze	  various	  other	  protein	  details	  such	  a	  post-­‐translational	  modifications,	  protein	  interactions,	  and	  subcellular	  distributions[101,	  102].	  	  	  	   Proteomics	  first	  began	  with	  two-­‐dimensional	  electrophoresis	  (2-­‐DE).	  	  In	  this	  method,	  protein	  staining	  patterns	  across	  samples	  were	  compared	  to	  identify	  “unregulated”	  and	  “downregulated”	  proteins.	  	  This	  method	  was	  roughly	  quantitative,	  as	  one	  could	  have	  a	  vague	  idea	  of	  relative	  amounts	  of	  protein	  between	  the	  different	  samples.	  However,	  a	  large	  caveat	  to	  this	  method	  was	  limited	  dynamic	  range	  and,	  eventually,	  over	  the	  next	  few	  years,	  2-­‐DE	  gels	  were	  replaced	  with	  the	  use	  of	  mass	  spectrometry-­‐based	  proteomics[102-­‐104].	  	   The	  current	  sample	  analysis	  workflow	  in	  mass	  spectrometry	  emerged	  from	  peptide	  mass	  fingerprinting.	  	  This	  technique	  utilized	  proteolytic	  digestion	  of	  simple	  protein	  mixtures	  with	  site-­‐specific	  proteases	  and	  subsequent	  mass	  spectrometric	  analysis	  of	  the	  resulting	  peptides.	  	  These	  peptides	  were	  analyzed	  against	  a	  theoretical	  digest	  of	  a	  protein	  database	  and	  the	  proteins	  with	  the	  closest	  theoretical	  digest	  were	  matched[105-­‐108].	  	  However,	  this	  method	  was	  largely	  unusable	  for	  highly	  complicated	  mixtures.	  	  In	  the	  next	  few	  years,	  with	  the	  development	  of	  collision	  induced	  dissociation	  (CID),	  electrospray	  ionization	  (ESI),	  and	  the	  
	  	  
26	  introduction	  of	  a	  new	  class	  of	  mass	  analyzers	  (quadropole-­‐ion	  trap	  mass	  spectrometers),	  the	  proteomics	  field	  dramatically	  changed[109-­‐111].	  	  These	  changes	  allowed	  for	  new	  advances	  in	  complicated	  polypeptide	  mixture	  analysis	  and,	  eventually,	  led	  to	  deep	  proteome	  sequencing[95].	  	   With	  the	  ability	  to	  rapidly	  identify	  large	  numbers	  of	  proteins	  with	  mass	  spectrometry,	  the	  focus	  in	  the	  field	  then	  shifted	  to	  the	  reliable	  quantitation	  of	  the	  proteins	  detected.	  Many	  different	  techniques	  and	  strategies	  for	  absolute	  or	  relative	  quantitation	  of	  protein	  mixtures	  emerged.	  	  One	  of	  the	  most	  popular	  methods,	  known	  as	  stable	  isotope	  labeling	  of	  amino	  acids	  in	  cell	  culture	  (SILAC),	  has	  proven	  to	  be	  one	  of	  the	  most	  powerful	  approaches.	  	  SILAC	  consists	  of	  growing	  two	  (or	  three)	  cell	  populations	  in	  media	  containing	  a	  heavy	  or	  light	  form	  of	  an	  essential	  amino	  acid.	  	  After	  several	  cell	  doublings,	  the	  complete	  cellular	  proteome	  is	  labeled	  with	  the	  incorporated	  amino	  acid	  and	  every	  peptide	  pair	  is	  separated	  by	  the	  mass	  difference	  introduced	  by	  the	  labeled	  amino	  acid.	  	  This	  method	  then	  employs	  mass	  spectrometry	  and	  sophisticated	  software	  packages	  to	  accurately	  identify	  and	  measure	  relative	  protein	  levels.[112]	  	  	   As	  far	  as	  the	  field	  has	  come	  in	  the	  last	  two	  decades,	  due	  to	  the	  complicated	  and	  sophisticated	  nature	  of	  the	  instruments	  and	  techniques,	  few	  laboratories	  in	  the	  world	  have	  been	  able	  to	  achieve	  this	  high	  level	  of	  mass	  spectrometry-­‐based	  quantitative	  proteomic	  sequencing.	  	  In	  this	  chapter	  we	  describe	  the	  implementation	  of	  a	  high-­‐throughput	  SILAC-­‐based	  quantitative	  mass	  spectrometry	  setup	  at	  Caltech.	  	  Although	  our	  laboratory	  did	  own	  the	  most	  advanced	  mass	  spectrometer,	  an	  LTQ-­‐Orbitrap	  (an	  instrument	  with	  the	  combination	  of	  an	  ion	  trap	  with	  a	  high	  mass	  
	  	  
27	  accuracy	  analyzer),	  little	  was	  known	  about	  optimal	  sample	  preparation,	  fractionation	  techniques,	  chromatography	  and	  instruments	  settings	  and	  setup,	  and	  data	  analysis.	  Caltech	  had	  an	  experimental	  arrangement	  that	  had	  not	  evolved	  with	  the	  rapidly	  changing	  field.	  As	  such,	  we	  attempted	  to	  revamp	  our	  entire	  experimental	  method	  and	  emulate	  the	  setup	  of	  the	  Mann	  Lab,	  a	  laboratory	  at	  the	  forefront	  of	  quantitative	  mass-­‐spectrometry	  based	  proteomics.	  This	  Chapter	  gives,	  in	  detail,	  a	  description	  of	  the	  changes	  we	  made	  to	  our	  system	  in	  order	  to	  achieve	  our	  goal	  of	  deep	  sequencing	  and	  quantitation	  at	  the	  level	  of	  the	  Saccharomyces	  cerevisiae	  proteome.	  	  	  The	  objective	  was	  to	  then	  utilize	  this	  technology	  to	  quantify	  changes	  in	  the	  proteome	  upon	  various	  perturbations	  or	  mutations	  in	  yeast	  cells,	  specifically	  in	  the	  UPS.	  	  
Methods	  
Yeast	  Cell	  Culture	  	  The	  wild-­‐type	  Saccharomyces	  cerevisiae	  strain	  RJD	  4614	  (S288C	  background)	  was	  used	  throughout	  all	  optimization	  experiments.	  Cells	  were	  grown	  to	  log-­‐phase	  (OD	  
600	  0.7-­‐1.0)	  in	  yeast	  extract	  peptone	  dextrose	  (YPD)	  liquid	  medium.	  	  Cells	  were	  harvested	  by	  centrifugation	  for	  5	  minutes	  at	  4,000	  x	  g,	  washed	  with	  cold	  TBS,	  and	  flash	  frozen.	  	  For	  SILAC	  experiments,	  a	  cell	  strain	  (S288C,	  arg4::HYG,	  lys2Δ0)	  that	  is	  an	  auxotroph	  for	  lysine	  and	  arginine	  was	  used.	  	  Cells	  were	  grown	  in	  Complete	  Synthetic	  Media	  (CSM)	  with	  2%	  dextrose	  containing	  20	  mg/L	  lysine	  and	  arginine	  or	  in	  “heavy”	  medium	  with	  20	  mg/L	  13C615N2-­‐lysine	  and	  13C6-­‐arginine	  (Cambridge	  Isotope	  Laboratories).	  	  Cells	  were	  grown	  for	  10	  generations	  to	  log-­‐phase	  (OD	  600	  1.0-­‐
	  	  
28	  2.0)	  and	  equal	  amounts	  of	  the	  normal	  and	  “heavy”	  SILAC-­‐labeled	  cells	  (as	  determined	  by	  OD	  600)	  were	  mixed	  1:1,	  harvested,	  washed,	  and	  flash	  frozen.	  	  	  	  
Lysate	  preparation	  via	  Milling	  Device	  Lysis	  of	  frozen	  cells	  was	  performed	  by	  mechanical	  disruption	  in	  a	  milling	  device	  (CryoMill	  MM400,	  Retsch).	  Cells	  were	  lysed	  during	  3	  cycles	  of	  3-­‐minute	  milling	  at	  20	  Hz	  with	  continuous	  cooling.	  	  	  	  
Lysate	  and	  Sample	  Preparation	  via	  Urea	  Lysis	  and	  In-­solution	  digestion	  Cells	  were	  resuspended	  in	  8M	  Urea	  Lysis	  Buffer	  (8M	  Urea,	  300mM	  NaCl,	  50	  mM	  sodium	  phosphate,	  10	  mM	  Tris-­‐HCl	  pH	  8.0,	  0.2%	  Triton)	  and	  lysed	  three	  times	  by	  bead	  beating	  in	  a	  FastPrep	  (MPBio)	  at	  top	  speed.	  	  The	  lysate	  was	  clarified	  by	  spinning	  at	  13,600	  rpm	  for	  15	  minutes	  at	  room	  temperature.	  	  Lysate	  was	  reduced	  with	  3mM	  (tris(2-­‐carboxyethyl)phosphine)	  (TCEP)	  (Sigma)	  by	  incubation	  for	  20	  minutes	  at	  room	  temperature.	  Next,	  reduced	  cysteines	  were	  alkylated	  by	  the	  addition	  of	  10mM	  chloroacetamide	  (Sigma)	  and	  incubated	  at	  room	  temperature	  in	  the	  dark	  for	  15	  minutes.	  	  Proteins	  were	  proteolytically	  digested	  at	  room	  temperature	  with	  the	  addition	  of	  Lys-­‐C	  (Wako)	  at	  a	  ratio	  of	  1:100	  (protease:	  protein)	  for	  four	  hours	  at	  room	  temperature.	  	  Samples	  were	  then	  diluted	  to	  2M	  Urea	  by	  the	  addition	  of	  100mM	  Tris-­‐HCl	  pH	  8.5	  and	  adjusted	  to	  1mM	  CaCl2	  (Sigma).	  Sequencing	  grade	  trypsin	  (Promega)	  was	  added	  at	  the	  ratio	  of	  1:200	  (protease:	  protein)	  and	  the	  lysate	  was	  incubated	  overnight	  at	  room	  temperature	  in	  the	  dark.	  	  
	  	  
29	  The	  next	  day,	  samples	  were	  acidified	  with	  1%	  TFA	  and	  desalted	  via	  a	  C18	  peptide	  MacroTrap	  (Microm	  Bioresources)	  on	  the	  Alliance-­‐HT	  (Waters	  Corporation).	  	  	  	  	  
Filter	  Aided	  Sample	  Preparation	  (FASP)	  Cells	  were	  milled	  with	  the	  milling	  device	  and	  powder	  was	  resuspended	  in	  SDT-­‐lysis	  buffer	  (4%	  SDS,	  100mM	  Tris-­‐HCl	  pH	  7.6,	  100	  mM	  DTT).	  Cells	  were	  boiled	  for	  5	  minutes	  and	  sonicated	  to	  reduce	  the	  viscosity	  of	  the	  sample.	  	  Samples	  were	  clarified	  by	  centrifugation	  at	  16,000	  x	  g	  for	  5	  minutes.	  	  The	  FASP	  II	  protocol	  on	  a	  30k	  filter	  was	  then	  closely	  followed	  as	  previously	  described[113].	  Digested	  peptides	  were	  collected,	  desalted,	  lyophilized,	  and	  resuspended	  prior	  to	  use.	  	  	  
	  




SDS-­Lysis	  for	  GeLC	  Frozen	  cells	  were	  boiled	  for	  three	  minutes	  at	  100°C	  to	  prevent	  protease	  activity.	  	  Cells	  were	  then	  lysed	  in	  SDS-­‐PAGE	  buffer	  (2%	  SDS,	  50mM	  Tris	  pH	  6.8,	  10%	  Glycerol,	  Bromophenol	  blue,	  0.1%	  2-­‐Mercaptoehtanol)	  by	  bead-­‐beading	  on	  a	  FastPrep	  (MPBio)	  for	  60	  seconds	  at	  top	  speed.	  The	  cells	  were	  boiled	  for	  3	  minutes	  and	  centrifuged	  in	  a	  microcentrifuge	  at	  top	  speed	  for	  5	  minutes.	  Lysate	  was	  then	  collected	  and	  used	  for	  SDS-­‐PAGE.	  
	  
GeLC	  Lysate	  (~50-­‐100	  µg)	  was	  separated	  by	  1D	  SDS-­‐PAGE,	  using	  4-­‐12%	  NuPage	  Novex	  Bis-­‐Tris	  gels	  (Invitrogen)	  and	  NuPage	  MES	  SDS	  running	  buffer.	  The	  gel	  was	  run	  at	  100	  milliAmps	  for	  1	  hour.	  The	  gel	  was	  stained	  using	  the	  Colloidal	  Blue	  Staining	  Kit	  (Invitrogen)	  and	  cut	  into	  12	  slices.	  The	  peptides	  were	  then	  prepped	  via	  in-­‐gel	  digestion.	  The	  gel	  bands,	  which	  were	  cut	  into	  1	  mm3	  cubes,	  were	  washed	  with	  100	  mM	  ammonium	  bicarbonate	  for	  5	  minutes	  and	  then	  washed	  with	  a	  1:1	  100mM	  ammonium:	  ACN	  for	  five	  minutes	  in	  order	  to	  destain.	  	  This	  was	  repeated	  until	  the	  gel	  pieces	  were	  no	  longer	  blue.	  The	  proteins	  were	  then	  reduced	  in-­‐gel	  with	  10mM	  DTT	  in	  100mM	  ammonium	  bicarbonate	  by	  incubating	  at	  50°C	  for	  30	  min.	  	  Next,	  the	  gel	  pieces	  were	  incubated	  in	  50	  µl	  of	  55mM	  chloroacetamide	  made	  in	  100mM	  ammonium	  bicarbonate	  for	  20	  minutes	  at	  room	  temperature	  for	  alkylation.	  	  The	  samples	  were	  then	  washed	  and	  dehydrated	  with	  ACN,	  rehydrated	  with	  a	  6ng/ul	  	  trypsin	  (Promega)	  solution,	  and	  incubated	  overnight	  at	  37°C.	  	  The	  next	  day	  peptides	  
	  	  
31	  were	  extracted	  by	  various	  washes	  with	  0.1%	  formic	  acid,	  ACN,	  and	  water.	  The	  peptides	  were	  then	  lyophilized	  and	  resuspended	  prior	  to	  MS	  analysis.	  	  	  	  
	  
Strong	  Anionic	  Exchange	  Fractionation	  Desalted	  peptides	  from	  whole	  cell	  lysate	  (~50-­‐100	  µg)	  were	  fractionated	  on	  in-­‐house	  built	  strong	  anion	  exchange	  (SAX)	  pipettes	  which	  were	  assembled	  based	  on	  the	  StageTip	  protocol	  [99]	  by	  stacking	  6	  layers	  of	  an	  Empore	  Anion	  Exchange	  disk	  (3M	  Purifications)	  into	  a	  200	  µl	  pipette	  tip.	  	  Equilibration	  and	  elution	  of	  fractions	  was	  done	  according	  to	  protocol	  with	  Britton	  and	  Robinson	  Buffer	  at	  various	  pH.	  	  Peptides	  were	  loaded	  at	  pH	  11	  and	  the	  flow-­‐through	  was	  captured	  on	  Stage	  Tip	  [114]	  containing	  3	  layers	  of	  C18	  membrane.	  	  Fractions	  were	  subsequently	  eluted	  from	  SAX	  with	  buffer	  solutions	  of	  pH	  8,	  6,	  5,	  4,	  3,	  respectively.	  	  The	  eluted	  peptide	  fractions	  were	  captured	  on	  C18	  StageTips,	  desalted,	  and	  eluted	  with	  80%	  acetonitrile,	  0.5%	  acetic	  acid,	  lyophilized,	  and	  resuspended	  prior	  to	  MS	  analysis.	  
	  
LC-­MS/MS	  After	  optimization,	  mass	  spectrometry	  experiments	  were	  performed	  on	  an	  EASY-­‐nLC	  (Thermo	  Scientific)	  connected	  to	  a	  hybrid	  LTQ-­‐Orbitrap	  Classic	  with	  a	  nanoelectrospray	  ion	  source	  (Thermo	  Scientific)	  in	  a	  setup	  and	  settings[115]	  very	  similar	  to	  those	  previously	  described[116].	  	  Binding	  and	  separation	  of	  the	  peptides	  took	  place	  on	  an	  in-­‐house	  packed	  15	  cm	  silica	  analytical	  column	  	  (75	  µm	  inner	  diameter)	  packed	  with	  reversed	  phase	  ReproSil-­‐Pur	  C18AQ	  3	  µm	  resin	  (Dr	  Maisch	  GmbH,	  Ammerbuch-­‐Entringen,	  Germany).	  Samples	  were	  run	  for	  varying	  amounts	  of	  
	  	  
32	  time	  on	  a	  5%	  to	  25%	  acetonitrile	  in	  0.2%	  formic	  acid	  gradient	  at	  a	  flow	  rate	  of	  350	  nL	  per	  minute.	  	  The	  mass	  spectrometer	  was	  programmed	  to	  acquire	  data	  in	  a	  data-­‐dependent	  mode,	  automatically	  switching	  between	  full-­‐scan	  MS	  and	  tandem	  MS	  acquisition.	  	  Survey	  full	  scan	  MS	  spectra	  (from	  m/z	  300	  to	  1,7000)	  were	  acquired	  in	  the	  Orbitrap	  after	  the	  accumulation	  of	  500,000	  ions,	  with	  a	  resolution	  of	  60,000	  at	  400	  m/z.	  	  The	  ten	  most	  intense	  ions	  were	  sequentially	  isolated,	  and	  after	  the	  accumulation	  of	  5,000	  ions,	  fragmented	  in	  the	  linear	  ion	  trap	  by	  CID	  (collisional	  energy	  35%	  and	  isolation	  width	  2	  Da).	  	  Precursor	  ion	  charge	  state	  screening	  was	  enabled	  and	  singly	  charged	  and	  unassigned	  charge	  states	  were	  rejected.	  	  The	  dynamic	  exclusion	  list	  was	  set	  for	  a	  90s	  maximum	  retention	  time,	  a	  relative	  mass	  window	  of	  10	  ppm,	  and	  early	  expiration	  was	  enabled.	  	  	  






Data	  Analysis	  All	  raw	  data	  files	  were	  analyzed	  by	  MaxQuant	  (v	  1.0.13.13)	  [100]	  and	  searched	  against	  the	  Saccharomyces	  Genome	  Database.	  	  The	  search	  parameters	  included	  tryptic	  digestion	  with	  a	  maximum	  of	  two	  missed	  cleavages.	  A	  fixed	  carboxyamidomethyl	  modification	  and	  the	  variable	  modifications	  of	  oxidation	  of	  methionine	  and	  protein	  N-­‐terminus	  acetylation	  were	  all	  included	  in	  the	  search.	  A	  1%	  False	  Discovery	  Rate	  (FDR)	  threshold	  for	  both	  peptide	  and	  proteins	  was	  used.	  At	  least	  two	  peptides	  were	  required	  for	  protein	  identification	  and	  at	  least	  two	  different	  scanning	  events	  were	  required	  for	  protein	  quantitation.	  	  	  	  	  
Results	  As	  mentioned,	  our	  objective	  was	  to	  optimize	  conditions	  of	  sample	  preparation	  and	  sequencing	  in	  order	  to	  achieve	  deep	  proteome	  sequencing.	  	  In	  order	  to	  accomplish	  this	  goal,	  we	  overhauled	  the	  entire	  experimental	  method	  from	  protein	  extraction,	  to	  sequencing,	  to	  analysis	  (Figure	  2.1).	  	  It	  was	  crucial	  to	  investigate	  any	  changes	  and	  enhancements	  that	  could	  be	  made.	  Our	  hope	  was	  to	  achieve	  deep	  yeast	  proteome	  sequencing	  at	  a	  level	  of	  ~3,600	  proteins	  which	  had	  just	  been	  demonstrated	  by	  the	  Mann	  group	  at	  Max-­‐Planck[95].	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Figure	  2.1	  Experimental	  workflow.	  	  To	  optimize	  the	  experimental	  method,	  conditions	  and	  parameters	  in	  all	  stages	  of	  sample	  preparation	  were	  tested	  as	  shown	  above.	  	  	  	  
Sample	  Preparation	  	  To	  begin	  we	  looked	  at	  sample	  preparation,	  first	  focusing	  on	  protein	  extraction.	  	  The	  two	  methods	  compared	  were	  standard	  lysis	  with	  bead	  beading	  on	  a	  FastPrep	  and	  extraction	  using	  a	  CryoMill	  milling	  device.	  	  The	  FastPrep	  lysis	  method	  uses	  a	  harsh	  and	  rapid	  method	  of	  extraction.	  	  Cells	  were	  resuspended	  in	  an	  8M	  Urea	  Buffer	  and	  then	  disrupted	  by	  “bead	  beating.”	  The	  addition	  of	  urea	  and	  detergent	  to	  the	  buffer	  allowed	  for	  complete	  denaturation	  and	  extraction	  of	  proteins.	  The	  CryoMill	  method	  of	  lysis	  is	  similar	  to	  cryogenic	  grinding.	  The	  sample	  underwent	  lysis	  with	  ball	  milling	  under	  constant	  cooling	  with	  liquid	  nitrogen.	  The	  process	  resulted	  in	  efficient	  grinding	  and	  extraction.	  	  The	  powder	  was	  then	  resuspended	  in	  an	  8M	  Urea	  buffer.	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  Unexpectedly,	  we	  found	  a	  significant	  difference	  in	  sequencing	  depth	  when	  comparing	  the	  two	  methods	  of	  preparation.	  During	  160	  minute	  sequencing	  gradients	  the	  samples	  prepared	  by	  the	  CryoMill	  consistently	  resulted	  in	  more	  protein	  identifications.	  The	  CryoMill	  samples	  in	  four	  of	  five	  experimental	  runs	  resulted	  in	  30-­‐40%	  higher	  protein	  identifications	  than	  the	  samples	  prepared	  by	  the	  FastPrep	  (Table	  2.1).	  	  This	  was	  further	  demonstrated	  when	  the	  samples	  where	  fractionated	  by	  isoelectric	  focusing.	  Again,	  the	  CryoMill	  samples	  delivered	  much	  more	  sequencing	  depth	  across	  all	  fractions,	  indicating	  that	  the	  CryoMill	  method	  of	  lysis	  leads	  to	  more	  efficient	  and	  thorough	  extraction	  of	  different	  proteins.	  	  	  	  	  
Yeast	  Lysate	   Fast	  Prep	  (Protein	  
Identifications)	  
Milling	  Device	  (Protein	  
Identifications)	  
	  Sample	  Set	  1	  	   344	  	   518	  
Sample	  Set	  2	   338	   452	  
Sample	  Set	  3	   452	   447	  
Sample	  Set	  4	  	   321	   422	  
Sample	  Set	  5	   299	   436	  	  
Table	  2.1	  	  Sample	  lysis	  with	  a	  Milling	  Device	  leads	  to	  deeper	  sequencing.	  In	  a	  comparison	  of	  sample	  preparation	  with	  a	  Fast	  Prep	  versus	  a	  Milling	  Device,	  yeast	  lysate	  samples	  prepared	  with	  the	  milling	  device	  led	  to	  more	  proteins	  identified	  across	  various	  experimental	  replicates.	  
	  	  




Figure	  2.2	  	  Urea	  digestions	  are	  more	  efficient	  at	  room	  temperature.	  The	  amount	  of	  spectrum,	  peptide,	  and	  sample	  missed	  cleavages	  after	  digestion	  of	  yeast	  lysate	  samples	  at	  room	  temperature	  versus	  37°C	  demonstrated	  an	  advantage	  to	  digesting	  at	  room	  temperature.	  	  These	  results	  may	  be	  due	  to	  carbamylation,	  an	  effect	  of	  performing	  the	  digestions	  in	  8M	  Urea.	  	  Urea	  (a	  chaotrope),	  when	  in	  solution,	  is	  in	  equilibrium	  with	  ammonium	  cyanate.	  Carbamylation	  occurs	  when	  a	  form	  of	  cyanate,	  isocyanic	  acid,	  reacts	  with	  the	  amino	  groups	  of	  proteins.	  Cyanate	  additionally	  reacts	  with	  the	  side	  chains	  of	  lysine	  and	  arginine	  residues,	  leading	  to	  peptide	  missed	  cleavages.	  	  For	  sequencing	  purposes,	  carbamylation	  and	  missed	  cleavages	  add	  another	  dimension	  of	  modifications	  and	  search	  parameters,	  making	  sequencing	  results	  complicated	  and,	  at	  times,	  difficult	  to	  match.	  	  A	  urea	  solution,	  if	  left	  at	  room	  temperature,	  will	  always	  
	  	  
38	  degrade	  to	  isocyanic	  acid.	  	  The	  reason	  we	  believe	  we	  witnessed	  less	  effective	  digestion	  at	  higher	  temperatures	  was	  due	  to	  more	  carbamylation.	  The	  degradation	  of	  urea	  is	  accelerated	  at	  higher	  temperatures.	  Indeed,	  when	  we	  adjusted	  and	  began	  doing	  digests	  at	  room	  temperature,	  this	  led	  to	  a	  ~10%	  increase	  in	  protein	  identifications	  across	  all	  experiments.	  	  	   Lastly,	  we	  implemented	  a	  FASP	  (Filter-­‐Aided	  Proteome	  Preparation)	  methodology	  in	  yeast.	  This	  method	  was	  originally	  developed	  for	  mammalian	  cells	  and	  lead	  to	  an	  almost	  40%	  increase	  in	  protein	  identifications	  in	  lysate	  samples[113].	  At	  the	  heart	  of	  the	  method	  is	  complete	  solubilization	  of	  the	  proteome	  in	  sodium	  dodecyl	  sulfate	  (SDS)	  	  which	  is	  exchanged	  by	  urea	  on	  a	  standard	  filtration	  device.	  Peptides,	  eluted	  after	  in-­‐solution	  digestion	  on	  the	  filter,	  are	  extremely	  pure,	  which	  leads	  to	  deep	  proteome	  coverage.	  A	  key	  difference	  between	  yeast	  and	  mammalian	  cells	  is	  their	  cell	  walls.	  Yeast	  cells	  are	  much	  more	  durable	  and	  difficult	  to	  lyse,	  making	  the	  recommended	  4%	  SDS	  lysis	  by	  boiling	  difficult.	  We	  attempted	  to	  adapt	  this	  methodology	  by	  milling	  cells	  and	  resuspending	  the	  powder	  in	  4%	  SDS	  buffer.	  After	  doing	  FASP,	  we	  noticed	  very	  clean	  spectra	  but	  saw	  a	  minimal	  improvement	  in	  the	  number	  of	  protein	  identifications	  in	  yeast	  lysate.	  	  	  	  	  
Fractionation	  	   Although	  we	  focused	  on	  optimization	  of	  sample	  processing	  and	  sequencing,	  we	  simultaneously	  investigated	  fractionation	  techniques	  to	  increase	  proteome	  sequencing	  depth.	  	  We	  compared	  four	  different	  fractionation	  methods	  including	  GeLC,	  Multi-­‐Dimensional	  Protein	  Identification	  Technology	  (MudPIT),	  Strong	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  Anionic	  Exchange	  (SAX),	  and	  Isoelectric	  Focusing	  (IEF).	  Protein	  lysate	  samples	  are	  hugely	  complex	  with	  a	  vast	  array	  of	  protein	  modifications	  and	  a	  large	  dynamic	  range.	  Fractionation	  is	  used	  to	  distribute	  samples	  into	  multiple	  simpler	  fractions,	  thereby	  decreasing	  the	  sample	  dynamic	  range	  and	  allowing	  for	  deeper	  sequencing.	  	  	   The	  GeLC-­‐MS/MS	  fractionation	  strategy	  of	  in-­‐gel	  digestion	  of	  proteins	  isolated	  by	  gel	  electrophoresis	  has	  been	  used	  in	  the	  mass	  spectrometry	  proteomics	  field	  for	  many	  years[90].	  	  In	  this	  method,	  proteins	  are	  separated	  by	  molecular	  weight	  using	  SDS-­‐PAGE	  gel	  electrophoresis.	  The	  gel	  is	  then	  cut	  into	  multiple	  fragments,	  and	  as	  mentioned	  above,	  the	  proteins	  undergo	  in-­‐gel	  digestion.	  The	  peptides	  are	  then	  extracted	  and	  each	  fraction	  is	  most	  often	  run	  on	  a	  60-­‐90	  minute	  gradient.	  A	  large	  caveat	  to	  this	  method,	  although	  one	  can	  use	  a	  large	  amount	  of	  starting	  material	  there	  is	  a	  large	  loss	  of	  sample	  during	  processing	  with	  inefficient	  and	  uneven	  elution	  of	  peptides.	  	  	   	  	   We	  next	  investigated	  the	  MudPIT	  strategy.	  	  In	  this	  fractionation	  technique,	  a	  sample,	  or	  in	  our	  case,	  a	  yeast	  cell	  lysate,	  is	  digested	  in	  urea	  and	  loaded	  directly	  onto	  a	  LC	  column	  where	  it	  undergoes	  various	  stages	  of	  fractionation	  on	  the	  column	  prior	  to	  sequencing.	  	  The	  peptides	  undergo	  three	  phases	  of	  fractionation	  on	  the	  column:	  reverse-­‐phase,	  followed	  by	  strong	  cationic	  exchange	  (SCX),	  followed	  by	  another	  reverse-­‐phase	  fractionation	  via	  a	  step	  gradient	  of	  acetonitrile	  and	  ammonium	  acetate	  buffers	  for	  12	  hours.	  MudPIT	  is	  commonly	  used	  as	  an	  alternative	  to	  gel-­‐based	  protein	  separation[118,	  119].	  An	  advantage	  of	  this	  method	  is	  that	  peptide	  samples	  undergo	  fractionation	  on	  column	  and	  are	  directly	  eluted	  in-­‐line	  to	  an	  ion	  trap	  mass	  spectrometer	  minimizing	  sample	  loss.	  	  	  
	  	  
40	  	   A	  fractionation	  method	  known	  as	  strong	  anionic	  exchange	  (SAX)	  was	  also	  tested.	  Strong	  anionic	  exchange	  (SAX)	  has	  been	  used	  in	  the	  field	  for	  many	  years	  with	  offline	  fractionation	  prior	  to	  running	  on	  a	  mass	  spectrometer.	  	  We	  implemented	  a	  protocol	  utilizing	  in-­‐house	  built	  SAX	  pipette	  tips	  resulting	  in	  six	  different	  fractions	  that	  were	  analyzed	  for	  160	  minutes	  each[99].	  	  	   Lastly,	  we	  implemented	  and	  tested	  an	  OFF-­‐GEL	  Isoelectric	  Focusing	  method,	  where	  peptides	  are	  separated	  based	  on	  their	  isoelectric	  points.	  	  This	  is	  achieved	  by	  carrier	  ampholytes	  in	  an	  immobilized	  pH	  gradient	  gel	  strip.	  	  Samples	  were	  collected	  in	  24	  liquid	  fractions,	  which	  were	  then	  analyzed	  for	  160	  minutes	  each.	  	  Analysis	  of	  all	  fractions	  was	  around	  72	  hours.	  	   After	  implementation	  of	  all	  the	  fractionation	  techniques,	  not	  surprisingly,	  the	  most	  sequencing	  depth	  was	  achieved	  with	  OFF-­‐GEL	  fractionation.	  	  For	  the	  purpose	  of	  yeast	  proteome	  identification,	  sequencing	  of	  24	  IEF	  fractions	  with	  the	  large	  amount	  of	  sequencing	  time	  was	  used	  in	  order	  to	  achieve	  a	  depth	  of	  ~3,500	  proteins.	  	  However,	  the	  SAX	  fractionation	  served	  as	  a	  convenient	  alternative,	  with	  sequencing	  for	  24	  hours	  leading	  to	  around	  2,300	  protein	  identifications.	  The	  GeLC	  and	  MudPIT	  strategies,	  although	  shorter	  sequencing	  methods,	  were	  not	  reproducible	  enough	  and	  did	  not	  give	  enough	  sequencing	  depth	  to	  be	  considered	  for	  large-­‐scale	  sequencing	  experiments.	  	  
LC-­MS/MS	  	   A	  large	  effort	  was	  undertaken	  into	  the	  optimization	  of	  chromatography	  methods	  and	  mass	  spectrometric	  settings.	  All	  chromatography	  parameters	  were	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  studied,	  including	  loading	  methods,	  gradients,	  elution	  times,	  and	  ion	  spray	  tips.	  	  As	  for	  the	  mass	  spectrometry	  settings,	  many	  changes	  were	  made	  to	  have	  the	  most	  optimized	  and	  efficient	  sequencing	  of	  complex	  mixtures.	  	   To	  begin,	  we	  purchased	  a	  brand	  new	  LC	  system.	  This	  system,	  the	  EASY-­‐nLC	  from	  Proxeon,	  is	  a	  high-­‐pressure	  chromatography	  system	  capable	  of	  nanoflow	  elution.	  This	  system	  allows	  for	  extremely	  sharp	  chromatography	  and	  is	  extremely	  sensitive	  and	  reproducible.	  Even	  though	  this	  is	  a	  very	  sophisticated	  and	  cutting	  edge	  system	  there	  were	  still	  many	  parameters	  to	  optimize	  on	  the	  EASY-­‐nLC.	  	  	  	   After	  implementing	  the	  new	  system,	  we	  investigated	  whether	  to	  install	  a	  pre-­‐column	  filter	  to	  the	  standard	  chromatography	  setup.	  When	  using	  high-­‐pressure	  chromatography	  systems,	  peptide	  mixtures	  are	  often	  passed	  through	  an	  online	  pre-­‐column	  filter.	  This	  is	  done	  to	  protect	  the	  column	  from	  dust,	  salts,	  or	  particles	  that	  pass	  from	  the	  HPLC	  pump	  onto	  the	  column.	  This	  prevents	  the	  system	  from	  clogging	  which	  can	  lead	  to	  a	  shut	  down	  of	  the	  system	  and	  a	  loss	  of	  the	  experimental	  run.	  In	  addition	  this	  keeps	  the	  mass	  spectrometer	  clean.	  However,	  use	  of	  a	  pre-­‐column	  can	  lead	  to	  sample	  loss	  and	  at	  times	  may	  be	  unnecessary	  if	  ample	  precaution	  is	  taken	  during	  sample	  preparation.	  We	  compared	  the	  use	  of	  pre-­‐column	  to	  direct	  loading	  (no	  pre-­‐column)	  in	  identical	  yeast	  lysate	  samples	  and	  gradients	  (Table	  2.2).	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Table	  2.2	  	  Comparison	  of	  LC	  loading	  methods.	  An	  evaluation	  of	  the	  number	  of	  proteins	  identified	  using	  the	  pre-­‐column	  versus	  the	  direct	  loading	  methods	  indicates	  a	  substantial	  increase	  in	  proteome	  coverage	  with	  the	  use	  of	  the	  direct	  load	  method.	  	  From	  these	  experiments,	  we	  deduced	  that	  use	  of	  the	  direct	  load	  method	  led	  to	  a	  consistent	  25-­‐30%	  increase	  in	  protein	  identifications	  in	  yeast	  lysate.	  This	  was	  further	  confirmed	  by	  intensities	  of	  experimental	  runs.	  When	  loading	  the	  same	  amount	  of	  sample,	  the	  direct	  load	  experiments	  consistently	  showed	  up	  to	  a	  magnitude	  higher	  signal	  than	  that	  of	  the	  run	  with	  a	  pre-­‐column.	  	   We	  then	  tested	  several	  other	  parameters	  in	  the	  chromatography	  system,	  upstream	  of	  ion	  injection.	  We	  investigated	  the	  use	  of	  several	  capillary	  column	  widths	  and	  lengths	  and	  tested	  various	  C18	  bead	  sizes	  within	  the	  column.	  Smaller	  beads	  provide	  more	  surface	  area	  and	  optimal	  separation,	  improving	  chromatographic	  resolution.	  However	  the	  optimal	  size	  of	  beads	  is	  dependent	  on	  the	  pressure	  limits	  of	  the	  chromatography	  system.	  Additionally,	  the	  larger	  the	  diameter	  of	  the	  capillary	  column	  the	  lower	  the	  electron	  spray	  ionization	  sensitivity	  due	  to	  sample	  dilution.	  We	  settled	  on	  what	  had	  previously	  been	  the	  lab	  standard	  of	  15	  cm	  
Loading	  Method	   Protein	  
Identifications	  
UPLC	  (Pre-­‐Column)	   521,	  542	  
Direct	  Load	   643,	  712	  
	  	  




Figure	  2.3	  	  An	  optimized	  chromatography	  gradient.	  A	  chromatogram	  of	  peptide	  elution	  (top)	  and	  MS/MS	  events	  	  (bottom)	  triggered	  throughout	  the	  length	  of	  an	  entire	  experimental	  run	  demonstrated	  the	  quality	  of	  the	  newly	  implemented	  elution	  gradient.	  	  	   Downstream	  of	  chromatography,	  significant	  efforts	  were	  made	  to	  optimize	  sequencing,	  with	  a	  complete	  overhaul	  of	  instrumental	  methods.	  	  Various	  parameters	  were	  tested,	  including	  lockmass	  calibration,	  the	  size	  of	  mass	  windows,	  sequencing	  range,	  and	  charge	  state	  recognition	  and	  sequencing.	  Our	  end	  goal	  was	  to	  have	  extremely	  efficient	  sequencing,	  with	  the	  highest	  number	  of	  sequencing	  events	  of	  different	  peptides.	  	  
	  	  
45	  	   To	  begin	  the	  overhaul	  of	  methods,	  we	  first	  altered	  our	  method	  of	  acquisition.	  	  In	  our	  original	  experimental	  methods,	  acquisition	  was	  done	  by	  utilizing	  long	  high	  resolution	  initial	  MS	  scans	  prior	  to	  selecting	  the	  most	  intense	  ion	  for	  fragmentation	  and	  sequencing.	  	  We	  tested	  a	  new	  approach	  of	  acquiring	  data,	  known	  as	  the	  data-­‐dependent	  mode,	  where	  the	  mass	  spectrometer	  automatically	  switches	  between	  full-­‐scan	  MS	  and	  tandem	  MS	  acquisition.	  	  Upon	  the	  accumulation	  of	  a	  certain	  threshold	  of	  ions,	  the	  instrument	  does	  an	  initial	  high-­‐resolution	  scan	  in	  the	  Orbitrap.	  Following	  the	  scan,	  the	  ten	  most	  intense	  ions	  are	  isolated	  and	  fragmented	  in	  the	  linear	  ion	  trap.	  This	  mode	  leads	  to	  a	  larger	  number	  of	  sequencing	  events,	  however,	  there	  is	  still	  a	  fine	  balance	  between	  large	  number	  of	  scans	  and	  scan	  quality.	  In	  order	  to	  achieve	  clear	  spectra,	  a	  higher	  threshold	  of	  ions	  is	  preferred,	  but	  in	  order	  to	  accumulate	  ions	  one	  must	  sacrifice	  time	  for	  accumulation.	  The	  ion	  threshold	  was	  monitored	  to	  see	  which	  threshold	  gave	  the	  best	  spectra	  with	  minimal	  sacrifice	  of	  sequencing	  events.	  We	  discovered	  that	  the	  data-­‐dependent	  configuration	  led	  to	  a	  four-­‐fold	  increase	  of	  MS2	  events	  and	  a	  large	  increase	  in	  protein	  identifications.	  Additionally	  we	  made	  other	  minor	  changes	  in	  sequencing	  settings.	  We	  allowed	  for	  charge	  state	  screening,	  permitting	  the	  instrument	  to	  monitor	  charge	  states	  of	  peptides,	  rejecting	  singly	  and	  assigned	  charge	  peptides.	  This	  mode	  decreased	  the	  likelihood	  of	  unassigned	  sequences.	  	  	  	   Additionally,	  we	  optimized	  our	  precursor	  mass	  window	  for	  sequencing.	  Upon	  the	  selection	  of	  an	  ion	  for	  fragmentation,	  the	  instrument	  accumulates	  ions	  within	  a	  certain	  mass	  range	  to	  allow	  for	  minimal	  mass	  deviation.	  It	  has	  been	  shown	  in	  complex	  mixtures	  that	  up	  to	  95%	  of	  peptides	  are	  within	  1.5ppm	  of	  the	  correct	  value	  
	  	  
46	  and	  almost	  none	  deviate	  by	  more	  than	  2ppm[120].	  	  Our	  initial	  settings	  allowed	  for	  3ppm,	  a	  conservative	  window	  to	  include	  all	  correct	  peptide	  hits.	  However,	  upon	  testing	  a	  2ppm	  window	  we	  found	  an	  almost	  20%	  increase	  in	  identifications	  and	  much	  cleaner	  MS2	  spectra	  (Figure	  2.4).	  	  	  
	  
Yeast	  Lysate	   2ppm	  Window	   3ppm	  Window	  
Sample	  1	   421	  Identifications	   357	  Identifications	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  Sample	  2	   372	  Identifications	   291	  Identifications	  
Figure	  2.4	  	  A	  smaller	  mass	  window	  leads	  to	  deeper	  sequencing	  of	  yeast	  lysate.	  MS/MS	  spectra	  of	  peptides	  using	  a	  2ppm	  (top)	  and	  3ppm	  (bottom)	  mass	  window	  are	  shown.	  Evaluation	  of	  the	  spectra	  and	  a	  comparison	  of	  the	  number	  of	  proteins	  identified	  in	  yeast	  lysate	  samples	  (two	  experimental	  replicates)	  using	  the	  different	  mass	  windows	  indicated	  an	  increase	  in	  proteome	  covering	  using	  the	  smaller	  mass	  window.	  	  	   	  	   Furthermore,	  we	  investigated	  the	  usage	  of	  lock	  mass	  calibration.	  Mass	  accuracy	  is	  a	  very	  important	  in	  proteomic	  experiments	  and	  is	  key	  to	  peptide	  identification.	  To	  compensate	  for	  drifts	  in	  instrument	  calibration	  during	  an	  experimental	  run,	  a	  ‘lock	  mass,’	  an	  internal	  mass	  standard	  for	  on-­‐going	  instrument	  calibrations	  during	  the	  run,	  is	  used.	  The	  lock	  mass	  most	  often	  added	  to	  LTQ-­‐Orbitrap	  spectra	  is	  found	  in	  laboratory	  air.	  We	  found	  that	  this	  recalibration	  had	  little	  impact	  on	  our	  overall	  protein	  identifications.	  	  	   Lastly,	  after	  making	  various	  changes	  to	  the	  instrument	  settings	  and	  chromatography,	  we	  investigated	  the	  ion	  injection	  time	  of	  our	  experimental	  runs.	  As	  mentioned	  earlier	  in	  this	  chapter,	  in	  the	  analytical	  cycle	  of	  the	  data-­‐dependent	  mode,	  ions	  are	  first	  injected	  into	  the	  Orbitrap	  and	  once	  a	  threshold	  of	  ions	  has	  filled	  the	  trap	  the	  most	  abundant	  parent	  ions	  are	  isolated	  and	  sequenced.	  To	  achieve	  the	  maximal	  number	  of	  sequencing	  during	  an	  experimental	  run,	  it	  is	  crucial	  to	  go	  through	  as	  many	  analytical	  cycles	  as	  possible.	  Ion	  injection	  is	  usually	  the	  rate-­‐determining	  step	  in	  this	  process	  for	  if	  there	  is	  a	  delay	  in	  ion	  injection	  MS2	  events	  will	  not	  be	  triggered.	  These	  delays	  may	  be	  due	  to	  inefficient	  spray	  or	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  chromatography	  and	  even	  improper	  settings.	  Prior	  to	  our	  overhaul	  of	  the	  experimental	  setup	  our	  mean	  injection	  time	  was	  366	  ms	  with	  a	  median	  of	  319	  ms.	  When	  studying	  the	  distribution	  of	  injection	  times	  throughout	  an	  experimental	  run,	  it	  was	  clear	  that	  ions	  were	  not	  being	  efficiently	  delivered	  to	  the	  trap	  and	  sequencing	  was	  suboptimal	  (Figure	  2.5).	  




Figure	  2.5	  Improvement	  in	  the	  distribution	  of	  injection	  times	  in	  experimental	  runs.	  Comparison	  of	  the	  efficiency	  of	  ion	  delivery	  prior	  to	  (top)	  and	  after	  (bottom)	  the	  optimization	  of	  the	  experimental	  method.	  	  Subsequent	  to	  our	  optimization	  there	  was	  a	  significant	  change	  in	  ion	  injection	  times.	  With	  our	  new	  setup,	  the	  mean	  injection	  time	  was	  57.6	  ms	  with	  a	  median	  of	  7.1	  ms.	  These	  results	  indicated	  that	  ion	  delivery	  and	  sequencing	  ere	  extremely	  efficient.	  	  	   It	  is	  also	  important	  to	  mention	  that	  we	  implemented	  the	  MaxQuant	  quantitative	  proteomics	  software	  package	  into	  our	  pipeline.	  This	  was,	  and	  currently	  still	  is,	  the	  most	  advanced	  tool	  for	  analysis	  of	  large	  mass	  spectrometric	  data	  sets.	  We	  consistently	  used	  this	  software	  to	  track	  our	  progress	  in	  the	  development	  of	  the	  experimental	  method.	  
	  	  
50	  	   Essentially,	  all	  possible	  parameters	  and	  changes	  were	  investigated	  to	  overhaul	  the	  experimental	  pipeline.	  As	  mentioned	  early	  on,	  we	  decided	  that	  although	  time-­‐consuming,	  the	  IEF	  fractionation	  method	  would	  provide	  the	  best	  sequencing	  depth.	  Additionally,	  we	  settled	  on	  the	  SILAC	  labeling	  technique,	  as	  in	  the	  field	  this	  seemed	  to	  be	  the	  most	  reliable	  and	  simple	  method	  for	  relative	  quantitation	  of	  samples.	  After	  implementation	  of	  various	  experimental	  changes,	  we	  monitored	  our	  progress,	  using	  MaxQuant,	  as	  we	  overhauled	  the	  experimental	  pipeline	  (Figure	  2.6)	  
	  
Figure	  2.6	  Successful	  implementation	  of	  a	  strategy	  for	  in-­‐depth	  sequencing	  of	  the	  yeast	  proteome.	  	  A	  graph	  of	  the	  number	  of	  proteins	  identified	  in	  24-­‐fraction	  IEF	  experiments	  upon	  the	  implementation	  of	  changes	  to	  the	  experimental	  pipeline.	  Experiments	  were	  compared	  to	  a	  yeast	  proteome	  sequencing	  data	  set	  from	  Godoy	  et	  al.	  The	  number	  of	  proteins	  identified	  in	  the	  February	  ’10	  experiment	  indicated	  we	  had	  successfully	  optimized	  our	  experimental	  method.	  Lysates	  are	  SILAC	  labeled.	  	  
	  	  
51	  Over	  the	  course	  of	  a	  year-­‐long	  effort	  we	  saw	  a	  significant	  increase	  in	  protein	  identifications	  and	  were	  finally	  able	  to	  reach	  our	  goal	  of	  yeast	  proteome	  sequencing	  at	  a	  similar	  level	  to	  the	  deepest	  sequencing	  that	  had	  been	  previously	  published[95].	  In	  the	  end	  our	  method	  consisted	  of	  the	  following:	  milling	  and	  mixing	  of	  SILAC	  labeled	  “heavy”	  and	  “light”	  cells,	  followed	  by	  tryptic	  digestion	  and	  IEF	  fractionation	  of	  peptides	  into	  24	  samples,	  followed	  by	  the	  analysis	  of	  each	  sample	  on	  a	  three-­‐hour	  gradient.	  	  	  
Discussion	  	   Here	  we	  have	  demonstrated	  the	  successful	  implementation	  of	  a	  mass	  spectrometry-­‐based	  method	  to	  perform	  accurate	  quantitative	  analysis	  of	  the	  yeast	  proteome.	  We	  have	  examined	  and	  optimized	  every	  step	  in	  the	  experimental	  process	  and	  have	  performed	  a	  complete	  overhaul	  of	  our	  previous	  methodologies.	  We	  have	  optimized	  our	  instrument	  and	  chromatography	  system	  to	  achieve	  a	  maximal	  sequencing	  speed	  while	  still	  sequencing	  with	  effective	  accuracy,	  sensitivity,	  and	  dynamic	  range.	  In	  terms	  of	  sample	  preparation	  our	  method	  now	  employs	  an	  isoelectric	  focusing-­‐based	  fractionation	  technique	  in	  addition	  to	  SILAC,	  a	  method	  of	  labeling	  cells	  to	  produce	  1:1	  pairs	  of	  true	  peptide	  signals	  for	  relative	  quantification.	  	  	   The	  applications	  and	  potential	  of	  this	  technology	  are	  tremendous.	  Using	  this	  technique,	  with	  minimal	  sample,	  one	  can	  identify	  several	  thousand	  proteins	  in	  the	  yeast	  proteome	  to	  look	  at	  the	  impacts	  of	  different	  treatments	  or	  mutations	  on	  the	  global	  proteome.	  We	  suspect	  that	  the	  sequencing	  depth	  we	  have	  achieved	  is	  sufficient	  and	  represents	  most	  of	  the	  expressed	  proteome,	  as	  all	  6,000	  yeast	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  proteins	  may	  not	  be	  expressed	  at	  once.	  However,	  although	  a	  promising	  and	  exciting	  experimental	  method	  this	  setup	  does	  have	  its	  limitations.	  	   The	  two	  largest	  limitations	  of	  the	  experimental	  setup	  are	  cost	  and	  the	  long	  duration	  of	  sequencing	  time	  of	  about	  72	  hours.	  However,	  if	  maximal	  sequencing	  depth	  is	  not	  necessary	  this	  setup	  can	  be	  modified	  and	  used	  in	  conjunction	  with	  other	  fractionation	  techniques	  described	  earlier	  in	  the	  chapter.	  For	  instance,	  we	  applied	  this	  technology	  and	  utilized	  a	  SAX	  fractionation	  technique	  to	  sequence	  changes	  in	  the	  ubiquitin	  proteome	  in	  cdc48	  and	  ubx	  mutants,	  in	  order	  to	  look	  for	  potential	  new	  substrates	  in	  the	  Cdc48	  network.	  These	  experiments,	  which	  only	  required	  24	  hours	  of	  sequencing	  time,	  are	  described	  in	  detail	  in	  the	  next	  chapter	  (Chapter	  3).	  In	  addition,	  our	  experimental	  setup	  was	  modified	  and	  utilized	  in	  various	  other	  publications[121-­‐123].	  Essentially,	  with	  an	  optimized	  chromatography	  and	  mass	  spectrometric	  system	  and	  a	  knowledge	  and	  understanding	  of	  the	  various	  fractionation	  techniques,	  we	  now	  have	  the	  capability	  to	  customize	  methods	  according	  to	  experimental	  sequencing	  requirements.	  As	  mentioned,	  the	  possibilities	  are	  endless.	  	   Despite	  these	  achievements	  and	  capabilities,	  quantitative	  proteomics	  by	  mass	  spectrometry	  is	  still	  a	  rapidly	  evolving	  field.	  Although	  one	  can	  do	  deep	  sequencing	  of	  the	  yeast	  proteome,	  our	  capabilities	  are	  still	  not	  as	  sensitive	  or	  do	  not	  have	  as	  much	  coverage	  as	  necessary	  for	  larger	  proteomes,	  such	  as	  human,	  which	  express	  up	  to	  three	  times	  more	  genes	  than	  yeast.	  Additionally,	  in	  yeast	  to	  have	  a	  more	  complete	  understanding	  of	  the	  proteome	  higher	  peptide	  sequencing	  coverage	  per	  protein	  is	  necessary.	  Sequencing	  of	  this	  caliber	  cannot	  be	  achieved	  with	  the	  
	  	  
53	  current	  technology.	  However,	  attaining	  this	  goal	  seems	  to	  be	  the	  trajectory	  of	  the	  field.	  New	  instruments,	  such	  as	  the	  LTQ	  Orbitrap	  Velos,	  are	  pushing	  the	  limits	  of	  sequencing	  depth	  and	  new	  hybrid	  approaches	  of	  targeted	  and	  shotgun	  proteomics	  are	  making	  larger	  proteome	  sequencing	  much	  more	  achievable	  in	  the	  not-­‐so-­‐distant	  future.	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Chapter	  3:	  	  
	  
Perturbations	  to	  the	  
Ubiquitin	  Conjugate	  
Proteome	  in	  ∆ubx	  Mutants	  
Identify	  Ubx2	  as	  a	  Regulator	  
of	  Membrane	  Lipid	  
Composition*	  	  	  	  	  	  *This	  chapter,	  currently	  under	  review	  for	  publication,	  was	  written	  by	  Natalie	  Kolawa,	  Michael	  J.	  Sweredoski,	  Robert	  L.J.	  Graham,	  Robert	  Oania,	  Sonja	  Hess,	  and	  Raymond	  J.	  Deshaies.	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Abstract	  Yeast	  Cdc48	  (p97/VCP	  in	  human	  cells)	  is	  a	  hexameric	  AAA	  ATPase	  that	  is	  thought	  to	  transduce	  the	  chemical	  energy	  of	  ATP	  hydrolysis	  into	  mechanical	  force	  that	  can	  be	  used	  to	  segregate	  ubiquitin-­‐conjugated	  proteins	  from	  tightly-­‐bound	  partners.	  Current	  models	  posit	  that	  the	  mechanochemical	  activity	  of	  Cdc48	  is	  linked	  to	  its	  substrates	  through	  adaptor	  proteins,	  including	  a	  family	  of	  seven	  proteins	  (13	  in	  human)	  that	  contain	  a	  Cdc48-­‐binding	  UBX	  domain.	  However,	  few	  substrates	  for	  specific	  UBX	  proteins	  are	  known,	  and	  hence	  the	  generality	  of	  this	  hypothesis	  remains	  largely	  untested.	  Here	  we	  report	  comprehensive	  identification	  of	  ubiquitin	  conjugates	  that	  accumulate	  in	  cdc48	  and	  ubx	  mutants	  using	  quantitative	  mass	  spectrometry.	  Different	  
ubx	  mutants	  exhibit	  reproducible	  patterns	  of	  conjugate	  accumulation	  that	  differ	  greatly	  from	  each	  other	  and	  that	  point	  to	  unexpected	  functional	  specializations	  of	  individual	  Ubx	  proteins.	  To	  validate	  our	  mass	  spectrometry	  findings,	  we	  examined	  in	  detail	  the	  endoplasmic	  reticulum-­‐bound	  transcription	  factor	  Spt23,	  which	  we	  identified	  as	  a	  putative	  Ubx2	  substrate.	  Mutant	  ubx2∆	  cells	  are	  deficient	  in	  both	  cleaving	  the	  ubiquitinated	  120	  kD	  precursor	  of	  Spt23	  to	  form	  active	  p90	  and	  in	  localizing	  p90	  to	  the	  nucleus.	  Consistent	  with	  reduced	  production	  of	  active	  p90,	  ubx2∆	  cells	  are	  deficient	  in	  expression	  of	  its	  target	  gene	  OLE1,	  a	  fatty	  acid	  desaturase.	  Our	  findings	  illustrate	  the	  utility	  of	  proteomics	  to	  identify	  ligands	  for	  specific	  ubiquitin	  receptor	  pathways	  and	  uncover	  Ubx2	  as	  a	  key	  player	  in	  the	  regulation	  of	  membrane	  lipid	  biosynthesis.	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Introduction	  Cdc48/p97	  is	  an	  essential,	  highly	  abundant	  member	  of	  the	  AAA	  (ATPase	  associated	  with	  various	  cellular	  activities)	  protein	  family.	  Cdc48	  has	  been	  linked	  to	  numerous	  functions	  throughout	  the	  cell	  but	  is	  best	  known	  for	  its	  critical	  role	  in	  ERAD	  (endoplasmic	  reticulum	  associated	  protein	  degradation),	  which	  occurs	  via	  the	  ubiquitin	  proteasome	  system	  (UPS).	  It	  is	  also	  involved	  in	  cell-­‐cycle	  progression,	  homotypic	  membrane	  fusion,	  chromatin	  remodeling,	  autophagy,	  and	  transcriptional	  and	  metabolic	  regulation[26-­‐29].	  Cdc48	  has	  been	  the	  subject	  of	  much	  attention	  over	  the	  last	  few	  years	  due	  to	  its	  causal	  links	  to	  amyotrophic	  lateral	  sclerosis	  (ALS)	  and	  inclusion	  body	  myopathy,	  Paget’s	  disease	  of	  the	  bone,	  and	  frontotemporal	  dementia	  (IBMPFD)	  as	  well	  as	  its	  implied	  role	  in	  a	  variety	  of	  diseases	  including	  cancer[30-­‐34].	  As	  a	  result,	  p97	  has	  been	  the	  target	  of	  multiple	  drug	  development	  efforts[35,	  36].	  	  Cdc48/p97	  interacts	  with	  a	  large	  number	  of	  putative	  substrate	  adaptors	  and	  co-­‐factors,	  including	  a	  family	  of	  proteins	  (seven	  in	  yeast,	  thirteen	  in	  human	  cells)	  that	  contain	  an	  UBX	  domain[41,	  42].	  The	  UBX	  domain	  binds	  to	  the	  N-­‐terminal	  region	  of	  p97	  and	  proteins	  bearing	  this	  domain	  have	  been	  suggested	  to	  serve	  as	  interchangeable	  adaptors	  that	  target	  Cdc48/p97	  to	  specific	  substrates.	  Although	  the	  functions	  and	  mechanism	  of	  action	  of	  Cdc48/p97	  remain	  poorly	  understood,	  it	  is	  generally	  presumed	  that	  it	  uses	  ATP	  hydrolysis	  to	  fuel	  the	  extraction	  of	  ubiquitinated	  proteins	  from	  multi-­‐subunit	  complexes	  or	  membranes	  as	  a	  prelude	  to	  their	  degradation	  by	  the	  proteasome.	  Cdc48/p97	  may	  also	  remodel	  protein:protein	  and	  protein:nucleic	  acid	  complexes	  in	  a	  manner	  that	  is	  not	  coupled	  to	  either	  prior	  ubiquitination[124]	  or	  subsequent	  degradation	  by	  the	  proteasome[44,	  125].	  
	  	  
57	  Based	  on	  the	  abundance	  of	  Cdc48/p97	  and	  the	  complexity	  of	  the	  network	  of	  adaptor	  proteins	  for	  which	  it	  serves	  as	  the	  hub,	  Cdc48/p97	  has	  the	  potential	  to	  exert	  a	  profound	  influence	  on	  the	  UPS.	  However,	  the	  number	  of	  known	  substrates	  of	  Cdc48/p97	  remains	  relatively	  small	  and	  smaller	  still	  is	  the	  number	  of	  substrates	  that	  have	  been	  linked	  to	  a	  specific	  UBX	  domain	  protein.	  Indeed,	  only	  a	  handful	  of	  specific	  cases	  are	  known	  and	  in	  half	  of	  them	  proteasomal	  degradation	  is	  not	  the	  final	  outcome[44,	  51-­‐53,	  125-­‐128].	  To	  understand	  why	  there	  is	  such	  a	  profusion	  of	  UBX	  domain	  proteins	  in	  cells	  it	  will	  be	  important	  to	  determine	  what	  these	  proteins	  do	  to	  their	  substrates,	  which	  will	  require	  knowing	  what	  their	  substrates	  are.	  Therefore,	  a	  major	  goal	  of	  this	  work	  is	  to	  enable	  future	  investigations	  into	  the	  function	  and	  regulation	  of	  UBX	  proteins	  by	  assembling	  a	  catalog	  of	  candidate	  substrates/targets.	  A	  key	  paradigm	  that	  guides	  our	  current	  understanding	  of	  Cdc48	  function	  emerged	  from	  studies	  on	  the	  processing	  of	  the	  transcription	  factors	  Spt23	  and	  Mga2	  [73,	  75,	  83].	  These	  seminal	  studies	  revealed	  the	  mechanism	  by	  which	  cells	  control	  their	  ratio	  of	  saturated	  to	  unsaturated	  fatty	  acids	  to	  maintain	  an	  appropriate	  lipid	  composition	  in	  cellular	  membranes.	  Central	  to	  this	  regulation	  are	  the	  transcription	  factors	  Spt23	  and	  Mga2	  which	  are	  released	  from	  the	  endoplasmic	  reticulum	  (ER)	  membrane	  so	  that	  they	  can	  translocate	  to	  the	  nucleus	  and	  activate	  expression	  of	  OLE1	  which	  encodes	  the	  stearoyl-­‐∆9	  desaturase	  that	  governs	  the	  conversion	  of	  saturated	  fatty	  acids	  (SFAs)	  to	  unsaturated	  fatty	  acids	  (UFAs)[71,	  72].	  Spt23	  and	  Mga2	  are	  initially	  produced	  as	  120	  kD	  precursors	  (p120)	  embedded	  in	  the	  ER	  by	  C-­‐terminal	  signal/anchor	  domains,	  such	  that	  the	  bulk	  of	  each	  protein	  projects	  into	  the	  cytosol.	  The	  p120	  form	  of	  each	  protein	  is	  ubiquitinated	  by	  Rsp5	  and	  cleaved	  by	  the	  proteasome,	  which	  yields	  a	  p90	  form	  that	  
	  	  





Yeast	  Strains	  and	  Growth	  Conditions	  Strains,	  plasmids,	  and	  primers	  used	  in	  this	  study	  are	  described	  in	  Supplemental	  Tables	  3.1-­‐3.3.	  All	  yeast	  strains	  are	  derivates	  of	  either	  the	  wild-­‐type	  strain	  RJD	  4614	  (S288C	  background	  from	  the	  Open	  Biosystems	  Yeast	  Knockout	  Library)	  or	  the	  wild-­‐type	  strain	  RJD	  360	  (W303	  background).	  Standard	  genetic	  techniques	  were	  used.	  Unless	  otherwise	  stated	  strains	  were	  grown	  at	  30°C	  and	  cultured	  on	  YPD.	  	  
	  
SILAC	  Labeling	  of	  Cells	  For	  SILAC	  experiments	  strains	  auxotrophic	  for	  lysine	  and	  arginine	  were	  used.	  Cells	  expressing	  His8ubiquitin	  were	  grown	  in	  complete	  synthetic	  medium	  with	  2%	  dextrose	  containing	  20	  mg/L	  lysine	  and	  arginine	  or	  in	  “heavy”	  medium	  with	  20	  mg/L	  13C615N2-­‐lysine	  and	  13C6-­‐arginine	  (Cambridge	  Isotope	  Laboratories).	  All	  mutant	  strains	  with	  the	  exception	  of	  cdc48-­3	  and	  ubx2Δ	  expressed	  His8ubiquitin	  and	  endogenous	  ubiquitin	  in	  a	  1:1	  ratio.	  Cdc48-­3	  and	  ubx2Δ	  cells	  expressed	  lower	  levels	  of	  His8ubiquitin,	  which	  we	  corrected	  for	  during	  quantification.	  Cells	  were	  grown	  for	  10	  generations	  to	  log-­‐phase	  (OD600	  1.0-­‐2.0)	  and	  equal	  amounts	  of	  the	  “light”	  and	  “heavy”	  -­‐labeled	  cells	  (as	  determined	  by	  OD600)	  were	  mixed,	  harvested,	  washed,	  and	  flash	  frozen.	  
	  
Purification	  of	  Ub	  Conjugates	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  Purifications	  were	  done	  similarly	  to	  the	  protocol	  described	  previously	  [131].	  200	  OD600	  units	  of	  cells	  were	  lysed	  in	  urea	  buffer	  (8M	  urea,	  300mM	  NaCl,	  100mM	  Na2PO4,	  10mM	  Tris-­‐HCl	  pH	  8.0,	  0.2%	  Triton	  X-­‐100,	  20mM	  imidazole,	  and	  5mM	  N-­‐ethylmaleimide	  (NEM))	  by	  vortexing	  with	  glass	  beads.	  Ubiquitinated	  proteins	  were	  purified	  by	  the	  addition	  of	  nickel-­‐NTA	  bead	  slurry	  (50μl	  beads/5-­‐10mg	  of	  lysate)	  to	  clarified	  lysate	  (13,200	  rpm	  for	  15	  minutes	  in	  an	  Eppendorf	  Centrifuge	  5417R)	  and	  mixed	  at	  room	  temperature	  for	  90	  minutes.	  Beads	  were	  washed	  three	  times	  with	  20	  bed	  volumes	  of	  buffer.	  A	  two-­‐step	  tryptic	  digestion	  was	  performed	  directly	  on	  proteins	  bound	  to	  the	  beads	  [121].	  
	  
Fractionation	  and	  LC-­MS/MS	  The	  tryptic	  peptides	  were	  desalted	  on	  a	  C18	  macrotrap	  (Michrom	  Bioresources)	  and	  concentrated	  in	  vacuo.	  Dried	  samples	  were	  resuspended	  and	  subjected	  to	  StageTip-­‐based	  strong	  anionic	  exchange	  (SAX)	  as	  previously	  described	  [99].	  Samples	  were	  eluted,	  concentrated,	  and	  then	  acidified	  prior	  to	  mass	  spectrometric	  analysis.	  Mass	  spectrometry	  experiments	  were	  performed	  on	  an	  EASY-­‐nLC	  (Thermo	  Scientific)	  connected	  to	  a	  hybrid	  LTQ-­‐Orbitrap	  Classic	  with	  a	  nanoelectrospray	  ion	  source	  (Thermo	  Scientific)	  in	  a	  setup	  and	  settings	  [115]	  very	  similar	  to	  those	  previously	  described	  [116].	  Binding	  and	  separation	  of	  the	  peptides	  took	  place	  on	  a	  15cm	  silica	  analytical	  column	  (75	  µm	  ID)	  packed	  in-­‐house	  with	  reversed	  phase	  ReproSil-­‐Pur	  C18AQ	  3	  µm	  resin	  (Dr	  Maisch	  GmbH,	  Ammerbuch-­‐Entringen,	  Germany).	  Samples	  were	  run	  for	  240	  minutes	  on	  a	  5%	  to	  25%	  acetonitrile	  gradient	  in	  0.2%	  formic	  acid	  at	  a	  flow	  rate	  of	  350	  nL	  per	  minute.	  The	  
	  	  
61	  mass	  spectrometer	  was	  programmed	  to	  acquire	  data	  in	  a	  data-­‐dependent	  mode,	  automatically	  switching	  between	  full-­‐scan	  MS	  and	  tandem	  MS	  acquisition.	  Survey	  full	  scan	  MS	  spectra	  (from	  m/z	  300	  to	  1,700)	  were	  acquired	  in	  the	  Orbitrap	  after	  the	  accumulation	  of	  500,000	  ions,	  with	  a	  resolution	  of	  60,000	  at	  400	  m/z.	  The	  ten	  most	  intense	  ions	  were	  sequentially	  isolated	  and,	  after	  the	  accumulation	  of	  5,000	  ions,	  fragmented	  in	  the	  linear	  ion	  trap	  by	  CID	  (collisional	  energy	  35%	  and	  isolation	  width	  2	  Da).	  Precursor	  ion	  charge	  state	  screening	  was	  enabled	  and	  singly	  charged	  and	  unassigned	  charge	  states	  were	  rejected.	  The	  dynamic	  exclusion	  list	  was	  set	  for	  a	  90s	  maximum	  retention	  time,	  a	  relative	  mass	  window	  of	  10	  ppm,	  and	  early	  expiration	  was	  enabled.	  	  
	  
Mass	  Spec	  Analysis	  and	  Quantification:	  Thermo	  raw	  data	  files	  were	  analyzed	  by	  MaxQuant	  (v	  1.3.0.5)[100]	  and	  were	  searched	  against	  the	  SGD	  yeast	  database	  (5911	  sequences)	  and	  an	  in-­‐house	  contaminant	  database	  (259	  sequences)	  including	  human	  keratins	  and	  proteases.	  All	  default	  options	  were	  used	  except	  as	  follows:	  match	  between	  runs	  was	  enabled	  (2	  min.	  maximum),	  GlyGly	  on	  Lys	  (+114.042927),	  and	  multiplicity	  of	  2	  with	  heavy	  labels	  Arg6	  (+6.020129)	  and	  Lys8	  (+8.014199).	  Tryptic	  digest	  was	  specified	  with	  up	  to	  two	  missed	  cleavages.	  Peptide,	  protein,	  and	  site	  false	  discovery	  rates	  were	  fixed	  at	  1%	  using	  the	  target-­‐decoy	  approach	  with	  a	  reversed	  database[100].	  Further	  data	  processing	  was	  performed	  to	  calculate	  ratios	  and	  standard	  errors	  of	  the	  ratios	  for	  each	  mutant	  using	  in-­‐house	  scripts	  described	  previously	  [132].	  Briefly,	  hierarchical	  models	  were	  constructed	  for	  each	  mutant	  where	  the	  overall	  ratio	  for	  each	  protein	  is	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  the	  geometric	  mean	  of	  the	  biological	  replicates	  and	  the	  biological	  replicate	  ratio	  is	  the	  median	  of	  all	  of	  the	  peptide	  ratios	  in	  the	  replicate.	  The	  standard	  error	  of	  the	  overall	  protein	  ratio	  is	  calculated	  by	  estimating	  the	  global	  peptide	  ratio	  standard	  error	  using	  pooled	  variance	  (calculated	  separately	  for	  peptide	  ratios	  based	  on	  requantified	  isotopic	  patterns)	  and	  using	  a	  bootstrapping	  procedure	  to	  resample	  at	  each	  level	  in	  the	  hierarchical	  model.	  All	  quantified	  proteins	  were	  used	  to	  construct	  Figures	  3.1B	  and	  Supplemental	  Figures	  3.2A,B.	  Proteins	  for	  which	  the	  probability	  that	  they	  changed	  more	  than	  10%	  in	  the	  WT:WT	  control	  experiment	  was	  >99%	  or	  were	  not	  significantly	  enriched	  (p-­‐value	  ≥	  0.05)	  in	  the	  His8Ub	  expressed	  cells	  in	  the	  untagged/tagged	  control	  experiment	  were	  filtered	  out	  due	  to	  the	  high	  likelihood	  that	  they	  would	  yield	  false	  positive	  identifications	  in	  the	  mutant:wild-­‐type	  comparisons.	  Analyses	  relating	  to	  comparisons	  with	  SCUD	  and	  the	  response	  of	  the	  ubiquitination	  enzymes	  in	  the	  
cdc48-­3	  mutant	  used	  all	  proteins	  that	  were	  not	  filtered	  out.	  All	  proteins	  that	  were	  not	  filtered	  out	  and	  were	  quantified	  in	  all	  mutants	  were	  used	  in	  the	  remaining	  bioinformatic	  analyses.	  In	  Figures	  3.1C	  and	  D,	  thresholds	  for	  significance	  were	  greater	  than	  10%	  change	  from	  1:1	  (p-­‐value	  <	  0.01)	  (i.e.,	  99%	  likely	  to	  have	  changed	  more	  than	  10%).	  Yeast	  GO-­‐Slim	  annotations	  for	  Figures	  3.2A	  and	  B	  were	  downloaded	  from	  the	  SGD.	  Proteins	  considered	  significantly	  enriched	  had	  a	  more	  than	  10%	  change	  from	  1:1	  (p-­‐value	  <	  0.05).	  Annotations	  for	  Supplemental	  Figure	  3.3A	  and	  Supplemental	  Figure	  3.4A-­‐E	  were	  downloaded	  from	  DAVID	  [133,	  134].	  Displayed	  terms	  were	  deemed	  significantly	  different	  at	  a	  p-­‐value	  <	  0.05	  (e.g.,	  the	  25th	  percentile	  of	  the	  ratios	  of	  the	  proteins	  annotated	  with	  the	  term	  was	  
	  	  
63	  significantly	  greater	  than	  random)	  after	  correcting	  for	  multiple	  hypotheses	  testing	  using	  the	  Benjamini	  and	  Hochberg	  method[135].	  
	  
Confirmation	  of	  Ub	  Conjugate	  Accumulation	  for	  Spt23	  
	   Ubiquitin	  conjugates	  were	  purified	  from	  100	  OD600	  units	  of	  cells	  expressing	  tagged	  ubiquitin	  as	  described	  in	  the	  purification	  of	  Ub	  conjugates	  section.	  However,	  after	  washing	  beads	  an	  equal	  volume	  of	  2X	  SDS-­‐PAGE	  buffer	  was	  added	  prior	  to	  boiling	  the	  beads	  for	  5	  minutes	  to	  elute	  conjugates.	  Boiled	  aliquots	  were	  resolved	  by	  SDS-­‐PAGE	  and	  immunoblotted	  for	  endogenously	  tagged	  mycSpt23V5.	  
	  
Confirmation	  of	  Ub	  Conjugate	  Accumulation	  for	  Mga2	  Cells	  (100	  OD600	  units)	  were	  disrupted	  using	  a	  FastPrep-­‐24	  in	  lysis	  buffer	  containing	  50mM	  Tris-­‐HCl	  (pH	  7.5),	  150mM	  NaCl,	  1mM	  EDTA,	  10mM	  NEM,	  0.5mM	  AEBSF	  and	  Protease	  Inhibitor	  Cocktail	  Tablet	  (Roche).	  Lysates	  were	  clarified	  by	  centrifugation	  (14,200	  rpm	  for	  20	  minutes	  on	  an	  Eppendorf	  Centrifuge	  5417R)	  and	  bound	  to	  30μL	  of	  TUBE2	  agarose	  beads	  (Boston	  Biochem)/5-­‐10	  mg	  lysate	  for	  2-­‐3	  hours	  with	  rotation	  at	  4°C.	  Beads	  were	  washed	  3	  times	  with	  lysis	  buffer	  and	  an	  equal	  volume	  of	  2X	  SDS-­‐PAGE	  buffer	  was	  added	  prior	  to	  boiling	  the	  beads	  for	  5	  minutes	  to	  elute	  conjugates.	  Boiled	  aliquots	  were	  resolved	  by	  SDS-­‐PAGE	  and	  immunoblotted.	  
	  
Quantitative	  Reverse	  Transcription	  PCR	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  RNA	  was	  isolated	  from	  3	  OD600	  units	  of	  cells	  using	  Trizol	  (Invitrogen)	  according	  to	  the	  manufacturer’s	  recommendations.	  cDNA	  was	  prepared	  using	  the	  Superscript	  first	  strand	  synthesis	  kit	  (Invitrogen)	  and	  quantitative	  PCR	  was	  performed	  using	  the	  SYBR	  GreenER	  super	  mix	  (Invitrogen)	  with	  primers	  described	  in	  Supplemental	  Table	  5.	  
	  




Growth	  Assays	  	  For	  plating	  assays	  cells	  were	  grown	  in	  YPD	  or	  SRaffinose-­‐URA	  and	  diluted	  to	  OD600	  of	  0.3	  in	  water.	  Serial	  five-­‐fold	  dilutions	  were	  prepared	  in	  water	  and	  spotted	  onto	  YPD	  +/-­‐	  0.2%	  oleic	  acid	  or	  minimal	  medium	  plates	  supplemented	  with	  various	  additives	  as	  described	  in	  the	  text.	  Plates	  were	  incubated	  at	  30°C	  or	  37°C	  for	  2-­‐4	  days.	  
	  
Turnover	  of	  Spt23	  RJD	  6138,	  6139,	  and	  6167	  cells	  were	  grown	  in	  YPD	  to	  an	  OD600	  ~1.0,	  at	  which	  point	  100μg/ml	  cycloheximide	  was	  added	  to	  initiate	  a	  chase.	  Samples	  were	  taken	  at	  the	  timepoints	  indicated.	  To	  monitor	  Spt23	  following	  the	  switch	  from	  medium	  containing	  oleic	  acid	  to	  medium	  lacking	  oleic	  acid,	  cells	  were	  grown	  in	  YPD+0.2%	  oleic	  acid,	  washed	  in	  water,	  and	  resuspended	  in	  YPD	  supplemented	  with	  cycloheximide.	  Proteins	  were	  extracted	  as	  described	  in	  the	  Immunoblot	  Analysis	  section	  with	  boiling	  SDS-­‐PAGE	  buffer	  supplemented	  with	  5mM	  NEM.	  Lysates	  were	  resolved	  by	  SDS-­‐PAGE	  and	  immunoblotted.	  
	  
Immunoprecipitation	  of	  Ubx2	  RJD	  3166,	  6172,	  6173,	  and	  4614	  were	  grown	  in	  YP	  plus	  2%	  galactose	  (to	  induce	  expression	  of	  mycSpt23HA	  from	  the	  GAL	  promoter)	  to	  an	  OD600	  ~1.0,	  harvested,	  and	  flash-­‐frozen	  in	  liquid	  nitrogen.	  Cells	  were	  lysed	  by	  grinding	  in	  liquid	  nitrogen.	  Frozen	  cell	  powder	  was	  resuspended	  in	  lysis	  buffer	  containing	  50mM	  Tris	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  (pH	  7.5),	  100mM	  NaCl,	  1mM	  EDTA,	  5mM	  Mg(OAc)2,	  0.2%	  Triton	  X-­‐100,	  5mM	  NEM,	  and	  Protease	  Inhibitor	  Cocktail	  Tablet	  (Roche),	  clarified	  by	  centrifugation	  (14,200	  rpm	  for	  20	  minutes	  on	  an	  Eppendorf	  Centrifuge	  5417R)	  and	  bound	  to	  rabbit	  IgG	  conjugated	  to	  superparamagnetic	  Dynabeads	  (Invitrogen)	  for	  three	  hours	  with	  mixing	  at	  4°C.	  Beads	  were	  washed	  3	  times	  with	  lysis	  buffer	  and	  bound	  proteins	  were	  eluted	  by	  boiling	  in	  SDS-­‐PAGE	  buffer	  and	  resolved	  by	  SDS-­‐PAGE	  prior	  to	  immunoblotting.	  
	  
Immunofluoresence	  RJD	  6172	  and	  6182	  cells	  were	  grown	  in	  YP	  plus	  2%	  galactose	  (to	  induce	  expression	  of	  mycSpt23HA	  from	  the	  GAL	  promoter)	  to	  an	  OD600	  ~0.5-­‐1.0.	  Cell	  cultures	  were	  adjusted	  to	  4%	  formaldehyde	  and	  incubated	  for	  15	  minutes	  before	  cells	  were	  collected,	  washed,	  and	  spheroplasted	  by	  treatment	  with	  50	  units	  of	  lyticase	  (Sigma)	  for	  10	  minutes.	  Spheroplasts	  were	  washed	  and	  placed	  on	  ConA-­‐coated	  glass	  slides.	  Cells	  were	  fixed	  with	  methanol	  and	  acetone	  washes.	  Cells	  were	  treated	  with	  blocking	  buffer	  (2%	  BSA,	  0.1%	  Tween20	  in	  PBS)	  and	  incubated	  with	  a	  primary	  antibody	  overnight	  at	  a	  dilution	  of	  1:1000.	  FITC-­‐conjugated	  secondary	  antibody	  was	  added	  and	  cells	  were	  incubated	  for	  another	  hour	  followed	  by	  DNA	  staining	  with	  DAPI.	  Mounting	  media	  was	  placed	  on	  cells	  and	  images	  were	  taken	  with	  a	  Zeiss	  confocal	  microscope	  with	  a	  100x	  objective.	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67	  To	  better	  understand	  the	  breadth	  of	  function	  of	  Cdc48	  and	  its	  adaptors	  that	  contain	  an	  UBX	  domain,	  we	  sought	  to	  identify	  ubiquitin	  conjugates	  whose	  levels	  increased	  in	  yeast	  cells	  deficient	  in	  these	  components.	  The	  rationale	  underlying	  this	  approach	  is	  based	  on	  the	  observation	  that	  ubiquitinated	  Rpb1	  substrate	  accumulates	  in	  ubx5∆	  and	  cdc48-­3	  cells[52].	  Wild-­‐type	  and	  mutant	  yeast	  cells	  expressing	  His8-­‐tagged	  ubiquitin	  were	  labeled	  with	  ‘heavy’	  and	  ‘light’	  lysine	  and	  arginine,	  respectively,	  and	  immediately	  prior	  to	  harvesting	  and	  lysis	  the	  cultures	  were	  mixed.	  Ubiquitin	  conjugates	  were	  purified	  on	  Ni2+-­‐NTA	  magnetic	  beads	  under	  denaturing	  conditions	  (8M	  urea)	  and	  digested	  with	  trypsin.	  The	  resulting	  peptides	  were	  subjected	  to	  strong	  anionic	  exchange	  (SAX)	  fractionation	  prior	  to	  sequencing	  in	  a	  mass	  spectrometer	  (Figure	  3.1A).	  We	  performed	  this	  analysis	  in	  triplicate	  with	  cdc48-­3	  and	  in	  duplicate	  with	  six	  of	  the	  seven	  ubx∆	  mutant	  strains	  (ubx2∆-­‐ubx7∆;	  
shp1∆/ubx1∆	  was	  not	  analyzed	  because	  it	  grew	  so	  poorly).	  	  To	  evaluate	  the	  reproducibility	  of	  our	  methodology	  we	  compared	  biological	  replicates	  (Supplemental	  Figures	  3.1A,B),	  which	  revealed	  that	  our	  datasets	  were	  highly	  correlated	  and	  demonstrated	  low	  coefficients	  of	  variation.	  To	  improve	  further	  the	  quality	  of	  our	  proteomic	  dataset,	  we	  performed	  two	  separate	  control	  experiments,	  the	  results	  of	  which	  were	  used	  to	  computationally	  filter	  our	  data	  prior	  to	  further	  analysis.	  In	  the	  first	  experiment	  both	  the	  ‘light’	  and	  ‘heavy’-­‐labeled	  cultures	  were	  wild-­‐type.	  This	  analysis	  yielded	  a	  narrow	  distribution	  of	  heavy:light	  ratios	  centered	  on	  20,	  confirming	  the	  significance	  of	  the	  broader	  ratio	  distributions	  seen	  in	  the	  wild-­‐type:mutant	  comparisons	  (Figure	  3.1B,	  Supplemental	  Figure	  3.2A).	  Proteins	  that	  exhibited	  ratios	  that	  deviated	  from	  20	  by	  >10%	  (p-­‐value	  <0.01)	  in	  this	  control	  experiment	  were	  excluded	  from	  our	  overall	  dataset.	  In	  the	  second	  control,	  we	  compared	  untagged,	  light-­‐labeled	  cells	  and	  His8Ub-­‐
	  	  
68	  expressing	  heavy-­‐labeled	  cells.	  Proteins	  that	  were	  significantly	  enriched	  in	  the	  His8Ub-­‐expressing	  cells	  (p-­‐value<0.05)	  were	  deemed	  to	  be	  derived	  from	  valid	  ubiquitin	  conjugates.	  After	  computational	  filtration,	  our	  dataset	  contained	  1,916	  ratios	  for	  ubiquitinated	  proteins	  identified	  and	  quantified	  in	  at	  least	  one	  mutant	  experiment	  and	  1,733	  ubiquitinated	  proteins	  across	  all	  experiments	  (all	  proteins	  identified	  are	  listed	  in	  Supplementary	  Table	  1).	  We	  additionally	  identified	  67	  di-­‐glycine	  peptide	  signatures,	  which	  are	  indicative	  of	  ubiquitination	  sites;	  25	  of	  the	  67	  were	  previously	  identified	  (Supplementary	  Table	  2).	  The	  proteins	  in	  this	  study	  covered	  over	  50%	  of	  the	  previously	  identified	  ubiquitinated	  proteins	  in	  the	  Saccharomyces	  cerevisiae	  ubiquitin	  database	  (SCUD,	  http://scud.kaist.ac.kr/)	  and	  included	  1,226	  proteins	  not	  previously	  listed	  (Supplemental	  Figure	  3.2B).	  These	  metrics	  suggest	  that	  we	  have	  sampled	  a	  substantial	  portion	  of	  the	  ubiquitinated	  proteome.	  	  
UBX	  Proteins	  Target	  Different	  Subsets	  of	  Ubiquitin	  Conjugates	  From	  the	  initial	  screen	  it	  was	  evident	  that	  cdc48-­3	  and	  ubx∆	  mutations	  had	  wide-­‐ranging	  and	  variable	  effects	  on	  the	  ubiquitin	  proteome.	  Comparison	  of	  the	  ratio	  distributions	  of	  the	  different	  experiments	  underscores	  this	  conclusion	  (Figure	  3.1B).	  Consistent	  with	  Cdc48	  being	  the	  hub	  of	  its	  eponymous	  network,	  cdc48-­3	  had	  the	  greatest	  effect	  on	  the	  ubiquitinated	  proteome.	  26%	  of	  ubiquitin	  conjugates	  were	  detected	  at	  higher	  levels	  in	  cdc48-­3	  compared	  to	  wild-­‐type	  cells	  whereas	  17%	  were	  decreased	  in	  amount.	  We	  do	  not	  know	  the	  reason	  for	  the	  latter,	  but	  it	  could	  be	  due	  to	  reduced	  expression	  of	  the	  protein	  or	  increased	  competition	  for	  free	  ubiquitin	  because	  total	  conjugated	  ubiquitin	  increases	  substantially	  in	  cdc48-­3	  cells[52].	  Among	  the	  ubx∆	  mutants	  ubx5∆	  and	  ubx6∆	  caused	  the	  strongest	  perturbations;	  by	  contrast	  ubx3∆	  had	  the	  least	  effect,	  followed	  by	  
ubx4∆.	  To	  evaluate	  the	  impact	  of	  the	  cdc48-­3	  and	  ubx∆	  mutations	  with	  more	  granularity,	  we	  
	  	  
69	  generated	  a	  heatmap	  that	  captures	  the	  behavior	  of	  the	  1,733	  conjugates	  quantified	  in	  all	  experiments	  in	  our	  dataset	  (Figure	  3.1C).	  Three	  important	  points	  are	  evident	  in	  this	  graphic.	  First,	  ubx6∆	  and	  ubx7∆	  displayed	  remarkable	  overlap	  with	  over	  85%	  of	  the	  ubiquitin	  conjugates	  accumulating	  in	  ubx7∆	  also	  accumulating	  in	  ubx6∆.	  Very	  little	  is	  known	  about	  Ubx6	  and	  Ubx7,	  but	  this	  result	  is	  consistent	  with	  their	  close	  homology	  and	  colocalization	  at	  the	  perinuclear	  membrane[55].	  Second,	  cdc48-­3	  mutants	  accumulated	  a	  set	  of	  ubiquitin	  conjugates	  (128	  proteins)	  that	  did	  not	  accumulate	  in	  any	  single	  ubx∆	  mutant.	  This	  suggests	  that	  many	  substrates	  can	  engage	  Cdc48	  without	  an	  Ubx	  protein,	  and	  may	  explain	  why	  a	  relatively	  low	  fraction	  of	  Cdc48/p97	  substrates	  have	  been	  shown	  to	  be	  dependent	  on	  an	  UBX	  domain	  co-­‐factor.	  Third,	  with	  the	  exception	  of	  ubx6∆	  and	  ubx7∆,	  the	  different	  mutations	  had	  markedly	  different	  effects	  on	  the	  ubiquitin	  conjugate	  proteome.	  This	  conclusion	  was	  also	  supported	  by	  an	  independent	  analysis	  (Figure	  3.1D),	  which	  indicated	  that	  for	  each	  ubx∆	  mutant	  except	  ubx6∆	  and	  ubx7∆,	  >40%	  of	  the	  accumulating	  conjugates	  were	  elevated	  only	  in	  that	  mutant	  and	  up	  to	  ~90%	  were	  elevated	  in	  that	  mutant	  and	  at	  most	  one	  other	  mutant.	  This	  supports	  the	  hypothesis	  that	  individual	  Ubx	  proteins	  target	  distinct	  sets	  of	  ubiquitin	  conjugates,	  which	  is	  consistent	  with	  their	  proposed	  role	  as	  substrate	  adaptors	  for	  the	  Cdc48	  engine.	  Remarkably,	  of	  the	  1,733	  proteins	  in	  our	  dataset,	  62%	  were	  elevated	  significantly	  in	  at	  least	  one	  mutant	  (62%	  was	  highly	  significant	  in	  comparison	  to	  the	  null	  hypothesis	  where	  peptide	  ratios	  are	  randomly	  assigned	  to	  proteins	  (p-­‐value	  <	  1e-­‐100)),	  suggesting	  that	  the	  Cdc48	  network	  has	  a	  profound	  impact	  on	  the	  UPS	  that	  is	  greater	  than	  has	  been	  previously	  appreciated.	  
Ubiquitin	  Conjugates	  that	  are	  Elevated	  in	  Different	  ubx∆	  Mutants	  Map	  to	  Diverse	  
Cellular	  Components	  and	  Cellular	  Processes	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  To	  understand	  the	  subcellular	  localization	  and	  functions	  of	  the	  ubiquitinated	  species	  identified	  in	  our	  analyses,	  we	  evaluated	  Yeast	  GO-­‐Slim	  cell	  components	  and	  GO-­‐Slim	  biological	  process	  annotations	  (Figures	  3.2A	  and	  3.2B).	  Many	  different	  trends	  were	  apparent	  from	  this	  analysis.	  Ubiquitin	  conjugates	  that	  were	  elevated	  in	  cdc48-­3	  cells	  (referred	  to	  hereafter	  as	  ‘cdc48-­3	  conjugates’)	  encompassed	  numerous	  known	  targets	  including	  Mga2	  and	  Spt23[75,	  76],	  the	  HMG-­‐CoA	  reductases	  Hmg1	  and	  Hmg2[136],	  and	  the	  Rpb1	  subunit	  of	  RNA	  Polymerase	  II[52].	  Consistent	  with	  the	  role	  of	  Cdc48	  in	  ERAD,	  cdc48-­3	  conjugates	  were	  significantly	  enriched	  for	  proteins	  of	  the	  endomembrane	  system	  including	  the	  ERP	  and	  ERV	  family	  of	  proteins	  involved	  in	  ER	  to	  Golgi	  transport,	  members	  of	  the	  GPI	  family	  of	  proteins,	  subunits	  of	  the	  Golgi	  mannosyltransferase	  complex,	  and	  all	  seven	  proteins	  of	  the	  PMT	  (Protein	  o-­‐mannosyltransferase)	  family.	  The	  cdc48-­3	  conjugates	  were	  also	  enriched	  for	  glycosylated	  proteins,	  enzymes	  of	  lipid	  and	  carbohydrate	  metabolism,	  and	  proteins	  involved	  in	  nuclear	  pore	  complex,	  nuclear	  organization,	  stress	  response,	  and	  the	  ubiquitin-­‐proteasome	  system	  (Supplemental	  Figure	  3.3A).	  Further	  investigation	  of	  the	  latter	  category	  revealed	  that	  cdc48-­3	  cells	  contained	  elevated	  levels	  of	  ubiquitin	  conjugated	  species	  of	  multiple	  E3	  ubiquitin	  ligases	  and	  F-­‐Box	  proteins	  (Supplemental	  Figure	  3.3B).	  This	  is	  consistent	  with	  recent	  identification	  of	  Cdc48	  as	  an	  SCFMet30	  disassembly	  factor[137]	  and	  suggests	  that	  Cdc48	  may	  be	  more	  widely	  involved	  in	  extraction	  and/or	  degradation	  of	  ubiquitinated	  F-­‐box	  proteins	  from	  SCF	  complexes.	  	  	   Analysis	  of	  the	  ubiquitin	  conjugates	  that	  were	  elevated	  in	  ubx2Δ	  relative	  to	  wild-­‐type	  cells	  (i.e.	  ‘ubx2∆	  conjugates’)	  indicated	  there	  was	  a	  significant	  enrichment	  of	  vacuolar	  and	  metabolic	  transport	  proteins,	  including	  secretory	  proteins	  (Figure	  3.2A-­‐C).	  Many	  of	  these	  proteins	  are	  synthesized	  in	  the	  ER	  where	  Ubx2	  is	  localized.	  Notably,	  elevated	  levels	  of	  
	  	  
71	  ubiquitinated	  forms	  of	  a	  number	  of	  ER	  proteins	  were	  detected	  in	  both	  ubx2∆	  and	  cdc48-­3	  cells,	  including	  members	  of	  the	  ergosterol	  biosynthesis	  pathway	  and	  the	  OLE1	  transcription	  factors	  Spt23	  and	  Mga2,	  indicating	  a	  possible	  role	  for	  Ubx2–Cdc48	  in	  regulating	  lipid	  metabolism.	  	   Deletion	  of	  UBX3	  had	  little	  impact	  on	  the	  ubiquitin	  conjugate	  proteome	  with	  no	  proteins	  changing	  consistently	  in	  a	  significant	  manner.	  The	  pool	  of	  ubx4Δ	  conjugates	  was	  likewise	  small,	  but	  was	  enriched	  for	  ER	  proteins	  involved	  in	  lipid	  metabolism	  including	  Spt23,	  Mga2,	  Hmg1,	  and	  Hmg2	  (Figure	  3.2A,B,	  Supplemental	  Figure	  3.4A,B).	  	  	   Ubiquitin	  conjugates	  that	  were	  elevated	  in	  ubx5∆	  cells	  were	  enriched	  for	  vacuolar	  and	  plasma	  membrane	  proteins,	  including	  proteins	  involved	  in	  ion	  and	  amino	  acid	  transport	  such	  as	  the	  TPO	  family	  of	  proteins	  involved	  in	  polyamine	  transport	  (Figure	  3.2A,B,	  Supplemental	  Figure	  3.4C).	  Ubx5	  contains	  an	  UIM	  domain	  that	  links	  it	  to	  Rub1-­‐conjugated	  cullin–RING	  ubiquitin	  ligases	  (CRLs)[54,	  138],	  raising	  the	  possibility	  that	  a	  CRL	  regulates	  trafficking	  of	  membrane	  proteins	  in	  yeast	  	   Lastly,	  ubiquitin	  conjugates	  that	  were	  elevated	  in	  ubx6∆	  and	  ubx7∆	  were	  highly	  enriched	  for	  nucleolar	  and	  ribosomal	  proteins,	  including	  proteins	  involved	  in	  ribosome	  assembly	  (Figure	  3.2A,B,	  Supplemental	  Figure	  3.4D,E).	  In	  agreement	  with	  a	  nuclear	  and	  nucleolar	  function,	  Ubx6	  and	  Ubx7	  localize	  to	  the	  nuclear	  periphery	  and	  nucleus[55].	  	  
Ubiquitinated	  Spt23	  and	  Mga2	  Accumulate	  in	  ubx2Δ	  The	  increase	  in	  ubiquitinated	  Spt23	  and	  Mga2	  species	  in	  cdc48-­3,	  ubx2Δ	  and	  ubx4Δ	  cells	  (Figure	  3.3A)	  piqued	  our	  interest	  because	  although	  it	  was	  already	  known	  that	  Cdc48–Ufd1–Npl4	  promotes	  release	  of	  Spt23	  and	  Mga2	  from	  the	  ER	  membrane	  and	  ubiquitinated	  forms	  of	  these	  transcription	  factors	  accumulate	  in	  cdc48,	  npl4,	  and	  ufd1	  cells[75,	  76,	  78,	  
	  	  
72	  83],	  Ubx	  proteins	  had	  not	  previously	  been	  implicated	  in	  this	  pathway.	  To	  evaluate	  the	  ubiquitination	  status	  of	  Spt23	  in	  ubx2∆	  and	  ubx4∆	  mutants,	  we	  first	  generated	  a	  yeast	  strain	  in	  which	  endogenous	  SPT23	  was	  modified	  to	  express	  proteins	  bearing	  an	  N-­‐terminal	  myc	  tag	  and	  C-­‐terminal	  V5	  tag	  (mycSpt23V5).	  We	  then	  purified	  ubiquitin	  conjugates	  from	  
mycSPT23V5	  strains	  expressing	  His8-­‐tagged	  ubiquitin	  with	  Ni2+-­‐NTA	  magnetic	  beads.	  Immunoblotting	  for	  tagged	  Spt23	  revealed	  robust	  accumulation	  of	  high	  molecular	  weight	  conjugates	  in	  both	  ubx2Δ	  and	  ubx4Δ	  as	  compared	  to	  wild-­‐type	  (Figure	  3.3B).	  For	  reasons	  we	  do	  not	  understand,	  overexpression	  of	  His8Ub	  had	  opposing	  effects	  on	  the	  accumulation	  of	  ubiquitin	  conjugates	  on	  mycSpt23V5	  in	  ubx2∆	  and	  ubx4∆.	  In	  the	  absence	  of	  His8Ub,	  we	  consistently	  observed	  stronger	  accumulation	  of	  ubiquitinated	  mycSpt23V5	  in	  ubx2∆	  (e.g.	  Figure	  3.5A,	  B).	  To	  evaluate	  the	  ubiquitination	  status	  of	  Mga2	  in	  ubx2∆	  and	  ubx4∆	  mutants,	  we	  used	  Tandem	  Ubiquitin	  Binding	  Entity	  (TUBE2)	  beads	  to	  purify	  endogenous	  ubiquitin	  conjugates	  from	  strains	  transformed	  with	  a	  plasmid	  that	  expressed	  Mga2	  with	  a	  myc	  tag	  appended	  to	  its	  N-­‐terminus	  (mycMga2).	  Immunoblotting	  for	  mycMga2	  revealed	  an	  accumulation	  of	  high	  molecular	  weight	  conjugates	  in	  ubx2Δ	  cells	  compared	  to	  wild-­‐type	  (Supplemental	  Figure	  3.5).	  By	  contrast,	  few	  if	  any	  high	  MW	  ubiquitin	  conjugates	  of	  Mga2	  were	  detected	  in	  ubx4∆	  cells.	  	  
Ubx2	  is	  a	  Component	  of	  the	  OLE1	  Pathway	  In	  rapidly	  growing	  cells	  that	  are	  producing	  lipids	  for	  membrane	  assembly,	  the	  transmembrane	  p120	  forms	  of	  Spt23	  and	  Mga2	  are	  ubiquitinated	  by	  the	  ubiquitin	  ligase	  Rsp5	  and	  cleaved	  by	  the	  proteasome[73].	  Subsequently,	  Cdc48–Ufd1–Npl4	  promotes	  release	  of	  cleaved	  p90	  forms	  of	  Spt23	  and	  Mga2	  from	  the	  ER	  membrane,	  allowing	  these	  proteins	  to	  translocate	  to	  the	  nucleus	  where	  they	  activate	  transcription	  of	  OLE1,	  which	  
	  	  
73	  encodes	  the	  essential	  enzyme	  that	  generates	  UFAs[71].	  The	  accumulation	  of	  ubiquitin-­‐conjugated	  Spt23	  and	  Mga2	  in	  ubx2Δ	  raised	  the	  question	  of	  whether	  Ubx2	  also	  functions	  in	  this	  pathway.	  To	  address	  this	  question	  we	  first	  tested	  for	  genetic	  interactions	  between	  
rsp5-­1	  and	  ubx∆	  mutants.	  Similar	  to	  the	  previously	  reported	  synthetic	  lethality	  of	  cdc48	  and	  
ufd1	  with	  rsp5[75],	  ubx2∆	  rsp5-­1	  cells	  failed	  to	  grow	  on	  YPD	  at	  30°C	  but	  were	  rescued	  by	  addition	  of	  the	  UFA	  oleic	  acid	  (Figure	  3.4A).	  By	  contrast,	  ubx4∆	  rsp5-­1	  did	  not	  exhibit	  synthetic	  lethality.	  To	  test	  more	  directly	  the	  hypothesis	  that	  Ubx2	  promotes	  expression	  of	  
OLE1,	  we	  measured	  OLE1	  mRNA	  levels	  in	  mutants	  grown	  in	  YPD.	  During	  normal	  log-­‐phase	  growth	  in	  YPD,	  ubx2Δ	  cells	  showed	  a	  five-­‐fold	  reduction	  in	  OLE1	  mRNA	  (Figure	  3.4B).	  Moreover,	  as	  was	  previously	  reported	  for	  rsp5	  mutants[73],	  both	  ubx2∆	  and	  rsp5∆	  cells	  failed	  to	  accumulate	  OLE1	  mRNA	  upon	  being	  shifted	  from	  a	  medium	  containing	  oleic	  acid	  to	  a	  medium	  lacking	  UFAs	  (Figure	  3.4C).	  By	  contrast,	  ubx4∆	  was	  not	  defective	  in	  OLE1	  regulation	  and	  did	  not	  exacerbate	  the	  effect	  of	  ubx2∆	  (Figures	  3.4B,C).	  The	  results	  above	  suggested	  that	  Ubx2	  is	  involved	  in	  activation	  of	  Spt23	  and	  Mga2.	  As	  further	  confirmation	  we	  examined	  the	  effect	  of	  Spt23	  and	  Mga2	  overexpression	  in	  mutant	  cells	  (Figure	  3.4D).	  Although	  UFAs	  are	  required	  for	  survival,	  the	  excess	  production	  of	  oleic	  acid	  that	  occurs	  upon	  hyperactivation	  of	  OLE1	  expression	  is	  toxic[139].	  Whereas	  overexpression	  of	  Spt23	  or	  Mga2	  from	  a	  galactose-­‐inducible	  promoter	  inhibited	  growth	  of	  wild-­‐type	  cells,	  ubx2∆	  cells,	  like	  rsp5-­1	  cells[140],	  were	  more	  tolerant	  (Figure	  3.4D)	  even	  though	  they	  equally	  overexpressed	  these	  OLE1	  activators	  (data	  not	  shown).	  	  
Ubx2	  Regulates	  Processing	  of	  Spt23	  We	  next	  wanted	  to	  determine	  if	  Ubx2	  is	  involved	  in	  processing	  of	  the	  OLE1	  activators	  from	  their	  p120	  precursor	  forms	  to	  their	  p90	  active	  forms.	  For	  these	  
	  	  
74	  experiments	  we	  focused	  on	  Spt23	  because	  we	  found	  it	  difficult	  to	  consistently	  detect	  tagged	  Mga2	  expressed	  from	  its	  endogenous	  locus.	  We	  examined	  steady	  state	  levels	  of	  
mycSpt23V5	  in	  YPD-­‐grown	  cells	  deficient	  in	  various	  components	  of	  the	  Cdc48	  and	  proteasome	  pathways	  (Figure	  3.5A).	  As	  anticipated	  from	  prior	  results[75],	  the	  cim3-­1	  and	  
rsp5-­1	  mutants	  exhibited	  a	  severe	  defect	  in	  p90	  accumulation	  (Figure	  3.5A,	  B;	  cim3-­1	  is	  a	  temperature-­‐sensitive	  allele	  of	  the	  gene	  that	  encodes	  proteasome	  subunit	  Rpt6).	  Notably,	  p90	  formation	  was	  also	  significantly	  impaired	  in	  cdc48-­3	  and	  ufd1-­2	  strains.	  In	  ubx2∆	  (Figure	  3.5A,	  B),	  but	  not	  in	  other	  ubx∆	  mutants	  (Figure	  3.5B),	  ubiquitinated	  high	  MW	  forms	  of	  mycSpt23V5	  accumulated	  and	  the	  p90:p120	  ratio	  was	  significantly	  reduced.	  However,	  the	  degree	  to	  which	  processing	  to	  p90	  was	  defective	  varied	  in	  different	  experiments.	  In	  the	  prevailing	  model,	  Cdc48–Ufd1–Npl4	  acts	  after	  the	  proteasome	  to	  promote	  release	  of	  p90	  from	  the	  ER	  membrane[39,	  75,	  78].	  However,	  it	  has	  also	  been	  reported	  that	  Cdc48–Ufd1–Npl4	  is	  required	  for	  processing	  of	  p120	  to	  p90[83].	  Our	  data	  are	  consistent	  with	  those	  of	  Hitchcock	  et	  al.	  and	  suggest	  that	  Cdc48–Ufd1	  and	  Ubx2	  contribute	  to	  efficient	  formation	  of	  p90.	  	  	   After	  establishing	  a	  role	  for	  Ubx2	  in	  Spt23	  processing,	  we	  next	  investigated	  the	  contribution	  of	  its	  UBA	  and	  UBX	  domains	  to	  this	  reaction.	  We	  immunoblotted	  for	  
mycSpt23V5	  in	  ubx2Δ	  strains	  in	  which	  full-­‐length	  and	  various	  domain	  mutants	  of	  Ubx2	  were	  integrated	  at	  the	  LEU2	  locus	  under	  control	  of	  the	  UBX2	  promoter[46]	  (Figure	  3.5C).	  This	  experiment	  confirmed	  that	  the	  defect	  in	  Spt23	  processing	  in	  ubx2∆	  cells	  was	  due	  to	  lack	  of	  Ubx2,	  and	  suggested	  that	  the	  UBX	  domain	  played	  a	  more	  important	  role	  in	  processing	  than	  the	  UBA	  domain.	  RT-­‐PCR	  analysis	  of	  these	  same	  strains	  grown	  in	  oleic	  acid	  and	  switched	  to	  
	  	  
75	  oleic	  acid-­‐free	  medium	  revealed	  a	  large	  decrease	  in	  OLE1	  mRNA	  induction	  in	  the	  UBA∆	  UBX∆	  mutant	  but	  not	  the	  single	  mutants	  (data	  not	  shown).	  	  Ubx2	  is	  orthologous	  to	  human	  UBXD8	  which	  may	  directly	  sense	  UFAs[141,	  142].	  We	  therefore	  tested	  whether	  Ubx2	  was	  required	  to	  sense	  UFAs	  in	  yeast.	  To	  address	  this	  question	  we	  grew	  wild-­‐type	  and	  mutant	  cells	  with	  and	  without	  oleic	  acid	  and	  evaluated	  processing	  of	  mycSpt23V5.	  We	  reasoned	  if	  Ubx2	  is	  required	  to	  sense	  UFAs	  that	  the	  residual	  level	  of	  p90	  formed	  in	  ubx2∆	  would	  be	  insensitive	  to	  their	  presence.	  Processing	  of	  
mycSpt23V5	  in	  wild	  type	  cells	  was	  strongly	  repressed	  by	  addition	  of	  oleic	  acid	  (Figure	  3.5D).	  Likewise,	  the	  residual	  formation	  of	  p90	  observed	  in	  cim3-­1,	  cdc48-­3,	  and	  ubx2∆	  cells	  remained	  sensitive	  to	  inhibition	  by	  oleic	  acid.	  Consistent	  with	  this,	  our	  analysis	  of	  OLE1	  mRNA	  revealed	  that	  although	  its	  levels	  were	  severely	  reduced	  in	  ubx2∆	  and	  ubx2∆	  ubx4∆,	  they	  were	  diminished	  further	  upon	  addition	  of	  oleic	  acid	  (Figure	  3.4C).	  Taken	  together,	  these	  data	  indicate	  that	  there	  must	  be	  at	  least	  one	  UFA	  sensor	  that	  remained	  in	  ubx2∆	  cells.	  Careful	  inspection	  of	  the	  modification	  state	  of	  mycSpt23V5	  in	  cdc48-­3	  and	  ubx2∆	  cells	  grown	  with	  or	  without	  oleic	  acid	  suggested	  that	  sensing	  of	  UFAs	  occurred	  at	  or	  before	  Rsp5-­‐dependent	  ubiquitination	  (Figure	  3.5D).	  To	  investigate	  in	  greater	  depth	  the	  role	  of	  Ubx2	  in	  Spt23	  processing,	  we	  performed	  cycloheximide	  chase	  experiments	  (Figure	  3.5E).	  The	  p90	  form	  of	  mycSpt23V5	  was	  rapidly	  degraded	  in	  wild-­‐type	  but	  was	  modestly	  stabilized	  in	  ubx2Δ	  and	  strongly	  stabilized	  in	  
cdc48-­3	  cells.	  In	  contrast,	  p120	  was	  more	  stable	  than	  p90	  in	  all	  conditions	  whereas	  the	  high	  MW	  ubiquitin	  conjugates	  that	  accumulated	  in	  ubx2∆	  and	  cdc48-­3	  were	  rapidly	  metabolized.	  Given	  that:	  (i)	  p90	  was	  unstable	  in	  wild	  type,	  (ii)	  more	  than	  half	  of	  mycSpt23V5	  detected	  at	  zero-­‐time	  in	  wild-­‐type	  was	  processed	  to	  p90,	  and	  (iii)	  conversion	  of	  p120	  to	  p90	  was	  very	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  slow	  and	  inefficient,	  we	  suggest	  that	  in	  wild-­‐type	  cells	  p120	  became	  conjugated	  with	  ubiquitin	  and	  rapidly	  processed	  to	  p90	  either	  during	  or	  very	  shortly	  after	  completion	  of	  synthesis,	  such	  that	  newly-­‐synthesized	  molecules	  that	  escaped	  modification	  were	  largely	  refractory	  to	  subsequent	  processing.	  	  





The	  Cdc48	  network	  plays	  a	  broad	  role	  in	  shaping	  the	  ubiquitin	  conjugate	  
proteome.	  To	  address	  globally	  the	  impact	  of	  Cdc48	  and	  its	  Ubx	  adaptors	  on	  the	  UPS,	  we	  evaluated	  changes	  to	  the	  ubiquitin	  conjugate	  proteome	  in	  yeast	  cells	  deleted	  for	  individual	  UBX	  genes	  or	  carrying	  a	  temperature-­‐sensitive	  cdc48-­3	  allele.	  Our	  findings	  support	  a	  broad	  role	  for	  the	  Cdc48	  network	  in	  the	  UPS.	  Overall,	  we	  identified	  1,916	  putative	  ubiquitin	  conjugates	  and	  1,733	  were	  quantified	  in	  all	  experiments.	  Of	  the	  1,733,	  over	  62%	  were	  found	  at	  statistically	  significant	  elevated	  levels	  relative	  to	  wild-­‐type	  in	  at	  least	  one	  of	  the	  mutant	  strains.	  Mutation	  of	  different	  UBX	  genes	  led	  to	  markedly	  distinct	  effects	  on	  the	  ubiquitin	  conjugate	  proteome.	  For	  example,	  our	  findings	  suggested	  novel	  and	  unexpected	  roles	  for	  Ubx2,	  Ubx5,	  and	  Ubx6/7	  in	  regulation	  of	  vacuolar,	  plasma	  membrane,	  and	  nucleolar/ribosomal	  proteins,	  respectively.	  	  Our	  approach	  assumes	  that	  ubiquitin	  conjugates	  that	  are	  elevated	  in	  a	  particular	  mutant	  relative	  to	  wild-­‐type	  represent	  intermediates	  that	  accumulate	  upon	  attenuation	  of	  Cdc48	  activity	  or	  deletion	  of	  the	  adaptor	  that	  normally	  links	  them	  to	  Cdc48.	  However	  it	  should	  be	  borne	  in	  mind	  that	  increased	  levels	  of	  a	  conjugate	  may	  arise	  from	  increased	  abundance	  of	  the	  protein.	  Of	  interest,	  numerous	  ubiquitin	  conjugates	  were	  selectively	  depleted	  in	  specific	  ubx∆	  strains.	  This	  was	  not	  investigated	  further,	  but	  during	  the	  course	  of	  this	  work	  it	  was	  reported	  that	  the	  human	  UBX	  protein	  SAKS1	  protects	  ERAD	  substrates	  from	  deubiquitination[143]	  and	  overproduced	  UBXD7	  binds	  to	  and	  increases	  the	  fraction	  of	  Nedd8-­‐conjugated	  Cul2	  in	  human	  cells[54,	  138].	  Hence,	  the	  large	  number	  of	  conjugate	  depletion	  events	  that	  we	  observed	  may	  represent	  species	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  whose	  ubiquitin-­‐conjugated	  forms	  are	  stabilized	  upon	  binding	  of	  Ubx	  proteins.	  Our	  extensive	  dataset	  provide	  a	  rich	  resource	  for	  future	  investigations	  into	  this	  and	  other	  questions	  related	  to	  the	  functions	  and	  regulation	  of	  the	  Cdc48	  network.	  
Ubx2	  and	  Cdc48	  promote	  proteasome-­dependent	  processing	  of	  Spt23	  Prior	  work	  from	  the	  Jentsch	  and	  Haines	  laboratories	  emphasized	  a	  role	  for	  Cdc48–Ufd1–Npl4	  in	  release	  of	  the	  processed	  forms	  of	  Spt23[75]	  and	  Mga2[78]	  from	  the	  ER	  membrane.	  By	  contrast,	  data	  from	  the	  Silver	  laboratory	  emphasized	  an	  upstream	  role	  for	  Cdc48–Ufd1–Npl4	  in	  processing	  of	  both	  proteins[83].	  Our	  data	  support	  a	  role	  for	  Cdc48–Ufd1	  and	  Ubx2	  in	  both	  steps.	  We	  observe	  diminished	  production	  of	  p90	  in	  mutant	  cells.	  However,	  the	  defect	  in	  p90	  formation	  in	  ubx2∆	  is	  variable	  and	  in	  general	  is	  less	  striking	  than	  the	  defect	  in	  OLE1	  induction.	  We	  propose	  that	  Cdc48–Ufd1–Npl4–Ubx2	  promotes	  both	  the	  processing	  of	  Spt23	  p120	  to	  p90	  and	  localization	  of	  p90	  to	  the	  nucleus.	  It	  remains	  unclear	  why	  different	  laboratories	  have	  reported	  discordant	  results	  on	  p90	  formation	  in	  Cdc48	  pathway	  mutants.	  There	  are	  a	  number	  of	  variables	  that	  differ	  in	  the	  various	  studies	  including	  the	  epitope	  tags	  and	  conditional	  alleles	  used	  and	  the	  expression	  level	  of	  p120.	  Notably,	  a	  role	  for	  Cdc48–Ufd1	  and	  Ubx2	  in	  proteasome-­‐dependent	  cleavage	  of	  p120	  resonates	  with	  data	  on	  other	  Cdc48–proteasome	  substrates,	  which	  consistently	  place	  Cdc48/p97	  function	  upstream	  of	  (or	  contemporaneous	  with)	  the	  proteasome.	  Regardless,	  sequential	  roles	  for	  Ubx2	  in	  the	  formation	  and	  activation	  of	  p90	  help	  explain	  why	  ubx2∆	  exhibits	  a	  severe	  defect	  in	  
OLE1	  regulation.	  Consistent	  with	  the	  prior	  data	  on	  rsp5	  mutants[75],	  ubx2∆	  cells	  are	  severely	  deficient	  in	  induction	  of	  OLE1	  expression	  and	  double	  mutants	  deficient	  in	  Ubx2	  and	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  Rsp5	  activity	  fail	  to	  grow	  on	  normal	  medium	  at	  30°C	  but	  are	  rescued	  by	  the	  addition	  of	  oleic	  acid,	  pointing	  to	  a	  crucial	  role	  for	  Ubx2	  in	  maintaining	  sufficient	  Ole1	  activity	  to	  meet	  the	  cellular	  requirement	  for	  UFAs.	  An	  important	  and	  interesting	  question	  that	  remains	  unresolved	  is,	  how	  are	  levels	  of	  fatty	  acids	  sensed	  so	  that	  the	  cell	  maintains	  an	  appropriate	  ratio	  of	  SFAs:UFAs?	  Addition	  of	  exogenous	  UFAs	  suppresses	  processing	  of	  p120	  to	  p90	  by	  the	  Rsp5–Ubx2–Cdc48	  pathway,	  which	  reduces	  expression	  of	  the	  desaturase	  enzyme	  encoded	  by	  OLE1.	  It	  was	  suggested	  in	  prior	  work	  that	  the	  human	  ortholog	  of	  Ubx2,	  UBXD8,	  directly	  senses	  UFAs[49,	  141,	  142].	  However,	  addition	  of	  UFAs	  suppresses	  accumulation	  of	  ubiquitinated	  Spt23	  and	  further	  reduces	  the	  residual	  expression	  of	  OLE1	  in	  ubx2∆,	  indicating	  that	  these	  cells	  retain	  the	  ability	  to	  sense	  UFAs.	  Thus,	  if	  Ubx2	  is	  a	  fatty	  acid	  sensor,	  it	  cannot	  be	  the	  only	  sensor	  in	  the	  OLE1	  pathway.	  Very	  recently	  it	  was	  reported	  that	  Ire1	  serves	  as	  a	  sensor	  for	  membrane	  lipid	  saturation	  in	  mouse	  cells[144].	  Our	  data	  suggest	  that	  either	  Rsp5	  itself	  or	  a	  step	  upstream	  of	  Rsp5-­‐dependent	  ubiquitination	  must	  be	  capable	  of	  sensing	  UFAs.	  
	  





Figure	  3.1	  Sequencing	  and	  quantification	  of	  the	  ubiquitin	  proteome	  reveals	  proteins	  regulated	  by	  Cdc48	  and	  its	  UBX	  domain	  adaptors.	  (A)	  Experimental	  workflow	  for	  identification	  and	  quantification	  of	  Ub	  conjugates.	  Proteins	  were	  quantified	  using	  the	  SILAC	  method.	  Light	  (WT)	  and	  heavy	  (mutant)	  isotope-­‐labeled	  cells	  constitutively	  expressing	  His8Ub	  were	  grown,	  collected	  in	  log-­‐phase,	  and	  mixed.	  The	  cells	  were	  lysed	  in	  denaturing	  urea	  buffer	  and	  ubiquitinated	  proteins	  were	  purified	  with	  nickel-­‐NTA	  magnetic	  beads.	  Proteins	  were	  digested	  into	  peptides,	  which	  were	  fractionated	  via	  strong	  anionic	  exchange	  and	  analyzed	  by	  mass	  spectrometry.	  (B)	  Smoothed	  histogram	  depicting	  changes	  in	  the	  ubiquitinated	  proteome	  in	  mutants.	  (C)	  Heatmap	  of	  relative	  changes	  to	  the	  ubiquitin	  proteome	  in	  various	  mutants.	  Only	  proteins	  that	  exhibited	  a	  significant	  change	  from	  a	  1:1	  ratio	  (mutant:	  wild-­‐type)	  in	  at	  least	  one	  experiment	  are	  shown.	  Abundance	  changes	  were	  deemed	  significant	  if	  the	  mutant:wild-­‐type	  ratio	  deviated	  from	  1:1	  with	  a	  p-­‐value	  less	  than	  .05	  corrected	  for	  multiple	  hypothesis	  testing	  by	  the	  Benjamini	  and	  Hochberg	  method[135].	  (D)	  Graphical	  representation	  of	  how	  frequently	  an	  ubiquitin	  conjugate	  found	  to	  accumulate	  in	  the	  query	  mutant	  also	  accumulated	  in	  other	  mutants.	  
Figure	  3.2	  Changes	  to	  the	  ubiquitin	  conjugate	  proteome	  in	  ubx∆	  mutants	  suggest	  functional	  specialization	  of	  Ubx	  proteins.	  	  
	  	  
81	  (A)	  Overview	  of	  how	  ubiquitin	  conjugates	  that	  accumulate	  in	  cdc48-­3	  and	  ubx∆	  mutants	  are	  distributed	  according	  to	  GO-­‐Slim	  cell	  components	  and	  (B)	  GO-­‐Slim	  biological	  processes.	  All	  of	  the	  proteins	  analyzed	  in	  (A)	  and	  (B)	  demonstrated	  enrichment	  greater	  than	  10%	  (with	  ≥95%	  confidence)	  in	  one	  or	  more	  mutants.	  (C)	  Box	  and	  whisker	  plot	  of	  annotation	  terms	  demonstrating	  a	  significant	  enrichment	  in	  the	  Ub-­‐Proteome	  for	  a	  majority	  of	  their	  identified	  members	  in	  the	  ubx2Δ	  mutant	  strain.	  Significance	  was	  calculated	  based	  on	  the	  25th	  percentile	  of	  the	  distribution	  of	  protein	  ratios	  of	  protein	  annotated	  with	  the	  term	  in	  comparison	  to	  all	  ubx2Δ	  ratios.	  Enriched	  GO	  Cellular	  Component	  (CC),	  GO	  Biological	  Process	  (BP),	  GO	  Molecular	  Function	  (MF),	  and	  Uniprot	  Keyword	  (KW)	  terms	  are	  shown.	  
Figure	  3.3	  Ubiquitin-­‐conjugated	  forms	  of	  Spt23	  and	  Mga2	  accumulate	  in	  ubx2Δ	  cells.	  	  (A)	  Table	  of	  Spt23	  and	  Mga2	  SILAC	  ratios	  in	  ubx2Δ:WT	  and	  ubx4Δ:WT	  comparisons.	  The	  reported	  ratios	  reflect	  the	  amalgamation	  of	  many	  independent	  peptide	  ratio	  measurements	  (Spt23	  ubx2Δ:	  7,	  ubx4Δ:	  24;	  Mga2	  ubx2Δ:	  21,	  ubx4Δ:	  37).	  (B)	  Validation	  of	  Spt23	  ubiquitin	  conjugate	  accumulation.	  Ubiquitin	  conjugates	  in	  WT,	  
ubx2Δ,	  and	  ubx4Δ	  cells	  expressing	  mycSpt23V5	  from	  the	  natural	  locus	  and	  His8Ub	  from	  a	  plasmid	  were	  purified	  with	  nickel-­‐NTA	  magnetic	  beads.	  The	  input	  extract	  and	  bound	  fractions	  were	  immunoblotted	  for	  the	  myc	  epitope,	  Ub,	  and	  tubulin	  (input	  loading	  control)	  as	  indicated.	  
Figure	  3.4	  Ubx2	  promotes	  inducible	  expression	  of	  OLE1.	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  (A)	  Synthetic	  lethality	  of	  rsp5-­1	  and	  ubx2∆	  mutations.	  Five-­‐fold	  serial	  dilutions	  of	  WT,	  rsp5-­1,	  ubx2Δ,	  ubx4Δ,	  rsp5-­1	  ubx2∆,	  and	  rsp5-­1	  ubx4∆	  cells	  were	  plated	  on	  YPD	  and	  YPD+0.2%	  oleic	  acid	  and	  incubated	  at	  30°C	  or	  37°C	  for	  two	  days.	  (B,C)	  Expression	  of	  OLE1	  mRNA	  in	  ubx2∆	  cells	  grown	  in	  YPD	  (B)	  or	  grown	  first	  in	  YPD	  +0.2%	  oleic	  acid	  and	  shifted	  to	  YPD	  for	  two	  hours	  (C).	  RNA	  from	  cells	  grown	  to	  log-­‐phase	  in	  YPD	  medium	  was	  used	  for	  qPCR	  to	  assess	  OLE1	  mRNA	  levels.	  Values	  were	  normalized	  to	  ACT1.	  Error	  bars	  denote	  SD;	  n=2.	  (D)	  Toxicity	  due	  to	  Spt23	  and	  Mga2	  overexpression	  is	  suppressed	  by	  ubx2Δ.	  WT,	  ubx2Δ,	  and	  ubx4Δ	  strains	  transformed	  with	  a	  2	  µm	  plasmid	  that	  contains	  either	  GAL-­SPT23	  or	  GAL-­MGA2	  were	  plated	  onto	  YPD	  and	  synthetic	  dextrose-­‐	  or	  galactose-­‐	  containing	  media	  and	  grown	  for	  4	  days	  at	  30°C.	  	  
Figure	  3.5	  	  Ubx2	  regulates	  processing	  and	  stability	  of	  the	  transcription	  factor	  Spt23.	  (A)	  Steady	  state	  level	  of	  Spt23	  in	  OLE1	  pathway	  mutants.	  The	  indicated	  mutant	  strains	  expressing	  mycSpt23V5	  from	  the	  endogenous	  locus	  were	  grown	  in	  YPD	  at	  30°C	  unless	  indicated	  otherwise,	  and	  cell	  lysates	  were	  fractionated	  by	  SDS-­‐PAGE	  and	  immunoblotted	  with	  anti-­‐myc,	  anti-­‐V5,	  and	  anti-­‐tubulin	  antibodies.	  (B)	  Steady	  state	  levels	  of	  Spt23	  in	  ubx∆	  mutants.	  The	  indicated	  strains	  were	  analyzed	  as	  in	  (A).	  (C)	  Influence	  of	  Ubx2’s	  UBA	  and	  UBX	  domains	  on	  the	  steady-­‐state	  level	  of	  Spt23.	  Same	  as	  (A)	  except	  that	  strains	  in	  lanes	  2-­‐6	  were	  ubx2∆	  bearing	  a	  copy	  of	  full-­‐length	  (FL)	  
UBX2	  or	  a	  version	  lacking	  the	  indicated	  domain	  integrated	  at	  LEU2.	  (D)	  Effect	  of	  UFAs	  on	  modification	  and	  processing	  of	  Spt23	  in	  various	  mutants.	  Same	  as	  (A)	  except	  that	  strains	  were	  grown	  in	  normal	  medium	  or	  medium	  supplemented	  with	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  0.2%	  oleic	  acid	  as	  indicated.	  (E)	  Role	  of	  Ubx2	  and	  Cdc48	  in	  p90	  degradation.	  Wild-­‐	  type,	  ubx2Δ,	  and	  cdc48-­3	  cells	  expressing	  mycSpt23V5	  from	  the	  endogenous	  locus	  were	  grown	  in	  YPD	  at	  30°C	  (left	  panels)	  or	  at	  25°C	  followed	  by	  a	  shift	  to	  37°C	  for	  2	  hours	  (right	  panels)	  prior	  to	  addition	  of	  cycloheximide	  to	  initiate	  a	  chase.	  At	  the	  indicated	  times	  cells	  were	  harvested	  and	  processed	  for	  SDS-­‐PAGE	  followed	  by	  immunoblotting	  with	  anti-­‐myc,	  or	  anti-­‐tubulin	  antibodies.	  	  
Figure	  3.6	  Ubx2	  interacts	  with	  the	  Spt23	  and	  influences	  its	  subcellular	  localization.	  	  (A)	  Ubx2	  directly	  interacts	  with	  Spt23	  and	  Rsp5.	  RJD	  6173	  cells	  expressing	  Ubx2TAP	  from	  the	  natural	  locus	  were	  grown	  at	  30°C	  in	  YP	  plus	  2%	  galactose	  to	  induce	  expression	  of	  Spt23.	  Native	  cell	  lysates	  were	  subjected	  to	  anti-­‐TAP	  immunoprecipitation	  (IP)	  and	  the	  immunoprecipitates	  and	  input	  lysates	  were	  immunoblotted	  (IB)	  for	  mycSpt23HA,	  Cdc48,	  Ufd1,	  and	  Rsp5.	  Input	  extracts	  were	  also	  blotted	  for	  tubulin.	  (B)	  Immunofluorescence	  localization	  of	  Spt23	  in	  WT	  and	  ubx2Δ	  cells.	  WT	  (RJD	  6172)	  and	  ubx2Δ	  (RJD	  6182)	  cells	  expressing	  Spt23	  from	  the	  GAL	  promoter	  were	  grown	  at	  30°C	  for	  6	  hours	  in	  YP	  plus	  2%	  galactose.	  All	  forms	  of	  Spt23	  containing	  an	  intact	  N-­‐terminus	  were	  detected	  by	  the	  anti-­‐myc	  antibody	  and	  the	  nucleus	  was	  marked	  by	  staining	  DNA	  with	  DAPI.	  (C)	  Quantification	  of	  percent	  of	  cell	  population	  from	  (B)	  that	  contain	  Spt23	  punctae.	  Seven	  fields	  of	  ~300	  cells	  were	  counted	  per	  strain.	  Error	  bars	  denote	  SD.	  	  
	  
Supplemental	  Figure	  3.1	  Reproducibility	  of	  biological	  replicates.	  
	  	  
84	  (A)	  Pairwise	  comparisons	  of	  three	  independent	  cdc48-­3:WT	  analyses,	  demonstrating	  low	  coefficients	  of	  variation	  between	  biological	  replicates.	  (B)	  Same	  as	  (A),	  except	  two	  independent	  analyses	  for	  each	  of	  the	  ubx∆	  mutants	  are	  plotted.	  In	  these	  replicates	  the	  SILAC	  labels	  were	  switched,	  hence	  the	  negative	  correlation.	  	  
Supplemental	  Figure	  3.2	  Curation	  of	  Ub	  conjugates	  and	  overlap	  with	  previous	  screens	  listed	  in	  SCUD.	  (A)	  2-­‐D	  plot	  of	  protein	  ratios	  from	  the	  His8Ub	  tagged	  vs	  untagged	  control	  experiment	  (x-­‐axis)	  and	  the	  WT	  His8Ub	  vs	  WT	  His8Ub	  control	  (y-­‐axis).	  Proteins	  that	  were	  recovered	  in	  significantly	  greater	  amounts	  (p-­‐value	  <	  0.05)	  from	  the	  His8Ub	  expressing	  cells	  in	  the	  tagged	  vs	  untagged	  control	  experiment	  and	  whose	  tagged	  vs	  tagged	  ratios	  did	  not	  differ	  by	  significantly	  greater	  than	  10%	  (p-­‐value	  ≥	  0.01)	  were	  deemed	  candidate	  Ub	  conjugates.	  (B)	  Overlap	  of	  Ub	  conjugates	  in	  the	  SCUD	  database	  with	  those	  identified	  in	  this	  publication.	  	  
Supplemental	  Figure	  3.3	  Changes	  in	  the	  Ub	  proteome	  in	  cdc48-­3	  mutants.	  (A)	  Box	  and	  whisker	  plot	  of	  annotation	  terms	  demonstrating	  a	  significant	  enrichment	  in	  the	  Ub	  proteome	  for	  a	  majority	  of	  their	  identified	  members	  in	  the	  
cdc48-­3	  mutant	  relative	  to	  WT.	  Significance	  is	  defined	  as	  the	  probability	  that	  a	  random	  subset	  of	  cdc48-­3	  proteins	  ratios	  would	  have	  a	  25th	  percentile	  at	  least	  as	  high	  as	  the	  25th	  percentile	  of	  the	  ratios	  of	  proteins	  annotated	  with	  the	  term.	  Enriched	  GO	  Cellular	  Component	  (CC)	  and	  GO	  Biological	  Process	  (BP)	  terms	  are	  shown.	  (B)	  Fold	  changes	  in	  enzymes	  of	  the	  Ubiqutin	  Proteasome	  System.	  Error	  bars	  indicate	  the	  standard	  error	  of	  the	  ratios	  and	  asterisks	  indicate	  significant	  deviation	  
	  	  
85	  from	  1:1	  (p-­‐value	  <	  0.05	  after	  correction	  by	  the	  Bejamini	  and	  Hochberg	  method).	  Colors	  indicate	  magnitude	  of	  change.	  
Supplemental	  Figure	  3.4	  Changes	  in	  the	  Ub	  proteome	  in	  ubx∆	  mutants.	  	  (A-­E)	  Box	  and	  whisker	  plots	  of	  annotation	  terms	  demonstrating	  a	  significant	  enrichment	  in	  the	  Ub	  proteome	  for	  a	  majority	  of	  their	  identified	  members	  in	  the	  corresponding	  ubx	  mutant.	  Significance	  is	  defined	  as	  the	  probability	  that	  a	  random	  subset	  of	  ubxΔ:WT	  protein	  ratios	  would	  have	  a	  25th	  percentile	  at	  least	  as	  high	  as	  the	  25th	  percentile	  of	  the	  ratios	  of	  proteins	  annotated	  with	  the	  term.	  Enriched	  GO	  Cellular	  Component	  (CC),	  GO	  Biological	  Process	  (BP),	  GO	  Molecular	  Function	  (MF),	  KEGG	  Pathway	  (KFFF),	  Uniprot	  Sequence	  feature	  (SF),	  Uniprot	  Keyword	  (KW),	  and	  Protein	  Superfamily	  (PIR)	  terms	  are	  shown.	  
Supplemental	  Figure	  3.5	  Orthogonal	  validation	  of	  Mga2	  ubiquitin	  conjugate	  accumulation.	  WT,	  ubx2Δ,	  and	  






Figure	  3.1	  Sequencing	  and	  quantification	  of	  the	  ubiquitin	  proteome	  reveals	  proteins	  regulated	  by	  Cdc48	  and	  its	  UBX	  domain	  adaptors.	  

























































































































Figure	  3.4	  Ubx2	  promotes	  inducible	  expression	  of	  OLE1.	  


































































































































































































































































































































































































Supplemental	  Figure	  3.4	  Changes	  in	  the	  Ub	  proteome	  in	  ubx∆	  mutants.	  	  
	  
A.   ubx3Δ
B.   ubx4Δ
C.   ubx5Δ
D.   ubx6Δ
E.   ubx7Δ
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Supplemental	  Table	  3.1	  Strains	  used	  in	  this	  study.	  	  Strain	   Genotype	   Source	  RJD	  4614	   his3Δ1,	  leu2Δ0,	  met15Δ0,	  ura3Δ0,	  lys2Δ0,	  MATa	   Open	  Biosystems	  RJD	  6137	  	  	   his3Δ1,	  leu2Δ0,	  met15Δ0,	  ura3Δ0,	  lys2Δ0	  ubx2::KANMX	  MATa	  	   Open	  Biosystems	  RJD	  6138	  	  	   his3Δ1,	  leu2Δ0,	  met15Δ0,	  ura3Δ0,	  lys2Δ0,	  SPT23::MYC-­SPT23-­V5[HIS]	  MATa	   This	  study	  RJD	  6139	  	  	   his3Δ1,	  leu2Δ0,	  met15Δ0,	  ura3Δ0,	  lys2Δ0,	  SPT23::MYC-­SPT23-­V5[HIS],	  ubx2::KANMX	  
MATa	  
This	  study	  
RJD	  6140	  	  	   his3Δ1,	  leu2Δ0,	  met15Δ0,	  ura3Δ0,	  lys2Δ0,	  SPT23::MYC-­SPT23-­V5[HIS],	  ubx1::KANMX	  
MATa	  
This	  study	  
RJD	  6141	  	  	   his3Δ1,	  leu2Δ0,	  met15Δ0,	  ura3Δ0,	  lys2Δ0,	  SPT23::MYC-­SPT23-­V5[HIS],	  ubx3::KANMX	  
MATa	  
This	  study	  
RJD	  6142	  	   his3Δ1,	  leu2Δ0,	  met15Δ0,	  ura3Δ0,	  lys2Δ0,	  SPT23::MYC-­SPT23-­V5[HIS],	  ubx4::KANMX	  
MATa	  
This	  study	  
RJD	  6143	  	  	   his3Δ1,	  leu2Δ0,	  met15Δ0,	  ura3Δ0,	  lys2Δ0,	  SPT23::MYC-­SPT23-­V5[HIS],	  ubx5::KANMX	  
MATa	  
This	  study	  
RJD	  6144	  	  	   his3Δ1,	  leu2Δ0,	  met15Δ0,	  ura3Δ0,	  lys2Δ0,	  SPT23::MYC-­SPT23-­V5[HIS],	  ubx6::KANMX	  
MATa	  
This	  study	  
RJD	  6145	  	   his3Δ1,	  leu2Δ0,	  met15Δ0,	  ura3Δ0,	  lys2Δ0,	  SPT23::MYC-­SPT23-­V5[HIS],	  ubx7::KANMX	  
MATa	  
This	  study	  
RJD	  6146	  	  	   his3Δ1,	  leu2Δ0,	  met15Δ0,	  ura3Δ0,	  lys2Δ0,	  SPT23::MYC-­SPT23-­V5[HIS],	  ubx2::KANMX	  ,	  
ubx4::NATMX,	  MATa	  
This	  study	  
RJD	  6147	  	  	   his3Δ1,	  leu2Δ0,	  met15Δ0,	  ura3Δ0,	  lys2Δ0,	  SPT23::MYC-­SPT23-­V5[HIS],	  ubx2::KANMX,	  
ubx4::KANMX	  MATa	  
This	  study	  
RJD	  4781	   CAN1,	  lys2::HISMX,	  arg4::KANMX,	  leu2-­3,-­112	  
his3-­11,-­15,	  trp1-­1,	  ura3-­1,	  ade2-­1,	  [pRS316-­
His8-­Ubiqutin],	  MATa	  
D.	  Chan	  
RJD	  4977	   cdc48-­3,	  CAN1,	  lys2::HISMX,	  arg4::KANMX,	  leu2-­ This	  study	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3,-­112	  his3-­11,-­15,	  trp1-­1,	  ura3-­1,	  ade2-­1,	  
[pRS316-­His8-­Ubiqutin],	  MATa	  RJD	  6148	  	  	   his3Δ1,	  leu2Δ0,	  met15Δ0,	  ura3Δ0,	  lys2Δ0,	  arg4::HYG,	  [pRS316-­His8-­Ubiqutin],	  MATa	   This	  study	  RJD	  6149	  	  	   his3Δ1,	  leu2Δ0,	  met15Δ0,	  ura3Δ0,	  lys2Δ0,	  arg4::HYG,	  ubx2::KANMX,	  [pRS316-­His8-­
Ubiqutin],	  MATa	  
This	  study	  
RJD	  6150	  	  	   his3Δ1,	  leu2Δ0,	  met15Δ0,	  ura3Δ0,	  lys2Δ0,	  arg4::HYG,	  ubx3::KANMX,	  [pRS316-­His8-­
Ubiqutin],MATa	  
This	  study	  
RJD	  6151	  	  	   his3Δ1,	  leu2Δ0,	  met15Δ0,	  ura3Δ0,	  lys2Δ0,	  arg4::HYG,	  ubx4::KANMX,	  [pRS316-­His8-­
Ubiqutin],	  MATa	  
This	  study	  	  
RJD	  6152	  	   his3Δ1,	  leu2Δ0,	  met15Δ0,	  ura3Δ0,	  lys2Δ0,	  arg4::HYG,	  ubx5::KANMX,	  [pRS316-­His8-­
Ubiqutin],	  MATa	  
This	  study	  
RJD	  6153	  	  	   his3Δ1,	  leu2Δ0,	  met15Δ0,	  ura3Δ0,	  lys2Δ0,	  arg4::HYG,	  ubx6::KANMX,	  [pRS316-­His8-­
Ubiqutin],	  MATa	  
This	  study	  
RJD	  6154	  	   his3Δ1,	  leu2Δ0,	  met15Δ0,	  ura3Δ0,	  lys2Δ0,	  arg4::HYG,	  ubx7::KANMX,	  [pRS316-­His8-­
Ubiqutin],MATa	  
This	  study	  
RJD	  6155	  	  	   his3Δ1,	  leu2Δ0,	  met15Δ0,	  ura3Δ0,	  lys2Δ0,	  [pMGA2-­MYC-­Mga2-­LEU],	  MATa	   This	  study	  RJD	  6156	  	  	   his3Δ1,	  leu2Δ0,	  met15Δ0,	  ura3Δ0,	  lys2Δ0,	  [pMGA2-­MYC-­Mga2-­LEU],	  ubx2::KANMX,	  MATa	   This	  study	  RJD	  6157	  	  	   his3Δ1,	  leu2Δ0,	  met15Δ0,	  ura3Δ0,	  lys2Δ0,	  [pMGA2-­MYC-­Mga2-­LEU],	  ubx4::KANMX,	  MATa	   This	  study	  RJD	  6158	  	  	   his3Δ1,	  leu2Δ0,	  met15Δ0,	  ura3Δ0,	  lys2Δ0,	  ubx2::KANMX,	  rsp5-­1,	  MATa	   This	  study	  RJD	  6159	  	  	   his3Δ1,	  leu2Δ0,	  met15Δ0,	  ura3Δ0,	  lys2Δ0,	  ubx4::KANMX,	  rsp5-­1,	  MATa	   This	  study	  RJD	  4472	   rsp5-­1,	  his4-­914ΔR5,	  lys2-­128Δ,	  ura3-­52,	  GAL2+,	  
MATalpha	  
J.	  Huibregtse	  RJD	  6160	  	  	   his3Δ1,	  leu2Δ0,	  met15Δ0,	  ura3Δ0,	  lys2Δ0,	  rsp5::KANMX,	  MATa	   N.	  Shcherbik	  RJD	  6161	  	  	   his3Δ1,	  leu2Δ0,	  met15Δ0,	  ura3Δ0,	  lys2Δ0,	  [pGAL-­FLAG-­SPT23-­HA-­URA3],	  MATa	   This	  Study	  RJD	  6162	  	  	   his3Δ1,	  leu2Δ0,	  met15Δ0,	  ura3Δ0,	  lys2Δ0,	  [pGAL-­FLAG-­SPT23-­HA-­URA3],	  ubx2::KANMX,	  MATa	   This	  Study	  RJD	  6163	  	  	   his3Δ1,	  leu2Δ0,	  met15Δ0,	  ura3Δ0,	  lys2Δ0,	  [pGAL-­FLAG-­SPT23-­HA-­URA3],	  ubx4::KAN,	  MATa	   This	  Study	  RJD	  6164	  	  	   his3Δ1,	  leu2Δ0,	  met15Δ0,	  ura3Δ0,	  lys2Δ0,	  [pGAL-­FLAG-­MGA2-­HA-­URA3],	  MATa	   This	  Study	  RJD	  6165	  	   his3Δ1,	  leu2Δ0,	  met15Δ0,	  ura3Δ0,	  lys2Δ0,	  [pGAL-­ This	  study	  
	  	  
99	  	   FLAG-­MGA2-­HA-­URA3],	  ubx2::KAN,	  MATa	  RJD	  6166	  	  	   his3Δ1,	  leu2Δ0,	  met15Δ0,	  ura3Δ0,	  lys2Δ0,	  [pGAL-­FLAG-­MGA2-­HA-­URA3],	  ubx4::KAN,	  MATa	   This	  study	  RJD	  6167	  	   his3Δ1,	  leu2Δ0,	  met15Δ0,	  ura3Δ0,	  lys2Δ0,	  SPT23::MYC-­SPT23-­V5[HIS],	  cdc48-­3,	  MATa	   This	  study	  RJD	  6168	  	  	   his3Δ1,	  leu2Δ0,	  met15Δ0,	  ura3Δ0,	  lys2Δ0,	  SPT23::MYC-­SPT23-­V5[HIS],	  npl4-­1,	  MATa	   This	  study	  RJD	  6169	  	  	   his3Δ1,	  leu2Δ0,	  met15Δ0,	  ura3Δ0,	  lys2Δ0,	  SPT23::MYC-­SPT23-­V5[HIS],	  ufd1-­2,	  MATa	   This	  study	  RJD	  6170	  	  	   his3Δ1,	  leu2Δ0,	  met15Δ0,	  ura3Δ0,	  lys2Δ0,	  SPT23::MYC-­SPT23-­V5[HIS],	  cim3-­1,	  MATa	   This	  study	  RJD	  6171	  	  	   his3Δ1,	  leu2Δ0,	  met15Δ0,	  ura3Δ0,	  lys2Δ0,	  SPT23::MYC-­SPT23-­V5[HIS],	  rsp5-­1,	  MATa	   This	  study	  RJD	  3166	   his3Δ1,	  leu2Δ0,	  met15Δ0,	  ura3Δ0,	  lys2Δ0,	  
sel1::SEL1-­TAP-­HIS3MX,	  MATa	  
Open	  Biosystems	  RJD	  6172	  	   his3Δ1,	  leu2Δ0,	  met15Δ0,	  ura3-­1,	  lys2Δ0,	  ura3::pGAL-­MYC-­SPT23-­HA,	  MATa	   This	  study	  RJD	  6173	  	  	   his3Δ1,	  leu2Δ0,	  met15Δ0,	  ura3-­1,	  lys2Δ0,	  ura3::pGAL-­MYC-­SPT23-­HA,	  sel1::SEL1-­TAP-­
HIS3MX,	  	  MATa	  
This	  study	  
RJD	  6174	  	  	   his3Δ1,	  leu2Δ0,	  met15Δ0,	  ura3Δ0,	  lys2Δ0,	  ubx2::KANMX,	  leu::pUBX2-­UBX2(FL),	  MATa	   C.	  Wang	  RJD	  6175	  	  	   his3Δ1,	  leu2Δ0,	  met15Δ0,	  ura3Δ0,	  lys2Δ0,	  SPT23::MYC-­SPT23-­V5[HIS],	  ubx2::KANMX,	  
leu::pUBX2-­UBX2(FL),	  MATa	  
This	  Study	  
RJD	  6176	  	   his3Δ1,	  leu2Δ0,	  met15Δ0,	  ura3Δ0,	  lys2Δ0,	  ubx2::KANMX,	  leu::pUBX2-­UBX2(ΔUBA),	  MATa	   C.	  Wang	  RJD	  6177	  	   his3Δ1,	  leu2Δ0,	  met15Δ0,	  ura3Δ0,	  lys2Δ0,	  ubx2::KANMX,	  SPT23:MYC-­SPT23-­V5[HIS],	  
leu::pUBX2-­UBX2(ΔUBA),	  MATa	  
This	  Study	  
RJD	  6178	  	   his3Δ1,	  leu2Δ0,	  met15Δ0,	  ura3Δ0,	  lys2Δ0,	  ubx2::KANMX,	  leu::pUBX2-­UBX2(ΔUBX),	  MATa	   C.	  Wang	  RJD	  6179	  	  	   his3Δ1,	  leu2Δ0,	  met15Δ0,	  ura3Δ0,	  lys2Δ0,	  ubx2::KANMX,	  SPT23:MYC-­SPT23-­V5[HIS],	  
leu::pUBX2-­UBX2(ΔUBX),	  MATa	  
This	  Study	  
RJD	  6180	  	   his3Δ1,	  leu2Δ0,	  met15Δ0,	  ura3Δ0,	  lys2Δ0,	  ubx2::KANMX,	  leu::pUBX2-­UBX2(ΔUBAΔUBX),	  
MATa	  
C.	  Wang	  
RJD	  6181	  	   his3Δ1,	  leu2Δ0,	  met15Δ0,	  ura3Δ0,	  lys2Δ0,	  ubx2::KANMX,	  SPT23:MYC-­SPT23-­V5[HIS],	  
leu::pUBX2-­UBX2(ΔUBAΔUBX),	  MATa	  
This	  Study	  
RJD	  6182	  	   his3Δ1,	  leu2Δ0,	  met15Δ0,	  ura3-­1,	  lys2Δ0,	  pGAL-­MYC-­SPT23-­HA::URA,	  ubx2::KANMX,	  MATa	   This	  Study	  RJD	  6183	  	   his3Δ1,	  leu2Δ0,	  met15Δ0,	  ura3Δ0,	  lys2Δ0,	  arg4::HYG,	  MATa	  	   This	  Study	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  RJD	  5246	   his3Δ1,	  leu2Δ0,	  met15Δ0,	  ura3Δ0,	  lys2Δ0	  
ubx4::KANMX,	  MATa	  
Open	  Biosystems	  RJD	  5772	   his3Δ1,	  leu2Δ0,	  met15Δ0,	  ura3Δ0,	  lys2Δ0	  
ubx2::KANMX,	  ubx4::KANMX,	  MATa	  
This	  Study	  	   	  	  
Supplemental	  Table	  3.2	  Plasmids	  used	  in	  this	  study.	  Plasmid	   Description	   Source	  RDB	  2818	   MYC-­MGA2	  in	  YEPlac181	   S.	  Jentsch	  RDB	  2819	   GAL-­MYC-­SPT23-­HA	  in	  YIPlac211	   S.	  Jentsch	  RDB	  1937	   GAL-­FLAG-­SPT23-­HA	  in	  YEPlac181	   D.	  Haines	  RDB	  1938	   GAL-­FLAG-­MGA2-­HA	  in	  YEPlac181	   D.	  Haines	  RDB	  1851	   HIS8-­Ubiquitin	  in	  pRS316	   Our	  Laboratory	  	  	  
Supplemental	  Table	  3.3	  Primers	  used	  for	  quantitative	  PCR	  in	  this	  study.	  	  Gene	   Forward	  Primer	   Reverse	  Primer	  ACT1	   5’	  -­‐CTGCCGGTATTGACCAAACT-­‐3’	   5’-­‐CGGTGATTTCCTTTTGCATT-­‐3’	  OLE1	   5’-­‐TAATGGGCTCCAAGGAAATG-­‐3’	   5’-­‐CATGGTTGTTCGGAGATGTG-­‐3’	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Summary	  	   The	  goal	  of	  this	  dissertation	  was	  to	  implement	  and	  optimize	  a	  quantitative	  mass	  spectrometry-­‐based	  method	  to	  monitor	  changes	  in	  Saccharomyces	  cerevisiae	  protein	  levels	  on	  a	  proteome-­‐wide	  scale.	  Secondly,	  this	  technique	  was	  then	  used	  to	  survey	  changes	  in	  the	  ubiquitin	  proteome	  in	  cdc48	  and	  ubx	  mutants	  in	  an	  effort	  to	  better	  understand	  their	  functions	  in	  the	  cell	  and	  discover	  potential	  new	  substrates.	  	  	   One	  of	  the	  major	  contributions	  of	  this	  work	  lies	  in	  the	  implementation	  of	  the	  aforementioned	  deep-­‐sequencing	  method.	  This	  cutting-­‐edge	  technology	  has	  a	  myriad	  of	  applications	  and	  leaves	  Caltech	  capable	  of	  quantitative	  sequencing	  of	  the	  highest	  caliber.	  	  	  	   Secondly,	  our	  proteomic	  screen	  provided	  both	  confirmation	  of	  and	  new	  insight	  into	  the	  roles	  of	  Cdc48	  and	  its	  Ubx	  adaptors	  in	  the	  cell.	  	  Our	  dataset	  contained	  1,196	  ratios	  for	  ubiquitinated	  proteins	  identified	  in	  at	  least	  one	  mutant	  experiment	  and	  1,733	  ubiquitinated	  proteins	  identified	  across	  all	  experiments.	  Our	  study	  covered	  over	  50%	  of	  the	  previously	  identified	  ubiquitinated	  proteins	  in	  the	  SCUD	  database	  and	  included	  1,226	  proteins	  not	  previously	  listed.	  These	  values	  suggest	  that	  we	  sampled	  a	  substantial	  portion	  of	  the	  yeast	  ubiquitinated	  proteome	  and	  in	  more	  depth	  than	  previously	  ever	  done.	  Notably,	  different	  ubx	  mutants	  exhibited	  reproducible	  patterns	  that	  differed	  greatly	  from	  each	  other.	  This	  supported	  the	  long-­‐standing	  hypothesis	  that	  individual	  Ubx	  proteins	  target	  distinct	  sets	  of	  ubiquitin	  conjugates	  and	  have	  functional	  specializations.	  This	  is	  consistent	  with	  their	  roles	  as	  substrate	  adaptors	  for	  the	  Cdc48	  engine.	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   Lastly,	  our	  findings	  also	  demonstrated	  the	  general	  value	  of	  proteomics	  and	  its	  utility	  to	  identify	  ligands	  for	  specific	  ubiquitin	  receptor	  pathways.	  Our	  list	  of	  changing	  ubiquitinated	  proteins	  among	  cdc48	  and	  ubx	  mutants	  provided	  a	  large	  catalog	  of	  potential	  substrates/targets	  and	  suggested	  new	  functions	  of	  the	  Ubx	  adaptors.	  Some	  of	  the	  key	  findings	  for	  Cdc48	  and	  the	  Ubx	  adaptors	  are	  listed	  below.	  	  Cdc48:	  Mutation	  of	  Cdc48	  had	  the	  largest	  effect	  on	  the	  ubiquitinated	  proteome.	  The	  
cdc48-­3	  dataset	  encompassed	  many	  known	  targets	  of	  Cdc48	  including	  the	  transcription	  factors	  Mga2	  and	  Spt23,	  HMG-­‐CoA	  reductases	  Hmg2,	  and	  the	  Rpb1	  subunit	  of	  the	  RNA	  Polymerase	  II[52,	  73,	  76,	  136].	  Additionally,	  the	  cdc48-­3	  conjugates	  were	  highly	  enriched	  for	  proteins	  of	  the	  endomembrane	  system	  and,	  very	  interestingly,	  multiple	  E3	  ubiquitin	  ligases	  and	  F-­‐box	  proteins.	  	  	  Ubx2:	  Deletion	  of	  UBX2	  also	  had	  a	  large	  effect	  on	  the	  ubiquitinated	  proteome.	  These	  strains	  showed	  a	  significant	  enrichment	  of	  ubiquitinated	  vacuolar	  and	  transport	  proteins,	  and	  proteins	  involved	  in	  fatty	  acid	  metabolism,	  including	  Spt23	  and	  Mga2.	  	  Ubx5:	  Ubiquitin	  conjugates	  that	  were	  elevated	  in	  ubx5Δ	  cells	  showed	  a	  strong	  enrichment	  for	  vacuolar	  and	  plasma	  membrane	  proteins.	  	  Ubx6	  and	  Ubx7:	  Close	  homologs,	  ubx6Δ	  and	  ubx7Δ,	  displayed	  a	  significant	  overlap	  with	  over	  85%	  of	  ubiquitin	  conjugates	  accumulating	  ubx7Δ	  also	  accumulating	  in	  
ubx6Δ.	  Consistent	  with	  Ubx6	  and	  Ubx7	  localizing	  to	  the	  nucleus	  and	  nuclear	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  periphery,	  the	  accumulating	  conjugates	  displayed	  enrichment	  for	  nucleolar	  and	  ribosomal	  proteins.	  	  	   To	  validate	  some	  of	  these	  mass	  spectrometric	  findings,	  we	  studied	  in	  detail	  the	  transcription	  factor	  Spt23,	  which	  was	  identified,	  as	  mentioned	  above,	  as	  a	  putative	  Ubx2	  substrate.	  Cdc48	  had	  already	  been	  linked	  to	  the	  promotion	  of	  release	  of	  Spt23	  and	  Mga2	  from	  the	  ER	  membrane[75,	  78].	  However,	  Ubx	  proteins	  had	  not	  been	  previously	  linked	  to	  this	  pathway.	  Our	  work	  demonstrated	  Ubx2	  as	  a	  regulator	  of	  processing	  and	  stability	  of	  Spt23.	  This	  work	  identified	  Ubx2	  as	  key	  player	  in	  the	  OLE	  pathway	  and	  as	  such,	  a	  regulator	  of	  cellular	  lipid	  biosynthesis.	  	  
Future	  Directions	  	   The	  proteomic	  screen	  not	  only	  led	  to	  the	  discovery	  of	  Ubx2	  as	  a	  key	  regulator	  in	  lipid	  biosynthesis	  but	  also	  provided	  a	  rich	  resource	  for	  future	  investigations	  related	  to	  the	  functions	  and	  regulation	  of	  the	  Cdc48	  network.	  Several	  key	  findings	  have	  potential	  for	  future	  research	  projects.	  	  	   1) Cdc48	  may	  act	  globally	  in	  the	  extraction	  and/or	  degradation	  of	  ubiquitinated	  F-­‐box	  proteins	  from	  SCF	  complexes.	  Our	  data	  revealed	  that	  cdc48-­3	  cells	  contained	  elevated	  levels	  of	  ubiquitin-­‐conjugated	  forms	  of	  multiple	  E3	  ubiquitin	  ligases	  and	  F-­‐box	  proteins.	  This	  idea	  is	  consistent	  with	  a	  recent	  finding	  of	  Cdc48	  as	  an	  SCFMet30	  disassembly	  factor[137].	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